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ABSTRACT OF DISSERTATION 
ROLE OF CAVEOLIN-1 AND NRF2 IN  
NUTRITIONAL MODULATION OF PCB TOXICITY 
Cardiovascular disease is the leading cause of mortality in Western societies and 
is linked to multiple modifiable risk factors including lifestyle choices. Emerging evidence 
implicates exposure to persistent environmental pollutants, such as polychlorinated 
biphenyls (PCBs), as a risk factor for the development or progression of cardiovascular 
disease. To reduce disease risks, it is critical to identify sensible means of biomedically 
reducing the toxicity of persistent organic pollutants and related environmental stressors. 
First, we tested a hypothesis that endothelial cell inflammation and subsequent 
cardiovascular toxicity initiated by coplanar PCBs is modulated by the crosstalk between 
caveolae and Nuclear factor (erythroid-derived 2)-like 2(Nrf2) related proteins. Caveolae 
are lipid-enriched organelles found abundantly in endothelial cells and are important 
mediators of endocytosis and signal transduction. Caveolin-1 (Cav-1), the major 
structural protein of caveolae, is known to bind and concentrate multiple proteins related 
to cardiovascular disease and PCB toxicity. Downregulation of Cav-1 protects against 
PCB-induced vascular toxicity, but possible mechanisms of this defense remain elusive. 
Studies using endothelial cells isolated from mice deficient in Cav-1 as well as in vitro 
silencing assays demonstrated that loss of Cav-1 increases available antioxidant 
enzymes by upregulating the antioxidant master controller Nrf2.   
Nutritional interventions focused on diets high in bioactive food components, 
such as polyphenols or certain fatty acids, may prove to be effective at decreasing 
environmental pollutant induced diseases. To test the hypothesis that dietary 
intervention can sensitize Nrf2 and/or caveolae signaling pathways, leading to a more 
effective anti-inflammatory defense against PCB insults, mice were fed a green tea 
polyphenol enriched diet and challenged with coplanar PCB 126. Mice fed an enriched 
diet and exposed to PCBs exhibited lower levels of oxidative stress and higher levels of 
multiple Nrf2 target antioxidant enzymes. Also, in separate in vitro studies, pretreatment 
of endothelial cells with the endogenously formed nutrient metabolite, nitro-linoleic acid, 
altered caveolae and Nrf2 related proteins, resulting in a modified response to PCB 
exposure. Together, these data support the paradigm that nutritional modulation may be 
a sensible means of reducing disease risks associated with exposure to environmental 
pollutants.   
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Chapter one: Introduction 
1.1 Background 
1.1.1 Risk factors for atherosclerosis and cardiovascular disease progression 
Cardiovascular disease (CVD) is the leading cause of death in the United States 
for both men and women and is associated with multiple modifiable and non-modifiable 
risk factors.  CVD however is not a singular pathology but a group of disorders 
encompassing the heart, blood vessels, and associated tissues.  Risk factors such as 
dyslipidemia, hypertension, obesity, sedentary lifestyle, and cigarette smoking have long 
been known to correlate with CVD, but recently nontraditional risk factors such as 
inflammatory status, insulin resistance, and genetic predisposition have emerged as 
additional important variables to identify and modulate in patients1.  Although CVD is a 
broad and diverse pathology, there is evidence that an underlying condition called 
atherosclerosis may play a key role.   
Atherosclerosis is a chronic inflammatory disease that can begin early on in life 
and eventually lead to blood vessel blockage and cardiac events such as stroke and 
myocardial infarction.  Atherosclerosis is initiated when the lining of the blood vessel 
becomes damaged or activated by exogenous compounds such as lipophilic toxicants or 
by endogenous signaling mediators such as pro-inflammatory cytokines.  This activation 
leads to increased blood flow, which aides in the recruitment of inflammatory blood cells 
such as leukocytes, as well as transcriptional upregeulation of adhesion molecules that 
bind and concentrate the leukocytes2.  Upregulation of endothelial adhesion molecules, 
chemokines, and cytokines such as vascular cell adhesion molecule-1 (VCAM-1) and 
monocyte chemoattractant protein 1 (MCP-1) in an NFκB mediated mechanism is critical 
for monocyte recruitment and infiltration (diapedesis) within the intima of the vessel2.  
Mature monocytes within an early atherosclerotic lesion, known as macrophages, can 
then upregulate receptors critical for the uptake of oxidized lipoproteins such as 
oxidized-LDL3.  These lipid rich macrophages known as foam cells cluster together and 
can lead to fatty streaks and an atheromatous necrotic core4.  As an atheroma 
progresses, nearby smooth muscle cells and macrophages undergo apoptosis which 
creates a “protective” fibrous cap3.  In advanced stages of atherosclerosis, these caps 
may rupture and lead to a possibly deadly thrombotic event3.  Although the hardening 
and thickening of vessel walls (atherosclerosis) requires multiple cell types, endothelial 
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cells appear to be a critical pathological mediator of both early and advanced stages of 
the disease.                   
1.1.2 Vascular endothelial cells- a link between nutrition, toxicology, and 
cardiovascular disease   
Vascular endothelial cells are dynamic modulators of CVD and come in contact 
with heterogenous blood components and stimuli such as a wide assortment of dietary 
nutrients, lipid soluble toxic pollutants, and endogenous pro-inflammatory signals and 
compounds.  Once believed to be a relatively unimportant regulatory cell type, 
endothelial cells are now known to be critical mediators of platelet adherence, 
modulators of vascular tone, regulators of thrombosis, and controllers of immune and 
inflammatory responses 5.  Endothelial cells display semi-permeable characteristics and 
can exert important paracrine and endocrine functions with surrounding smooth muscle 
cells and leukocytes5.  Although endothelial cells create a relatively tight barrier between 
the blood and intima, controlled passage of proteins is possible via vesicular transport 
mechanisms such as lipid raft caveolae-assisted endocytosis2.  Since endothelial cells 
are constantly exposed to blood and associated proteins, it is not surprising that nutrient 
and chemical compounds from the diet may play a critical role in the regulation of 
endothelial cell dysfunction and subsequent cardiovascular disease.   
   Dietary components may directly advantageously or detrimentally modulate 
endothelial cell function.  A large body of evidence implicates certain nutritional choices 
as a means to protect against cardiovascular disease. For example, a highly studied 
class of nutrients known as omega 3 polyunsaturated fatty acids (PUFAs) may protect 
against atherosclerosis and cardiovascular disease by interactions with vascular 
endothelial cells6.  PUFAs such as DHA and EPA found in fish oil may be protective for 
many reasons; they have been shown to decrease expression of endothelial cell 
adhesion molecules, increase protective nitric oxide formation from endothelial cells via 
endothelial cell nitric oxide synthase (eNOS), and reduce the levels of pro-inflammatory 
omega 6 unsaturated fatty acids in phospholipids6.  Linoleic acid, the pro- inflammatory 
parent omega-6 fatty acid has been shown, through an NFκB mediated mechanism, to 
activate endothelial cells, upregulate Interleukin-6 cytokine production, release 
arachidonic acid, and allow for the leaking of albumin between endothelial cells7.  The 
toxicity of linoleic acid deserves further investigation because it is a fatty acid found 
readily in Western diets and has grown in popularity since saturated and trans fat 
sources have been decreased due to highly publicized fears.  Linoleic acid’s pro-
3 
inflammatory nature and endothelial cell toxicity may be attributed to the ability of the 
fatty acid to become oxidized and create detrimental metabolites such as 9- and 13 
hydroxy-octadecadienoic acid (9- and 13-HODE)8.  In addition to diet-derived fatty acids, 
endothelial cells can come into contact with multiple other bioactive food components, 
many of which can be described as polyphenols or flavonoids.  For example the major 
bioactive component of green tea, epigallocatechin-3-gallate (EGCG) has been found at 
concentrations of 0.1- 1.0 µM in human plasma and has been shown to not only act as 
an antioxidant, but can directly bind to at least one specific receptor, (e.g., the laminin 
receptor) which is found on endothelial cells9.  This paradigm that endothelial cells can 
directly sense and react to their ever changing plasma environment deserves much 
further investigation, but interestingly, the scope of this environmental sensing may not 
be limited to bioactive nutrients. 
    Accompanying nutrients from the diet, many lipophilic persistent organic 
pollutants (POPs) are also distributed throughout the body via blood flow and plasma 
proteins.  Developing a body burden of POPs is not rare; for example, in studies 
attempting to identify the concentrations of multiple pollutant compounds in human 
plasma, it is not uncommon for the researchers to find known toxicants in 99-100% of 
their test subjects in the parts per billion range (ppb)10.  Also, due to their lipophilic 
nature, many POPs such as polychlorinated biphenyls (PCBs) and other 
organochlorines can sequester within adipose tissue creating a large storage bank of 
highly concentrated toxicants which can be released in a steady state or acute time 
frame (e.g., weight loss)11.  Not surprisingly, many of these manmade compounds have 
been shown to interact and activate endothelial cells; some causing toxicity via many of 
the same mechanisms as detrimental nutrient components.  For example, certain 
toxicants such as PCBs have been shown to increase oxidative stress, upregulate 
NFκB, and lead to endothelial cell dysfunction and inflammation12.  Due to 
commonalities between certain dietary nutrients and toxicants in regards to activation of 
endothelial cells, more research describing the interplay between nutrition and toxicology 
is critical to better understand the risks of environmental pollutants in a world of multiple 
concomitant stressors.    
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1.1.3 Polychlorinated biphenyls – an overview13 
Polychlorinated biphenyls are a diverse class of manmade chemicals that have 
been outlawed in the United States since the 1970’s, but still pose toxicological risks due 
to their persistence to environmental degradation14.  Marketed for their effective thermal 
and electrical properties, PCBs became commonplace in capacitors, caulking, and 
hydraulic fluids but have become notorious for their correlations to multiple human 
toxicities ranging from endocrine disruption to vascular inflammation15.  A major source 
of human exposure to PCBs is through dietary intake of contaminated foods and through 
inhalation of airborne pollutants16.  Because most halogenated POPs, including PCBs, 
are lipid soluble, they easily accumulate in human tissues, leading to a perpetually 
increasing disease risk throughout a life span, especially in overweight populations17.    
PCBs are detrimental to multiple target organ systems and tissue types16, but the 
breadth of this dissertation will focus on vascular related toxicity.  Of the 209 individual 
congeners that were manufactured, coplanar PCBs, which lack chlorine substitutions on 
ortho positions of both phenyl rings, are most toxic to the endothelium and associated 
vasculature18.  These non-ortho substituted PCBs such as PCB 77 and PCB 126 are 
able to, much like dioxin, bind to the aryl-hydrocarbon receptor (AhR) found within 
vascular endothelial cells and increase reactive oxygen species (ROS) through 
cytochrome P450 1A1 (CYP1A1)-mediated uncoupling12b, 12c.  Mechanistically, an 
increase in cellular oxidative stress often precedes an inflammatory response19.  
CYP1A1 induction allows for the detoxification of multiple xenobiotics, but when in the 
presence of PCB, can become inefficient and leaky (i.e., uncoupled) and produce 
detrimental reactive oxygen species20. A hallmark of the pathology of vascular diseases, 
including atherosclerosis, includes a change in the cellular redox status and a resultant 
increase in oxidative stress, which favors chronic and low level inflammation21.  There is 
sufficient evidence that POPs contribute to inflammation by activating oxidative stress-
sensitive transcription factors such as nuclear factor kappa-light-chain-enhancer of 
activated B cells (NFκB)22.  For example, our previous studies suggest that PCBs, and in 
particular coplanar PCBs, can increase cellular oxidative stress and induce inflammatory 
parameters such as inflammatory cytokines, chemokines, and adhesion molecules in the 
vascular endothelium, which are metabolic events that foster an inflammatory response 
and atherosclerosis12c, 22-23.  Through these pro-inflammatory mechanisms, PCBs and 
related environmental toxicants have been correlated with increased risk of multiple 
human chronic disease phenotypes including myocardial infarction, diabetes, stroke, and 
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hypertension24.  Historically, epidemiological studies have been focused on occupational 
exposures such as those that occurred with Swedish capacitor workers in the mid-20th 
century, but it is becoming clearer that chronic low dose exposure may pose the most 
risk for the general public25.  For example, populations most at risk for chronic exposure 
are those that ingest high levels of fatty fish due to the fact that PCBs preferentially 
bioaccumulate in adipose tissue and thus can be transported vertically through the food 
chain24c, 26.  Although Inuit populations have been observed to have 3.4-fold higher 
plasma PCB levels than Caucasians, low ppb concentrations are common for the 
general United States population27.  Importantly, according to National Health and 
Nutrition Examination Survey (NHANES) there appears to be an association with plasma 
levels of PCBs and cardiovascular disease in women in the United States28.  Although 
these association studies are far from causative and can only correlate levels of PCBs 
with disease outcome, there are human studies that show PCB exposure can alter blood 
lipid profiles and increase total blood cholesterol and triglycerides, lending merit to the 
paradigm that environmental toxicants can promote or exacerbate vascular pathologies 
in humans24c.  
1.1.4 Epidemiological links between PCBs and cardiovascular disease 
Cardiovascular disease (CVD) is a non-communicable disease that 
encompasses a group of disorders of the heart and blood vessels including coronary 
heart disease, cerebrovascular disease, peripheral arterial disease, rheumatic heart 
disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism29. 
The World Health Organization estimates that 17.3 million people died from 
cardiovascular diseases (CVD) in 2008 alone, accounting for 30% of global deaths and 
serving as the number one cause of death globally30.  Several risk factors and 
associated diseases including type 2 diabetes, hypertension, obesity, sedentary lifestyle, 
and over nutrition can contribute to the pathology of CVD.  Furthermore, environmental 
pollutants, such as PCBs, can thus contribute to CVD directly or indirectly via promotion 
of these and other risk factors and associated diseases.  Considering the significant 
burden that CVDs have on global mortality, it is imperative to explore and assess factors 
that may promote or exacerbate the pathogenesis of these diseases30. The goal of this 
section, then, is to summarize current epidemiological findings linking environmental 
exposures to PCBs with the development of CVD. 
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Type 2 diabetes 
 In 2000, an estimated 171 million people were diagnosed with diabetes; this 
estimate is expected to increase to 366 million by the year 203031. Diabetes mellitus is 
characterized by poorly regulated high blood glucose levels and is primarily categorized 
into two groups, type 1 and type 2. Although most epidemiological studies do not 
distinguish between type 1 and type 2 diabetes, it is estimated that type 2 diabetes 
accounts for 90-95% of all diabetes cases32. Among patients with type 2 diabetes, CVD 
is the major cause of death, with more than 60% of patient deaths associated with 
myocardial infarction and stroke33. In addition, adults with diabetes have a 2 to 4-fold 
increased risk of CVD-related events compared to those without diabetes34 and are at 
substantially higher risk for developing CVD35. 
Increasingly, data and an expanding body of literature are associating PCB 
exposure with heightened risk and incidence of type 2 diabetes development 36.  These 
studies involve a variety of cohorts and subject ages, suggesting that PCB exposure 
increase type 2 diabetes risk regardless of age or cohort. In addition to type 2 diabetes, 
PCBs also have been implicated in the development of gestational diabetes. Serum 
concentrations of PCB 138 and PCB 180 were associated with increased 2-hour glucose 
levels and PCB 180 with increased immunoreactive insulin levels, suggesting that PCBs 
contribute to insulin resistance in these mothers37. Gestational diabetes, characterized 
by the development of any degree of glucose intolerance in mothers during pregnancy, 
occurs during approximately 7% of pregnancies, or 200,000 cases annually. Women 
who develop gestational diabetes are at an increased risk for the development of type 2 
diabetes after pregnancy38. 
While the molecular mechanisms that regulate the development of type 2 
diabetes from PCB exposure remain elusive, several recent studies have shed light on 
this subject. Some, like the gestational diabetes paper, have proposed the development 
of insulin resistance as the mechanism by which PCBs cause type 2 diabetes36d, 37, 39. 
One recent study suggests that PCBs exhibit toxic effects by adversely affecting insulin 
producing β-cells in the pancreas as opposed to simply decreasing insulin sensitivity40. 
Additional studies have reported no association with exposure and insulin resistance41, 
suggesting that the observed inverse relationship between PCB exposure and serum 
insulin40 is indicative of β-cell toxicity. Impaired fasting glucose tests have also been 
reported to be associated with PCB exposure42.  It has also been suggested that PCBs 
may modulate adiponectin levels, leading to increased rates of type 2 diabetes 
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development43. Adiponectin is a hormone produced by adipocytes that is significantly 
reduced in patients with insulin resistance, and is suggested as a strong predictor of type 
2 diabetes43a. Studies have shown a negative correlation between plasma levels of 
adiponectin and plasma PCB 153 concentrations, which may explain the role of PCB 
exposure in the development of type 2 diabetes43-44. Additionally, PCB exposure has 
been associated with a decreased production of insulin growth factor I, providing another 
potential link between exposure to environmental pollutants such as PCBs and 
increased risk for the development of type 2 diabetes45.  
Hypertension 
Of the 17.3 million deaths attributed to CVD in 2008, complications associated with 
hypertension, or high blood pressure, accounted for roughly half (9.4 million) of those 
deaths. Even more significant, these 2008 data indicated that 40% of all adults 
worldwide (aged 25 and above) had been diagnosed with hypertension, an increase 
from 600 million reported cases in 1980 to 1 billion cases in 2008. This drastic rise in 
rates of hypertension has been attributed to a number of factors including poor nutrition, 
lack of physical activity, and exposure to persistent chemical stressors46.  
Growing epidemiological evidence is substantiating a link between exposure to PCBs 
and increased risk of hypertension. The National Health and Nutrition Examination 
Survey (NHANES) data set has been a significant source of information on the 
association between hypertension and PCB exposure. Two recent studies showed that 
serum PCB levels were significantly associated with hypertension47 and that serum PCB 
levels were, on average, higher among individuals with hypertension47b. Additional 
studies of NHANES data have indicated that dioxin-like PCB put a person at a higher 
risk for hypertension than non-dioxin-like PCBs, but that the arrangement of chlorines 
may also be an important factor36c, 48. 
While the NHANES data set has provided a wealth of information, a variety of 
epidemiological studies involving different cohorts have also found similar associations 
between PCB exposure and an increased risk of hypertension. Two studies of the 
Anniston, Alabama cohort, a group of 758 participants residing near the original 
Monsanto Corporation PCB manufacturing site, showed a correlation between rates of 
hypertension and serum PCB concentration49, and that other than age, total serum 
PCBs were the strongest determinant of blood pressure level in 394 participants50 
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Additionally, a study of 1,374 Japanese residents substantiated these findings with their 
own data indicating that serum levels of dioxin-like PCBs are directly correlated with high 
blood pressure51. Finally, hospital discharge rates for hypertension for residents living in 
upstate New York in zip codes with POP contaminated sites were increased by 19.2%, 
although it is worth noting that these POP sites contained PCBs in addition to other 
pollutants52.  
Studies analyzing the correlation between PCB exposure and rates of 
hypertension have been performed with sample sizes from 59 participants to 12,20047a, 
50, 53. With the exception of one, all studies found a significant relationship. Studies with 
sample sizes of 394 participants and above have shown a positive relationship between 
PCB serum level and rate of hypertension. An older study, with a significantly smaller 
sample of 59 participants failed to find a correlation53a, suggesting sample size, as well 
as technological limitations, may have influenced the these findings. 
Obesity 
While atherosclerosis and hypertension are the most common risk factors for the 
development of cardiovascular disease, obesity serves as a primary modulator of these 
diseases and has been implicated heavily in CVD development54. Limited information 
has implicated PCB exposure in the etiology of obesity development, with primary 
correlations drawn from laboratory studies14, 55 as well as from multiple epidemiological 
studies that have shown an association that warrants further examination56.  
Epidemiological studies into the association of PCB exposure and the 
development of obesity primarily have relied upon the comparison of serum PCB levels 
and body mass index (BMI) or birth weight, although studies have yielded mixed results. 
An interesting prospective study of 12,313 non-obese participants in the Seguimiento 
Universidad de Navarra (SUN) cohort showed that after a median 8.1 years there were 
621 new incidences of obesity among these participants, with a direct correlation seen 
between increased dietary PCB intake (estimated from an earlier study of dioxin-like 
PCB concentrations in food) and incidences of obesity56a.  Additional studies of 
adolescent and adult patients have reported total PCB56b, 57 and congener-specific58 
obesity modulation, while others have found no correlation59 or even an inverse 
association60, indicating the complexity of this question. These discrepancies, and 
especially data indicating an inverse relationship between obesity rates and level of PCB 
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exposure, are likely due to bioaccumulation of highly lipophilic PCBs in human and 
animal fat tissue44, 61 leaving low and/or inconsistent levels of PCB remaining in serum 
samples for analysis. This suggests that serum PCB concentration measurement may 
not provide an accurate estimate of a subject’s PCB exposure or body burden that 
contributes to obesity risk factors. Recent weight loss or gain may also significantly alter 
the measured concentration of PCBs, which would also impact findings. While there are 
still many questions about the role of PCBs in modulating obesity risk factors, growing 
epidemiological evidence along with in vitro and in vivo findings have implicated PCBs 
as a part of a much larger group of environmental pollutants that act as obesogens, or 
chemicals capable of inappropriately activating molecular pathways that induce 
adipocyte differentiation and lead to a predisposition to obesity through dysfunctional 
weight-control62.  
 
Dyslipidemia 
 Dyslipidemia refers to a wide array of lipid abnormalities that can be causative in 
the development of CVD. Efforts to prevent CVD have focused significant effort on 
addressing dyslipidemia because it is readily modifiable by lifestyle changes and drug 
therapies, most notably statins63. There is compelling evidence that decreasing total 
cholesterol (TC), triglycerides (TG), and low-density lipoproteins (LDL) can help 
markedly reduce a patient’s risk of CVD35, 64.  Similar to findings on the association 
between obesity and PCB exposure, the most compelling and complete evidence comes 
from laboratory studies65.  For instance, ApoE (-/-) mice injected with PCB 77 exhibited 
increased serum cholesterol and atherosclerosis14.  Although the small volume of 
epidemiological literature directly examining a potential causal relationship between 
dyslipidemia and PCB exposure is certainly a limiting factor, serum lipid measurements 
are widely published within much larger analyses that implicate environmental stressors 
more broadly in metabolic dysfunction. Despite these limitations, though, there is 
epidemiological evidence suggesting PCB exposure may contribute to dyslipidemia24c, 39, 
51. Among the contributors to dyslipidemia, elevated TG levels has been most 
consistently associated with PCB exposure42, 66. Increases in both LDL67 and total 
cholesterol53b, 67a, 68 have also been reported, although there are findings of no 
correlation66b.  An inverse relationship between PCB exposure and high-density 
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lipoproteins (HDL) has also been shown66c, 67b which is significant considering that 
increasing levels of HDL are associated with a decrease in cardiovascular disease risk69 
 
 
1.1.5 Mechanisms of coplanar PCB-induced vascular inflammation – a focus on 
the Aryl hydrocarbon receptor  
 
Coplanar PCBs activate the AhR and cause increased oxidative stress and inflammation 
The toxicity of coplanar PCBs, such as PCBs 77 and 126, is primarily induced 
through constant basal activation of the aryl hydrocarbon receptor (AhR), a transcription 
factor involved in xenobiotic metabolism. As a so-called orphan receptor, AhR has no 
associated high-affinity endogenous ligands, but rather binds to a wide array of ligands 
that include PCBs70. Without a ligand present, AhR exists in the cytoplasm of cells as 
an inactive complex with a heat-shock protein (Hsp90) as well as other co-chaperone 
proteins such as the p23 protein71. Once bound to a ligand, AhR translocates into the 
nucleus, dissociates from both Hsp90s and its co-chaperone proteins, and forms a 
heterodimer with the aryl hydrocarbon receptor nuclear translocator (ARNT). The AhR-
ARNT complex then binds to a xenobiotic responsive element (XRE) in the promoter 
region of the target genes72.  A large number of drug-metabolizing enzymes are 
induced as a result of AhR activation, including the phase I (oxidation), phase II 
(conjugation), and transporters of the phase III (excretion) metabolic pathways. The 
activation of these enzymes results in AhR ligands inducing their own metabolism and 
clearance from the body70. This, combined with the fact that AhR is a relatively 
ubiquitous protein that is expressed in most bodily tissues, has resulted in AhR being 
recognized as the body’s primary molecular defense when presented with an 
environmental toxin73. Previous work has demonstrated that coplanar PCBs are 
capable of acting as AhR agonists12b, 22, 73. The toxicity that is then caused by these 
coplanar PCBs while stimulating AhR is often attributed to the release of reactive 
oxygen species (ROS) and the subsequent increase in oxidative stress20.  It has been 
suggested that ROS-induced oxidative stress in conjunction with coplanar PCB 
exposure is the result of increased expression of, and eventual uncoupling of 
cytochrome P450 1A subfamily (CYP1A1)20a, 22. The metabolism of PCBs by 
cytochrome P450 enzymes involves a catalytic cycle of reactions that produce 
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metabolites of the parent compound74. The metabolism of PCBs is a slow process and, 
unlike many other drugs, the metabolites produced are not currently thought to be a 
major source of toxicity20a.  The sluggish rate of PCB oxidation, though, causes the 
uncoupling of the CYP1A1 catalytic cycle and allows ROS to leak out of the active site, 
causing oxidative stress. Increased amounts of oxidative stress have been shown to be 
heavily involved in many of the risk factors for cardiovascular disease75, including the 
development of atherosclerosis76. In addition to increasing oxidative stress, ROS also 
accelerate the degradation of nitric oxide, which impairs vasorelaxation by the 
endothelium and is often referred to as endothelial dysfunction77. Patients with coronary 
heart disease and increased endothelial dysfunction were shown to have an increased 
risk of cardiovascular events, demonstrating the importance of oxidative stress in 
cardiovascular disease78.  
In addition to increasing oxidative stress, coplanar PCBs acting as AhR agonists 
also induce cellular inflammation that is largely mediated by nuclear factor κB (NF-κB)22, 
79. Previous research has shown that activation of NF-κB drives expression of target 
genes that activate immune response mechanisms, ultimately resulting in the release of 
proinflammatory cytokines and adhesion molecules that attract immune cells to 
modulate pollutant-induced toxicity80. These effects, combined with oxidative stress 
associated with ROS, have been shown to be atherogenic81. The compensatory 
mechanism intended to help combat these effects, known as the nuclear factor 
(erythroid-derived 2)-like 2 (Nrf2) antioxidant response pathway, regulates the response 
to oxidative stress and, once activated by ROS, Nrf2 protein binds to antioxidant 
response elements on target genes, leading to their upregulated expression. These 
target genes include xenobiotic metabolizing enzymes, such as glutathione S-
transferases (GSTs), and many cytochrome P450s (CYPs), as well as antioxidant 
enzymes, NAD(P)H: quinone oxidoreductase-1 (NQO1)82. 
 
Role of AhR in cardiovascular disease  
 As seen in multiple epidemiological and laboratory studies, AhR ligands such as 
dioxins and coplanar PCBs can negatively affect the cardiovascular system and lead to 
phenotypes including hypertension and atherosclerosis83.  Although the AhR’s main 
evolutionary role may be to control detoxification and excretion of xenobiotic 
compounds, emerging evidence now shows a role for the AhR in endogenous 
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physiological functions.  AhR is found in many cell types and tissues including placenta, 
lung, heart, and liver and can be activated by many non-toxicant ligands including 
arachidonic acid metabolites, heme metabolites, and LDL84.  AhR knockout animals 
display developmental abnormalities, especially related to the vasculature.  For example, 
deficient mice display aberrant hepatovascular and ocular blood flow due to improper 
developmental blood vessel formation84b.  Xenobiotic and endogenous ligands may also 
promote aberrant blood pressure regulation through an AhR mediated mechanism.  AhR 
null mice have been shown to have elevated angiotensin II and endothelin 1 levels which 
are known to be linked with hypertension, but these differences may also be related to 
specific environmental conditions such as geographic elevation84a.  Interestingly, 
circulating AhR expression levels have been used as a surrogate biomarker for coronary 
arterial disease in certain populations, and specific AhR polymorphisms have been 
linked to a greater likelihood of developing the disease85.  With an obvious role in proper 
mammalian development, early life exposures that alter AhR signaling may play a critical 
role in the toxicities of many environmental pollutants.   
 
Cross-talk between AhR and other toxicant-related signaling proteins  
AhR is known to cross-talk with multiple signaling partners, many of which are 
involved with inflammation and detoxification of xenobiotics.  AhR has been shown to 
directly or indirectly alter the signaling of multiple proteins including hypoxia inducible 
factor (HIF), constitutive androstane receptor (CAR), estrogen receptor (ER), NFκB, 
caveolin-1, and Nrf212b, 86.  Although this may make deciphering the mechanisms of 
toxicity of environmental pollutants difficult, cross-talk between many of these pathways 
makes physiological sense.  For example, many POPs including coplanar PCBs activate 
AhR and subsequent Phase 1 detoxification enzymes; while simultaneously activating 
Nrf2 and subsequent Phase 2 and 3 detoxification enzymes.  Thus, AhR and Nrf2 
pathways work concurrently to more effectively excrete and decrease the toxicity of 
pollutants.  Mechanistically, the Nrf2 promotor contains AhR binding elements, whereas 
the AhR promotor contain Nrf2 binding elements86b.  Also, certain compounds known as 
“bifunctional inducers”, such as β-napthoflavone, can activate AhR first, and only 
activate Nrf2 once CYP1A transforms the compound to a reactive intermediate86b.      
Cross-talk between AhR and NFκB is a complicated area of study, but one that 
deserves further investigation.  Overall, it appears that NFκB suppresses AhR and AhR-
   
13 
 
regulated CYP1A1 induction, but this is not universally agreed upon in the literature87.  
Directly, NFκB can act as a transcription factor and bind cis-acting sequences in the AhR 
promoter, leading to upregulation of CYP1A1 and related genes87b.  Interestingly, NFκB 
has been shown to upregulate multiple cytochrome p450s directly.  This upregulation 
has been shown to be due to multiple non-AhR mediated mechanisms including 
transcriptional and post-transcriptional means87b.  However, it has also been shown that 
NFκB can directly suppress AhR-mediated pathways leading to exacerbated toxic 
responses in a preexisting inflammatory environment87a.  This inhibitory cross-talk, is still 
controversial, as opposite effects are seen in certain cell types.  Cell signaling pathways 
related to inflammation and xenobiotics are incredibly intertwined which makes it difficult 
if not futile to determine a direct mechanism of toxicant-induced disease.  For example, 
CYP1A1 activation has long be studied and used as a surrogate/biomarker for AhR 
ligand binding.  However, as more information related to the complicated cross-talk 
between these signaling pathways emerges, a larger view of mechanistic toxicology, 
including the roles of other AhR-related signaling pathways must be utilized to better 
understand all of the interactions. 
 
1.1.6 Caveolae, Caveolin-1, and PCB-induced endothelial cell dysfunction  
 
Caveolae are flask shaped organelles found primarily at the plasma membrane in 
endothelial cells, adipocytes, and other cell types88.  Caveolae are composed of primarily 
cholesterol and sphingolipids, whereas the majority of plasma membrane is made up of 
phospholipids89.  Caveolae have historically been believed to be primarily an 
endocytosis mediator, but emerging evidence implicates caveolae as a critical regulator 
of signaling transduction90.  In fact, numerous proteins have been shown to be 
associated with/concentrated in caveolae membranes (see table 1.1).  Important 
structural proteins of caveolae called caveolins (1, 2, or 3) are known to bind cholesterol, 
fatty acids, and many signal transduction related proteins88-89, 91.  Caveolin-1 (Cav-1) has 
two important domains. The central domain contains 33 hydrophobic amino acids which 
act as a membrane anchor allowing for a hairpin structure that points both the N- and C-
termini toward the cytoplasm92.  The second important domain, known as the “Cav-1 
binding domain”, allows for Cav-1 to bind itself as well as many other proteins92.   Cav-1, 
a major component of endothelial cell caveolae, has been known to directly bind, and 
modulate many proteins related to inflammation, redox sensing, and cardiovascular 
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disease88, 90, 93.  This has lead multiple research groups to examine the therapeutic 
potential of downregulating caveolin-1.   
Due to their high abundance in cell and tissue types related to cardiovascular 
diseases, caveolae may have an important role in the pathogenesis of vascular disease.  
The creation of whole body knock out animals has allowed researchers to identify links 
between Cav-1 and caveolae to non-communicable diseases such as atherosclerosis 
and cancer90, 93.  Currently, it appears that loss of Cav-1 may have protective or 
detrimental effects depending on what cell type, organ system, or disease pathology one 
is interested in92-94.  Specifically relevant to this dissertation however, decreasing Cav-1 
most likely is protective against the early stages of atherosclerosis and endothelial cell 
dysfunction93-94. 
Decreasing Cav-1 protects against atherosclerosis by multiple mechanisms.  
Over a decade ago it was determined that Cav-1 knockout animals had protection 
against atherosclerosis94.  Early work showed that Cav-1-null mice bred with ApoE 
knockouts (spontaneously develop atherosclerosis) displayed a pro-atherogenic lipid 
profile, but interestingly showed dramatic decreases in lesion formation and decreased 
levels of pro-inflammatory adhesion molecules94.  This protection may be due to 
decreased transcytosis of LDL particles across endothelial cells.  In fact, some studies 
have shown upwards of 50% reduction in LDL uptake in cells lacking Cav-193.  Most of 
the anti-atherosclerotic phenotype may be due to loss of Cav-1 in endothelial cells95.  A 
recent study clearly showed that overexpression of Cav-1 only in endothelial cells 
accelerated atherosclerosis as evidenced by increased levels of VCAM-1 in the vessel 
wall, increased atheroma formation, and decreased nitric oxide production95.  Cav-1 has 
also been shown to regulate the expression of pro-inflammatory receptors such as TNF-
α96.  Taken together, a growing body of evidence now implicates a decrease in 
endothelial cell Cav-1 as anti-inflammatory and protective against the early stages of 
atherosclerosis.  Previous work in our laboratory has also identified a role for Cav-1 and 
caveolae in PCB-induced endothelial cell toxicity. 
 Since PCBs are highly lipophilic we previously hypothesized a role relating lipid raft 
microdomain caveolae and associated proteins to PCB-induced vascular toxicity.  Using 
cellular fractionation techniques and subsequently GC-MS to quantify PCB levels, we 
determined that PCBs selectively accumulate in caveolae12b and induce pro-
inflammatory genes associated with caveolae.  For example, we determined that PCB 
77, a coplanar PCB, promotes phosphorylation of Cav-1 and subsequent 
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phosphorylation of eNOS, which when dysfunctional, can lead to the creation of reactive 
nitrogen species97. It is also known that AhR is critical for PCB-induced inflammation. 
Using an immunoprecipitation analysis, we determined that coplanar PCBs increase 
AhR binding to Cav-1 and that silencing of Cav-1(siRNA) attenuated PCB-mediated 
induction of CYP1A1, oxidative stress, and MCP-112b, 23b.  In vivo, we exposed ApoE-/- 
mice to coplanar PCB (49 mg/kg), and observed higher overall cholesterol levels, serum 
dyslipidemia and greater atherosclerotic lesion size.  We demonstrated via real time 
PCR that PCB 77 treatment increased both aortic mRNA expression levels of MCP-1 in 
LDL-R−/− mice and plasma protein levels of MCP-1, suggesting that coplanar PCBs 
induce cellular dysfunction in vivo. However, no MCP-1 induction was detected in mice 
deficient in both LDL-R and Cav-1 genes23b. Similarly, Cav-1 KO mice did not induce the 
pro-inflammatory cytokines interleukin-6 (IL-6)23b when exposed to coplanar PCB. These 
findings imply that the loss of Cav-1 is protective of the earliest stages of PCB-induced 
inflammation and atherosclerosis.  The mechanisms of this protection have remained 
elusive, however, interesting data has now linked loss of Cav-1 to an increase in 
protective antioxidant enzymes via an upregulated Nrf2 response98 
    
 
1.1.7 The role of Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)  in protecting 
against PCB-induced oxidative stress and vascular inflammation  
Physiological systems have evolved multiple mechanisms of protection against 
xenobiotics and reactive oxygen species.  Nrf2 has been shown to be a redox sensitive 
master regulator of antioxidant enzymes and plays an integral role in cellular protection 
against persistent environmental pollutants such as PCBs.  There are multiple 
mechanisms of Nrf2 activation, including direct phosphorylation of Nrf2 by PKC delta 
and loss of contact between Nrf2 and inhibitory kelch-like ECH-associated protein 1 
(Keap-1)99. Upon activation, Nrf2 is able to evade ubiquitination, enter the nucleus, and 
bind cis-acting antioxidant response elements (ARE) in target genes such as heme-
oxygenase 1 (HO-1) and NAD(P)H:quinoneoxidoreductase 1(NQO1)82a. Importantly, 
Nrf2 activation leads to decreased inflammation which is a hallmark of PCB toxicity100.  
Primarily, activation of Nrf2 is regulated through interactions between Keap1.  
Modifications of Keap1 by oxidation or alkylation promotes a conformational change that 
eliminates an important Keap1:Nrf2 molecular connection and allows the protein lifespan 
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of Nrf2 to increase from 7-15 to 30-100 minutes101.  Key residues in Keap1, such as 
Cys151, Cys273, and Cys288, control the interactions between Keap1, Nrf2, and 
ubiquitin ligase E3101.  Genetic deletion of Nrf2 increases sensitivity to oxidants and 
inflammatory agents, whereas activation of the Keap1-Nrf2 pathway allows survival and 
adaptation under various conditions of cellular stress82a, 102, suggesting that Nrf2 is a 
critical player in down-regulating pro-inflammatory genes103. Also, Nrf2 activation can 
play a role in atherosclerosis and vascular disease. 
 Atherosclerosis is a disease of inflammation and oxidative stress so it is not 
surprising that Nrf2 can play modulatory roles.  In certain models of induced-disease, 
Nrf2-null mice display increased production of pro-inflammatory cytokines, chemokines, 
and adhesion molecules such as TNF-α, CXC, and VCAM-1100.  Upregulating Nrf2, 
either via overexpression mechanisms or therapeutically, can decrease these pro-
inflammatory mediators100.  Activation of Nrf2 can lead to an upregulation of HO-1 which 
can suppress lesion formation by limiting the migration of monocytes into the intima104.  
HO-1 upregulation leads to an increase in endogenous antioxidants such as biliverdin 
and bilirubin which have been shown to decrease inflammation in many disease states.  
Interestingly, the endothelial cell response to reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) may have a critical role in the development of 
atherosclerosis.  As blood flows through vessels, a dragging force called fluid shear 
stress can activate enzymes such as NADPH oxidases resulting in the formation of 
superoxide105.  Depending on the location of the vessel as well as other factors, 
endothelial cells may come into contact with disturbed flow or steady laminar flow.  
Disturbed shear stress (oscillatory/turbulent) has been shown to upregulate pro-
inflammatory mediators such as MCP1 whereas laminar shear stress (steady) has been 
shown to be anti-atherogenic by upregulating Nrf2105-106.  Endothelial cell activation of 
Nrf2 appears to be primarily anti-atherosclerotic, and our laboratory and others have 
also shown that Nrf2 is a critical mediator of toxicant-induced inflammation. 
Genetic deletion of Nrf2 increases sensitivity to oxidants and inflammatory agents, 
whereas activation of the Keap1-Nrf2 pathway allows survival and adaptation under 
various conditions of cellular stress82a, 102, suggesting that Nrf2 is a critical player in 
down-regulating pro-inflammatory genes103.  Our data in ECs suggest a regulatory 
function of Nrf2 in PCB 126-mediated induction of CYP1A1, as silencing Nrf2 further 
increased CYP1A1 induction by PCB73b.  Silencing of Nrf2 appears to shut off the 
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cellular defense against PCB toxicity as silencing of Nrf2 also increased inflammatory 
markers, such as MCP-1 and VCAM-1 at basal and post PCB-exposure conditions.  Nrf2 
has also been shown to protect against TCDD-induced oxidative injury and liver 
steatohepatitis, as Nrf2 deficient mice were less capable of preventing fat accumulation, 
lipid peroxidation, impaired adipogenesis, and depletion of glutathione when exposed to 
the toxicant107. Since Nrf2 is more of a redox sensing platform, a wide variety of 
activators have been identified and hypothesized including POPs, metals, nutrients, and 
chemotherapeutics.  Many of these activators may be electrophiles or Michael reaction 
acceptors that can disrupt the Nrf2-Keap1 interactions82a.  Interestingly, certain bioactive 
nutrients may be able to activate Nrf2 prior to a toxicological insult, which may help to 
prevent toxicant-induced disease.    
 
1.1.8 Nutrition as a modulator of environmental pollutant-induced toxicity13  
 
Sub-optimal or unhealthy nutrition modulates the toxicity of environmental pollutants  
 
There is a large collection of evidence pointing to the role that a person’s dietary 
makeup and eating habits can play in the promotion of chronic inflammation, metabolic 
disorders and vascular diseases108.  Additionally, emerging data show that exposure to 
persistent organic pollutants such as PCBs may work in concert with unhealthy diets to 
promote cumulative or synergistic negative effects109.  In fact, POPs and subprime 
nutritional status share mechanisms of disease development including the induction of 
pro-inflammatory pathways.  Interestingly, a growing body of evidence implicates an 
exacerbated toxic effect of PCBs and other environmental pollutants when combined 
with an additive pro-inflammatory dietary environment13b.  Our data support the paradigm 
that a poor nutritional state can exacerbate toxicity associated with exposure to PCBs 
and other persistent organic pollutants (POPs), and taking into account the interactions 
between diet and toxicants will help to better elucidate the impacts that PCBs and 
related compounds have on human health. 
Multiple research groups have shown negative interactions between unhealthy or 
refined diets and environmental pollutants ranging from heavy metals to PCBs.  For 
example, high fat diets appear to intensify arsenic-induced inflammation, 
hepatofibrogenesis, and cancer initiation110, while diets high in saturated fats exacerbate 
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polycyclic aromatic hydrocarbon-induced adenomas111.  Unfortunately, studies that 
investigate the impacts of mixing multiple types of exposures, (e.g. chlorinated pollutants 
and heavy metals) in combination with the added variable of an unhealthy diet are 
lacking.  These types of comprehensive integrated toxicity studies will better mirror real 
world exposure conditions especially for people residing in close proximity to Superfund 
and other hazardous waste sites.   
PCBs are prime pollutant candidates to study the interactions between diet and 
toxicants because they can sequester in adipose for long durations, and exposures are 
due often to ingestion of contaminated foods. Our research has focused on the 
interactions of PCBs and proinflammatory omega-6 fatty acids.  We have shown that 
omega-6 fatty acids, and in particular linoleic acid, can cross-amplify the detrimental 
effects of coplanar PCBs and produce increases in oxidative stress, CYP1A1 induction, 
and endothelial permeability109.   This work was expanded in vivo as we observed 
increased proinflammatory cytokine levels and lipid staining in mice fed oils rich in 
omega-6 fatty acids and exposed to PCB compared to mice exposed to PCB alone112.  
Animal fats such as those found in beef and chicken are significant sources of pro-
inflammatory medium and long-chain omega-6 fatty acids as well as PCBs and other 
related POPs113.    Mechanistically, synergism between unhealthy diets (e.g., high-
fat/high caloric diets) and toxicants makes logical sense because both factors act upon 
many of the same receptors and cell signaling pathways.  For example, omega-6 fatty 
acids and PCBs have both been implicated in inflammatory initiation through AhR, 
cytochrome P450’s, and toll-like receptors (TLRs)114.  With the growing rates of obesity 
and chronic oxidative and inflammatory stress, it is important to more thoroughly 
elucidate interactions between proinflammatory diets and toxicants.    Although it does 
appear that unhealthy nutrition can work in concert with PCBs and related toxicants to 
create an increasingly proinflammatory phenotype, a new paradigm has emerged that 
implicates certain bioactive food components in protection against persistent organic 
pollutant-induced vascular toxicity.   
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Healthful nutrition decreases the toxicity of pro-inflammatory pollutants 
Polychlorinated biphenyls and related Superfund POPs induce chronic oxidative 
stress and disregulated inflammatory responses, but anti-inflammatory nutritional 
antioxidants may buffer and protect against toxicant-induced disease through multiple 
cell signaling mechanisms13b.  Polyphenols and bioactive fatty acids have been shown to 
decrease toxicant-induced maladies including liver diseases, tumor formation and 
growth, and endothelial cell activation13b, 115.  Our work has shown that plant-derived 
flavonoids such as epigallocatechin-3-gallate (EGCG), and long-chain omega-3 fatty 
acids such as docosahexaenoic acid (DHA) can protect cellular systems by decreasing 
pro-inflammatory lipid raft signaling domains called caveolae and by simultaneously 
upregulating antioxidant defenses through increased nuclear factor (erythroid-derived 2)-
like 2 (Nrf2) activation116.   
Polyphenols, for example, are an abundant and diverse class of bioactive 
compounds found in many fruits and vegetables and have been linked to decreased 
toxicity from dioxin and dioxin-like PCBs117.  These ROS scavenging compounds can 
also increase PCB excretion rates118, prevent AhR-induced inflammation73b, limit body 
wasting119 and decrease cellular dysfunction120.  Resveratrol, a well-studied polyphenol, 
has been shown to interact with the primary receptor of coplanar PCBs, AhR, and to limit 
its activation and subsequent proinflammatory signaling cascade121 122.  Other groups 
have shown that bioactive food compounds such as those found in broccoli 
(sulphoraphane) and red wine (resveratrol) can activate Nrf2 through multiple 
mechanisms and decrease oxidative stress levels in cells and in animals123.  A goal of 
our research is to determine the efficacy of causative nutrients or plant-derived bioactive 
compounds found in everyday healthy diets, such as Vitamin E, that can bolster 
protective physiological mechanisms and prevent against PCB-induced vascular 
toxicity115a.  Obviously, most Western diets are not fruit and vegetable focused, so it is 
important to identify and classify lipid-based bioactive compounds as well. 
Omega-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid 
(DHA) and eicosapentaenoic acid (EPA) are the main components of fish oil and have 
been shown to decrease inflammation, reduce vascular diseases, and protect against 
dioxin and PCB-mediated toxicity115b, 124.  Unfortunately, most Western diets lack 
adequate levels of omega-3 PUFAs, and the ratio of unhealthy omega-6 fats to omega-3 
fats is very high115b, 125.  Experimentally, it was determined that diets predominantly made 
up of oils rich in linoleic acid (omega-6) increased PCB-induced cellular dysfunction, but 
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this negative effect was blunted as the ratio favored protective omega-3’s126.  
Interestingly, we have shown that mice fed a DHA-supplemented diet and subsequently 
exposed to coplanar PCB 126 exhibited a more profound antioxidant response as 
observed by higher expression levels of protective heme-oxygenase 1 (HO-1) and 
NAD(P)H:quinoneoxidoreductase 1 (NQO1)127.  This preliminary work illustrates that 
omega-3 PUFAs may help to protect against PCB-induced vascular toxicity by allowing 
for a more efficient and intense endogenous protective response that utilizes multiple 
physiological cell signaling pathways.  Polyunsaturated fatty acids, and especially 
omega-3 fatty acids, as well as their anti-inflammatory breakdown metabolites can 
protect against PCB-induced disease by activating Nrf2 but interestingly also by 
disrupting functional caveolae116a.  Although caveolae and Nrf2 pathways appear to be 
prime candidates for modulation by bioactive food components, more research is 
necessary to better elucidate other novel pathways that can be targeted both in vitro and 
in vivo.         
 
 
Healthful nutrition can decrease body burden of environmental toxicants 
An emerging paradigm implicates healthful nutrition as an effective protective 
modulator of environmental toxicant-induced inflammation and human disease.  Multiple 
laboratories have investigated the decreased toxicities of environmental pollutants due 
to bioactive nutrients such as flavonoids and omega-3 polyunsaturated fatty acids, but 
many of these studies rely on in vitro assays that lack the complexity of a whole body 
organismal approach.  Importantly, emerging classes of bioactive food components such 
as polyphenols also have been shown to modulate the pro-inflammatory effects of 
environmental toxicants.  Our laboratory and others have shown that a wide array of 
phenolic compounds such as EGCG, curcumin and quercetin can decrease toxicant-
induced oxidative stress and inflammation in multiple cell types, tissues and animal 
species118-119, 128.  Although human studies are lacking, strong evidence in animal models 
implicates a protective role for flavonoids and other polyphenols perhaps through the 
induction of antioxidant enzyme pathways and increased fecal excretion rates129. 
Interstingly, plant-derived polyphenols are being found to not only protect against POP-
mediated oxidative stress, inflammation, and toxicity but also to bind to POPs and thus 
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contribute to a decrease in body burden.  In fact, if has been proposed that green tea, 
containing high levels of polyphenols including EGCG,  can inhibit the intestinal 
absorption of lipids and highly lipophilic organic compounds and accelerate excretion of 
PCBs118, 130. 
Certain foods and polluted air can be major sources of toxicant exposures16. 
Thus, altering nutritional choices may prove to effectively modulate risks associated with 
exposure to POPs.  Making informed dietary decisions such as substituting lower fat 
versions of protein sources (e.g. legumes, nuts, or lean meats and dairies) may have 
multiple health benefits including decreased exposure to detrimental pollutants such as 
dioxins and PCBs131.  For many populations it may be difficult or cost-prohibitive to 
change major dietary protein sources; thus, increasing dietary intake of other bioactive 
nutrients may buffer already exposed individuals against the negative ramifications of 
pollutant exposures.  For example, several laboratories have shown that diets high in 
fiber can alter the absorption and excretion rates of pollutants such as PCBs132.  
Mechanistically, multiple dietary fibers have been shown to effectively bind pollutants 
such as dioxins, which may help to explain increased fecal excretion rates, decrease in 
body burden, and observed protection132a.  Increasing excretion of lipophilic toxicants 
through other nutritional compounds such as fat substitutes may also effectively 
decrease risk.  For example, much emphasis including human clinical trials has been 
placed on the interactions between the non-absorbable fat substitute olestra and 
environmental toxicants133.  Researchers determined that low levels of olestra 
supplementation (25 grams/day) increased the excretion of multiple PCBs and related 
contaminants upwards of 11 fold compared to normal diet134.  Interestingly, in a human 
study, an olestra-supplemented diet completely eliminated excessive POP 
concentrations in adipose tissue and reversed POP-mediated clinical conditions such as 
diabetes and hyperlipidemia135.  Diet-derived bioactive compounds such as EGCG are 
attractive modulators of toxic exposure because they may both help to prime the 
physiological system prior to a toxic insult by upregulating protective detoxifying 
enzymes as well as protect therapeutically after exposure by increasing the rate of 
excretion and lowering overall body burden129b.  Altering diets to increase fiber and 
bioactive nutrients from fruits and vegetables is an effective and cost-efficient means of 
modulating POP toxicity. 
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Protective cellular signaling pathways        
Multiple signaling pathways have been attributed to nutritional modulation of 
environmental toxicants, but we have shown that caveolae and the antioxidant master 
controller nuclear factor (erythroid-derived 2)-like 2 (Nrf2) play integral protective roles.  
There is increasing evidence that lipid raft membrane microdomains, i.e. caveolae, may 
play an important role in atherosclerosis, the toxicity of coplanar PCBs, and nutritional 
protection12a, 90, 94.  Caveolae are flask shaped membrane invaginations that are 
important in cholesterol transport, nutrient and xenobiotic import into cells and cellular 
signaling93.  Due to the lipophilicity of PCBs, they may enter the cell through lipid raft 
mediated events or come into contact with caveolae-related signaling proteins.  
Caveolae are abundant in vascular endothelial cells and the cardiovascular system in 
general, which points to a highly probable role for caveolae in inflammation and 
atherosclerosis92. Our laboratory has previously reported that coplanar PCBs promote 
the upregulation of genes related to the activation of endothelial cells and the initial 
stages of atherosclerosis and that the loss of functional caveolae ameliorates these 
detrimental effects97.  Caveolin-1 (Cav-1), the major structural protein of caveolae, 
contains the “Cav-1 binding domain” that is known to bind multiple proteins including 
endothelial nitric oxide-synthase (eNOS), v-src sarcoma (SRC), protein kinase C (PKC), 
extracellular-signal-regulated kinase(ERk) and protein kinase B (Akt); many of which are 
involved in inflammatory pathways90.  For example, downregulation of Cav-1 can lead to 
eNOS activation and subsequent increases in diffusible nitric oxide, which has been 
shown to play a major role in healthy blood pressure and vessel tone12c.  Many 
publications from our laboratory and others show downregulation and elimination of Cav-
1 to be anti-atherosclerotic12b, 23b. Importantly, eliminating Cav-1 prevents PCB-induced 
cellular dysfunction97.  Our data point to Cav-1 as a possible anti-atherosclerotic 
therapeutic target and we hypothesize that nutritional intervention can downregulate 
Cav-1 and, in turn, protect against PCB-induced inflammation. 
Nrf2 is a transcription factor that can upregulate cytoprotective genes in response 
to oxidative stress, xenobiotics, and bioactive food molecules100, 136.  Many nutrients, 
including resveratrol, sulforaphane, and epigallocatechin gallate (EGCG), have been 
shown to activate Nrf2123c, 137. There are multiple mechanisms of Nrf2 activation, 
including direct phosphorylation of Nrf2 by PKC delta and loss of contact between Nrf2 
and inhibitory kelch-like ECH-associated protein 1 (Keap-1)99. Upon activation, Nrf2 is 
able to evade ubiquitination, enter the nucleus, and bind cis-acting antioxidant response 
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elements (ARE) in target genes such as heme-oxygenase 1 (HO-1) and 
NAD(P)H:quinoneoxidoreductase 1(NQO1)82a. Importantly, Nrf2 activation leads to 
decreased inflammation which is a hallmark of PCB toxicity100.  Activation of Nrf2 may 
lead to vascular protection from PCB-induced toxicity and we hypothesize that a diet rich 
in bioactive food components can activate Nrf2 and prevent PCB-induced inflammation. 
Nrf2 has been shown to cross-talk with multiple signaling partners, especially with the 
major player in PCB toxicity, AhR138.  Although it has been known for decades that dioxin 
and dioxin-like compounds activate both AhR- and Nrf2-related genes, it was shown only 
recently that Nrf2 is required for induction of AhR genes such as CYP1A1139.  This 
observed cross-talk can be explained mechanistically at the genetic level by the fact that 
the promoter region for Nrf2 contains AhR binding regions and the gene promoter for 
AhR contains multiple Nrf2 binding elements138.  Our laboratory previously determined 
that AhR is a binding partner of Cav-1, so it is plausible that cross-talk between caveolae 
and Nrf2 signaling pathways also exists12b. 
Little is known about the cross-talk between Nrf2 and caveolae signaling and 
how bioactive compounds such as omega-3 lipids, flavonoids and other polyphenols 
interact to protect against environmental insults.  We have shown that decreasing 
cellular Cav-1 levels results in a more intense antioxidant response.  Mechanistically, we 
attribute this to decreased AhR activity as well as increased Nrf2 activity73b.  Recently, 
an intimate example of cross-talk between Cav-1 and Nrf2 was illustrated140, and our 
published data supports this phenomenon98, 116b.  Using bioactive food components such 
as flavonoids and omega-3 PUFAs may be an economically and logistically beneficial 
method to counteract PCB-induced vascular inflammation.  Although it does appear that 
both caveolae and Nrf2 signaling pathways play an important role in nutritional 
modulation of vascular inflammation, other signaling cascades may also prove to be 
involved.  Phytochemicals may work through multiple mechanisms that upregulate 
protective genes, downregulate pro-inflammatory genes and/or decrease overall 
oxidative stress (Figure1.1).   
           
Emerging and future directions 
 The paradigm of nutritional modulation of environmental toxicants is still new, 
thus many issues remain unresolved.  One critically important area in need of further 
investigation involves the metabolism of protective nutrients.  With the advent of more 
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precise and high-resolution analytical techniques, researchers have finally begun to 
elucidate truly causative bioactive food components.  In a physiological system, both 
nutrients and xenobiotics interact with similar cell signaling molecules and pathways.  
Both nutrients and toxicants are impacted by all aspects of absorption, distribution, 
metabolism and excretion, and understanding how bioactive compounds are altered or 
influenced at each step will allow for more efficient biomodulation.  Specifically, the 
detection and identification of bioactive metabolites is of utmost importance due to the 
fact that many parent compounds are altered and modified in vivo.  As mentioned 
previously, resveratrol is an extensively studied protective phytochemical, and 
exemplifies the necessity of further investigating the roles that bioactive metabolites 
play.  For example, a major limitation with resveratrol supplementation involves poor gut 
absorption of the parent compound and fast metabolism to sulfate and glucuronide 
products141.  However, even with the short half-life of the parent compound, there is a 
large body of evidence associating resveratrol supplementation with protective 
phenotypes in vivo123a.  This has led some research groups to investigate the bioactivity 
of specific metabolites and observed protection via the activation of Sirtuin1(SIRT1) and 
inhibition of cyclooxygenase123a. This is an important finding worthy of further exploration 
because bioactive metabolites, such as the glucuronide and sulfate forms of resveratrol, 
have much longer half-lives than the parent compound, which may qualify the 
metabolites as more appropriate and effective nutritional modulators142.  Also, our 
laboratory has shown that oxidized metabolites of the bioactive omega-3 PUFA DHA are 
more protective against such PCB-induced vascular toxicity compared to the parent 
PUFA116a.  Mechanistically, oxidation of PUFAs can lead to multiple F-type isoprostanes 
with active cyclopentenone rings that have been shown to activate Nrf2, inhibit NFκB, 
and decrease inflammation143. Also, other metabolically-relevant electrophilic fatty acid 
modifications, such as nitro-fatty acids, may play a role in combating inflammation and 
environmental toxicant-induced diseases144.  Nitro-fatty acids are a newly discovered 
class of modified lipids that exhibit anti-inflammatory properties via multiple 
mechanisms145.  Unsubstituted fatty acids such as oleic acid (18:1) and arachidonic acid 
(20:4) can be nitrated endogenously by multiple enzymatic and non-enzymatic reactions, 
resulting in the inhibition of pro-inflammatory mediators, induction of protective heme 
oxygenase-1 and the relaxation of blood vessels146.  This class of bioactive lipid can 
protect via multiple mechanisms including upregulation of PPARγ and Nrf2 as well as 
downregulation of pro-inflammatory NFκB147.  More work needs to be accomplished to 
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elucidate the mechanistic impact of nitro and oxidized PUFAs on vascular inflammation 
and toxicant-induced diseases. It appears that both oxidized PUFAs and nitro-fatty acids 
are anti-inflammatory, which may implicate the importance of bioactive modified lipids in 
a clinical and therapeutic setting.  Although research linking bioactive lipids, vascular 
inflammation and environmental toxicants is lacking, state of the art high-resolution mass 
spectroscopy technologies are beginning to allow researchers to explore the most 
efficient and physiologically-relevant bioactive compounds, which will in turn help further 
the use of nutrition in a clinical and preventative setting.      
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1.2 Scope of Dissertation 
1.2.1  Aims of dissertation 
The general hypothesis of the research described herein is that coplanar PCBs 
can promote cardiovascular disease by modulating endothelial cell caveolae.  We also 
hypothesize that nutritional modulation of PCB-toxicity is modulated through the cross-
talk between caveolae and Nrf2 signaling pathways.  To test these hypotheses the 
following Specific Aims were proposed: 
Specific Aim 1: To test the hypothesis that endothelial PCB toxicity and associated 
inflammatory events are regulated through the crosstalk between caveolae and Nrf2 
related proteins such as Keap1. 
Specific Aim 2:  To test the hypothesis that dietary intervention with green tea 
polyphenols can sensitize Nrf2 and/or caveolae signaling pathways, leading to a more 
effective anti-inflammatory cellular defense/response against PCB insults in vivo. 
Specific Aim 3:  To test the hypothesis that treatment with nutrient metabolites, such as 
nitro-fatty acids, instead of parent compounds will better sensitize Nrf2, caveolae, and/or 
AhR signaling pathways leading to a more effective anti-inflammatory cellular response 
against PCB insults.  
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Table 1.1 Proteins related to inflammation and atherosclerosis that are concentrated in 
caveolae lipid micro-domains88 
. 
Protein 
Name 
Function Related to 
Atherosclerosis 
Cav-1 Inhibits eNOS, cholesterol 
regulation 
SRC Plaque destabilization 
eNOS Vascular tone, Superoxide 
production 
ERK Inflammation 
AhR NFκB induced inflammation 
CD36 Involved in fatty acid uptake 
PKC Inflammation, Vasoconstriction 
ER α 
and β 
Control of eNOS 
SR-B1 HDL scavenger receptor 
gp60 Control of albumin transcytosis 
Fyn Negative regulator of Nrf2 
MMP-
1/2 
Plaque destabilization 
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Fig. 1.1 Nutritional modulation of PCB-induced vascular toxicity.  Bioactive nutrients 
such as certain flavonoids found in fruits and vegetables or bioactive fatty acids such as 
long chain PUFAs may work through caveolae and/or Nrf2 signaling to decrease the 
toxicity of PCBs and related persistent organic pollutants (POPs).  Coplanar PCBs 
induce oxidative stress and inflammation, while certain bioactive food components are 
anti-inflammatory and may be able and decrease the severity of toxicant-induced 
disease. 
Figure 1.2 The configuration and amount of chlorines evident in a specific PCB congener 
relates directly to the molecular mechanism of toxicity of that congener. A. General structure of 
a polychlorinated biphenyl with relevant nomenclature highlighted B. Structure of 3,3’,4,4’,5-
Pentachlorobiphenyl (PCB 126), a coplanar, non-ortho substituted PCB that exerts toxicity 
primarily through the AhR C. Structure of 2,2’,4,4’,5,5’-Hexachlorobiphenyl (PCB 153), a non-
coplanar, di-ortho substituted PCB that does not bind the AhR and exerts toxicity primarily 
through endocrine disruption. 
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Chapter 2: PCB 126 toxicity is modulated by cross-talk between caveolae and Nrf2 
signaling98 
2.1 Synopsis 
Environmental toxicants such as polychlorinated biphenyls (PCBs) have been 
implicated in the promotion of multiple inflammatory disorders including cardiovascular 
disease, but information regarding mechanisms of toxicity and cross-talk between 
relevant cell signaling pathways is lacking. To examine the hypothesis that cross-talk 
between membrane domains called caveolae and nuclear factor (erythroid-derived 2)-
like 2 (Nrf2) pathways alter PCB-induced inflammation, caveolin-1 was silenced in 
vascular endothelial cells, resulting in a decreased PCB-induced inflammatory response. 
Cav-1 silencing (siRNA treatment) also increased levels of Nrf2-ARE transcriptional 
binding, resulting in higher mRNA levels of the antioxidant genes glutathione s-
transferase and NADPH dehydrogenase quinone-1 in both vehicle and PCB-treated 
systems. Along with this upregulated antioxidant response, Cav-1 siRNA treated cells 
exhibited decreased mRNA levels of the Nrf2 inhibitory protein Keap1 in both vehicle 
and PCB-treated samples.  Silencing Cav-1 also decreased protein levels of Nrf2 
inhibitory proteins Keap1 and Fyn kinase, especially in PCB-treated cells.  Further, 
endothelial cells from wildtype and Cav-1-/- mice were isolated and treated with PCB to 
better elucidate the role of functional caveolae in PCB-induced endothelial inflammation. 
Cav-1-/- endothelial cells were protected from PCB-induced cellular dysfunction as 
evidenced by decreased vascular cell adhesion molecule (VCAM-1) protein induction.  
Compared to wildtype cells, Cav-1-/- endothelial cells also allowed for a more effective 
antioxidant response, as observed by higher levels of the antioxidant genes. These data 
demonstrate novel cross-talk mechanisms between Cav-1 and Nrf2 and implicate the 
reduction of Cav-1 as a protective mechanism for PCB-induced cellular dysfunction and 
inflammation.     
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2.2 Introduction 
Exposure to persistent environmental pollutants such as polychlorinated 
biphenyls has been linked to the induction and/or exacerbation of multiple human 
pathologies including diabetes and atherosclerosis24a, 24b, 25b, 49, 148.  Specifically, coplanar 
polychlorinated biphenyls (PCBs) have been shown to initiate the earliest stages of 
atherosclerotic plaque formation, e.g., endothelial cell dysfunction and inflammation12b, 
23b, 97.   
Once utilized extensively for their productive thermal and electrical capabilities, 
the production of PCBs and PCB mixtures, such as aroclors, was banned in the 1970s 
due to further data highlighting their substantive public health concerns149. However, 
PCBs continue to impact ecosystems and human health due to their environmental 
prevalence and persistence (chemical stability)13b.  Additionally, the lipophilic nature of 
coplanar PCBs allows for their interaction with lipid membranes and lipid storage depots, 
leading to bioaccumulation and biomagnification through the food chain.  Even today, 
PCB-containing products continue to be used in developing nations, further exposing 
humans to high occupational levels of these harmful pollutants25a.  In countries such as 
the United States, the primary sources of exposure stem from air pollution and 
contaminated food149a.  Although multiple categories of PCBs have been developed, 
dioxin-like, non-ortho-substituted coplanar PCBs such as PCB 77 and PCB 126 exhibit 
the highest levels of in vitro and in vivo toxicity and pro-inflammatory properties, 
especially in the vasculature18.   
Once believed to be an innate barrier, endothelial cells now appear to play an 
extremely important role in the initiation and progression of atherosclerosis3, 21, 150.  
Coplanar PCBs can further promote endothelial cell inflammation and dysfunction 
through caveolae lipid micro-domains151. Endothelial cell activation can lead to an 
upregulation of adhesion molecules such as Vascular Cell Adhesion Molecule-1 (VCAM-
1) which promotes pro-inflammatory leukocyte infiltration and chemokine production that
left unchecked can lead to the formation of foam cells and subsequent arterial 
blockage152.  Coplanar PCBs can induce oxidative stress in endothelial cells and in turn 
cause the upregulation of pro-inflammatory proteins through an NFκB-mediated 
signaling cascade12b.  Interestingly, it has been shown that PCBs may also be pro-
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atherogenic by activating other pro-inflammatory pathways such as the lipid signaling 
domain caveolae97.  
Lipid raft microdomains known as caveolae are flask-shaped invaginations found 
at the lipid membrane and have been shown to play important roles in endocytosis, 
atherosclerosis, and environmental pollutant toxicity23b, 93.  Caveolin-1 (Cav-1), the major 
structural and signaling protein involved in the caveolae pathway, has been shown 
through its “Cav-1 binding domain” (CBD) to interact and bind multiple other proteins, 
many of which are involved in inflammation and atherosclerosis90, 92, 94.  Coplanar PCBs 
preferentially sequester in caveolae cellular fractions, and exposure to coplanar PCBs 
upregulates Cav-1 protein expression and caveolae formation12b.  Silencing Cav-1 via 
siRNA technology prevents PCB-induced cytochrome P450-mediated superoxide 
production and subsequent endothelial activation and dysfunction12b. Importantly, it has 
been shown that aortic endothelial cells isolated from mice that lack the Cav-1 gene are 
protected from toxicant-induced cellular dysfunction, but the mechanism of this 
protection has yet to be elucidated12a.       
Physiological systems have evolved multiple signaling pathways to limit the 
toxicity of xenobiotics such as PCBs.  The most significant regulator of redox status and 
homeostasis, the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) antioxidant pathway, 
has been shown to be critical in protecting endothelial cells from PCB toxicity73b.  Nrf2 is 
primarily regulated by its major inhibitory protein, iNrf2 or Keap1, which promotes Nrf2’s 
ubiquitination and maintains basal levels of Nrf2 activation. Nrf2 also can be inhibited by 
Fyn kinase, which can promote Nrf2 nuclear exit and degradation153. Nrf2 also can be 
directly activated via phosphorylation by kinases such as Akt and PKC delta99a, 154. Nrf2 
can become activated by xenobiotic electrophiles, reactive oxygen species (ROS), and 
bioactive phytochemicals found in healthful nutrition82a, 100, 123b.  Multiple electrophilic 
bioactive nutrients including components of ginseng, green tea and vegetables such as 
broccoli have been shown to activate Nrf2, but interestingly, different nutrients may 
induce Nrf2 through differing mechanisms (e.g., disruption of Keap1/Nrf2 interaction or 
increased phosphorylation via relevant kinases137a, 155.  Nrf2 has been shown to be 
regulated through the cross-talk of multiple signaling cascade pathways such as the aryl 
hydrocarbon receptor (AhR) and NFκB pathways86b, 138-139.  Many xenobiotics such as 
dioxins and coplanar PCBs can activate both AhR and Nrf2 simultaneously, and in fact, 
this concordant upregulation can be evolutionarily explained since the gene promoter for 
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AhR contains multiple Nrf2 binding elements (AREs) and the promoter for Nrf2 contains 
AhR binding sites (xenobiotic response elements)138.  Evidence for direct cross-talk 
between Nrf2 and NFκB is not as well understood, but multiple studies have shown that 
activation of Nrf2 leads to a diminished pro-inflammatory NFκB response156.  
Interestingly, we have previously shown that the AhR is a binding partner of Cav-112b  
which has led us to hypothesize that novel cross-talk between Cav-1 and Nrf2 could 
exist and that this cross-talk may help to explain mechanistically the protection from 
coplanar PCBs observed in Cav-1 -/- animals.  
Thus, the current study has been designed to investigate mechanistically how the 
cross-talk between Cav-1 and Nrf2 can modulate PCB-induced cellular dysfunction.  Our 
data provide strong evidence that there are multiple levels of Cav-1/Nrf2 cross-talk and 
that Cav-1 inhibits the Nrf2 antioxidant response.  Thus, reduction or downregulation of 
endothelial Cav-1 may lead to an upregulated antioxidant response regulated by Nrf2, 
which could better prime a physiological system prior to toxicological insult. 
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2.3  Materials and Methods: 
2.3.1 Materials and Chemicals 
3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) was obtained from AccuStandard Inc. (New 
Haven, CT).  VCAM-1 and Keap1 primary antibodies and horseradish peroxidase-
conjugated goat secondary antibody were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA).  β-actin and GST primary antibodies were purchased from Sigma (St. 
Louis, MO).  The GST antibody used recognized native as well as denatured-reduced 
forms of GST protein.  NQO1 primary antibody was purchased from Abcam (Cambridge, 
MA).  Fyn kinase, P-Akt, Akt, P-PKC delta and Nrf2 primary antibodies and horseradish 
peroxidase-conjugated rabbit secondary antibody were purchased from Cell Signaling 
Technologies (Danvers, MA).   
2.3.2 Cell culture and experimental media 
Primary vascular endothelial cells were isolated from porcine pulmonary arteries12a. Cells 
were cultured in M199 (Gibco, Grand Island, NY), supplemented with fetal bovine serum 
(FBS; Gibco).  EAhy.926 human endothelial cells were cultured as described 
previously12c.   Endothelial cells were grown to confluence, followed by incubation 
overnight in medium containing 1% FBS prior to cell treatment. Stock solutions of PCB 
126 were prepared in DMSO; control cultures were treated with DMSO vehicle. The 
levels of DMSO in experimental media were 0.05%. Porcine and human endothelial cells 
were treated with PCB 126 at 0.25 μM for 16 h and mouse pulmonary endothelial cells 
were treated with 2.5 μM for 24 h, which are established concentrations used previously 
in our laboratory12a, 73b.  Porcine primary endothelial cells, Eahy.926 human endothelial 
cells, and isolated mouse endothelial cells contained Cav-1 protein levels (wildtype) and 
exhibited VCAM-1 induction due to PCB 126 treatment, as previously reported12b, 12c.  
Endothelial cells isolated from wildtype and Cav-1 -/- mice were identified by 
morphology, platelet endothelial cell adhesion molecule-1 (PECAM1) bead pull-down, 
and Von Willebrand Factor (VWF) protein expression.   
2.3.3 Mouse endothelial cell isolation 
Endothelial cells were isolated from Cav-1 deficient (Cav-1−/−) and wildtype mice (both 
genotypes were purchased from Jackson Laboratory, Bar Harbor, ME). All animals were 
housed in Association for Assessment and Accreditation of Laboratory Animal Care-
certified animal facilities at the University of Kentucky.   Age matched C57BL/6 mice 
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were used as controls because Cav-1-deficient mice are backcrossed onto C57BL/6 
mice.  Endothelial cells were isolated and cultured as described previously157.  Briefly, 
whole lungs were homogenized in culture media containing type II collagenase and 
dispase.  Cells were added to gelatin-coated tissue culture plates in DMEM media 
containing 20% FBS, heparin, antibiotics, and endothelial cell growth supplement.  
Endothelial cells were preferentially selected by using an antibody-coated magnetic 
bead mix (Invitrogen, Carlsbad, CA.  Briefly, sheep anti-rat IgG beads were prepared 
and mixed with rat anti-mouse CD31 PECAM antibodies overnight (BD Biosciences, San 
Jose, CA).  Bead/antibody conjugates were collected via magnetic separation and 
subsequently were incubated for 1 h with cells isolated from lungs.  Cells were then 
trypsinized, transferred to a magnetic separator, and magnetically bound cells were 
seeded in 35mm plates.  Endothelial cell isolation was confirmed by cobblestone 
morphology and the presence of VWF endothelial cell marker.    
2.3.4 Real-time PCR  
The levels of mRNA expression were assessed by real-time PCR using a 7300 Real-
Time PCR System (Applied Biosystems,Foster City, CA) and SYBR Green master mix 
(Applied Biosystems) as described earlier12a. Sequences were designed using the 
Primer Express Software 3.0 for real-time PCR (Applied Biosystems) and synthesized by 
Integrated DNA Technologies, Inc. (Coralville, IA). Sequences for porcine VCAM-1 and 
β-actin were described in earlier articles published from our laboratory23b, 158. Porcine 
NQO1 sequences were: sense, 5′-CCCGGGAACTTTCAGTATCCT-3′; and antisense, 5′-
CTGCGGCTTCCACCTTCTT-3′; porcine GST-omega 1 sequences were: sense, 5′-
GCTGAGCCAAGTGGGAGACA-3′; and antisense, 5′CCTCGGCCATTGAAATAGTGA-
3′; Porcine Keap1 sequences were: sense, 5’ AGCTGGGATGCCTCAGTGTT-3’; and 
antisense, 5’-AGGCAAGTTCTCCCAGACATTC-3’; porcine GPx1 sequences were: 
sense, 5′-TGCCTTCAATCCGGAGGTAA-3′; and antisense, 
5′GAATGGGATGACCTGGAAGTTAGT-3′; porcine MRP1 sequences were: sense, 5′-
GTCCTGTTTGCTGCCTGTT-3′; and antisense, 5′AGTATGCGGTGATCTGCAGTGA-3′; 
2.3.5 Cav-1 siRNA and transfection studies  
Double stranded small interfering RNA targeting Cav-1 was synthesized as described 
previously12c, 159. Porcine endothelial cells and human endothelial cells were transfected 
with control or Cav-1 siRNA at a final concentration of 80 nM using GeneSilencer 
transfection reagent (Genlantis, SanDiego, CA) in OptiMEM serum free media. Cells 
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were incubated with the transfection mixture for 4 h, followed by the addition of 10% FBS 
to the cell media. Cells were used for treatments after 48 h incubation.   
2.3.6 Immunoblotting  
Western blot analyses for VCAM-1, β-actin, NQO1, Keap1, Fyn kinase, GST, Nrf2, P-
PKC delta and P-Akt were performed as described previously12a.  Briefly, cells were 
lysed in RIPA buffer, centrifuged and the protein concentrations were determined via 
Bradford Assay.  Proteins were separated via 10% SDS-PAGE, transferred to 
nitrocellulose membranes, and blocked in 5% non-fat milk or BSA.  Primary antibodies 
were added at a concentration of 1:1000 overnight and appropriate secondary 
antibodies subsequently were added for 2 h at a concentration of 1:4000.   
2.3.7 Preparation of nuclear extracts and electrophoretic mobility shift assay (EMSA) 
Nuclear extracts of endothelial cells were prepared using NE-PER nuclear extraction 
reagents (Thermo, Rockford, IL) according to the manufacturer’s protocol. Nuclear 
extract concentrations were determined using Bradford reagent (Bio-Rad, Richmond, 
CA). DNA binding activities of Nrf2 were determined using a LightShift 
Chemiluminescent EMSA kit (Pierce, Rockford, IL) according to the manufacturer’s 
protocol. DNA-binding reactions were performed with a final volume of 20 µL buffer 
containing 5 µg of nuclear extract, 50 ng/µL Poly (dI•dC), and biotin end-labeled 
oligonucleotides. Synthetic 5’-biotinylated complementary oligonucleotides were 
purchased from Integrated DNA Technologies (Coralville, IA). Oligonucleotides 
containing the antioxidant response element (ARE) sequence from the porcine NQO1 
promoter (5’-TAGTCACAGTGACTCAGCGAGATTC-3’) were used as described 
previously159b.  
2.3.8 Statistical analysis  
Data were analyzed using SigmaStat software (Systat Software, Point Richmond, CA). 
Comparisons between treatments were made by two-way ANOVA with post-hoc 
comparisons of the means.  To elucidate trends within groups, multiple comparison 
procedures were completed for tests that displayed overall significance (p≤0.05-0.1).  
Groups were considered significantly different with a determined p value of p<0.05.     
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2.4. Results 
2.4.1 Cav-1 silencing prevents PCB-induced endothelial cell dysfunction by increasing 
antioxidant gene expression 
 Previously, we have shown that coplanar PCBs can initiate cellular dysfunction, 
as evidenced by an increase in VCAM-1 protein levels, in endothelial cells that contain 
functional caveolae12a, 12b.  Here, we treated primary porcine vascular endothelial cells 
with a single low dose (0.25 µM) of PCB 126 for 16 h and saw a statistically significant 
upregulation of VCAM-1 mRNA expression in control siRNA treated cells (Fig. 2.1).  
However, this upregulation was not observed in cells treated with Cav-1 siRNA.  We 
have previously shown that the antioxidant controller Nrf2 is critical for cellular defense 
against PCB toxicity, thus we hypothesized that Cav-1 silenced cells were protected 
through a Cav-1/Nrf2 cross-talk mechanism.  Cav-1 siRNA treated cells displayed 
increased Nrf2- antioxidant response element (ARE) transcriptional binding (EMSA) 
which was most evident when comparing between baseline levels of vehicle DMSO 
treated groups (Fig. 2.2B).  We then investigated, via real time PCR (RT-PCR), mRNA 
expression levels of two major Nrf2 target genes GST and NQO1 and saw statistically 
significant increases of expression for both genes in cells treated with Cav-1 siRNA 
compared to control scrambled siRNA (Fig. 2.2A).  As with the EMSA results, the most 
drastic and significant differences between Cav-1 and control siRNA treated cells were 
seen in DMSO vehicle groups.  Basal levels of GST expression were approximately 10 
fold higher in Cav-1 siRNA treated cells but only approximately 5 fold higher in Cav-1 
siRNA treated cells after exposure to PCB.  NQO1 levels were also significantly higher in 
cells silenced for Cav-1 but to much less of a degree (Fig. 2.2A).  Additionally, NQO1 
basal protein levels were significantly increased in Cav-1 transfected cells after 48 h 
compared to control transfected cells (Supplemental. Fig. 2.1A).  Finally, basal mRNA 
levels of two additional Nrf2 targets, glutathione peroxidase-1 (GPX1) and multi-drug 
resistance protein-1 (MRP1) were compared between Cav-1 and control transfected 
cells, and it was determined via RT-PCR that even after just 24 h of Cav-1 transfection, 
expression levels of both of these cytoprotective genes were doubled in cells silenced 
for Cav-1 (Supplemental Fig. 2.1B).    
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2.4.2 Decreased Cav-1 expression promotes Nrf2 activity by decreasing levels of 
multiple Nrf2 inhibitory proteins 
Nrf2 is inhibited by multiple factors including Keap1 and Fyn kinase; therefore we 
investigated levels of these proteins in an attempt to elucidate further novel mechanisms 
of Cav-1/Nrf2 cross-talk (Fig. 2.3).  To explain the upregulated Nrf2 activity in Cav-1 
depleted cells, we hypothesized that levels of these inhibitory proteins necessarily would 
be diminished early on during PCB exposure.  Thus, we treated human endothelial cells 
(HUVEC fusion) with control or Cav-1 targeted siRNAs and subsequently exposed the 
HUVEC-based cell line to 0.25 µM PCB 126 for a minimal time duration (4 h).  As 
expected, PCB exposure caused a decrease in protein expression of the Nrf2 inhibitory 
proteins Keap1 and Fyn kinase in both Cav-1 and control siRNA treated cells.  More 
importantly, at basal DMSO conditions, cells silenced for Cav-1 also displayed 
significantly lower levels of Keap1 and Fyn compared to DMSO-treated control siRNA 
cells.  Exposing PCB to these Cav-1 silenced cells resulted in a statistically significant 
decrease in Fyn and Keap1 compared to Cav-1 silenced cells treated with DMSO.  
Although antibodies for Fyn and Keap1 used by our laboratory did not work considerably 
well in our mouse and porcine models, we did examine, via RT-PCR, Keap1 mRNA 
levels in Cav-1 silenced porcine cells and observed similarly significant trends as with 
human endothelial cell protein data (Fig. 2.8).  Finally, whole livers were harvested from 
wildtype and Cav-1 -/- mice, and via RT-PCR it was determined that Cav-1 -/- mice 
expressed approximately 50% mRNA expression levels of Keap1 in the liver compared 
to age matched wildtype controls (n=4 for each genotype, Fig. 2.9).  This observed 
decrease in Keap1 in whole livers of Cav-1 -/- was similar to the diminished levels 
observed in endothelial cells from porcine or human silenced for Cav- 1(compare to Fig. 
2.3 or Fig. 2.8); which is interesting due to the fact that multiple cell types can be found 
in whole liver lysates).      
2.4.3 Decreased Cav-1 expression promotes the phosphorylation of Akt but not 
phosphorylation of PKC delta. 
Alternative mechanisms of Nrf2 activation have been investigated including direct 
phosphorylation of Nrf2 by PKC delta and Akt.  To investigate the ability of Cav-1 
silencing to alter either of these Nrf2 effectors, human endothelial cells were transfected 
with either scrambled or Cav-1 targeting siRNAs and subsequently treated with 0.25 µM 
PCB 126 for 4 h. Interestingly, Cav-1 silencing decreased levels of phosphorylated PKC 
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delta in both DMSO and PCB treatment groups, although significantly increased levels of 
phosphorylated Akt were seen in baseline vehicle treatment groups but not when treated 
with PCB (Fig. 2.4).  
2.4.4 Cells isolated from Cav-1 -/- mice are protected from PCB-induced inflammation 
via upregulated Nrf2 activity 
Lung endothelial cells were next isolated from Cav-1 deficient and wildtype mice 
of the same background and subsequently exposed to coplanar PCB 126 to confirm the 
importance of Cav-1/Nrf2 cross-talk in PCB-induced toxicity.  VCAM-1 protein levels 
were measured via Western blot and quantified via densitometry.  As mirrored in the 
siRNA experiments utilizing porcine cells, PCB 126 only increased cellular dysfunction 
(VCAM-1 induction) in cells isolated from C57BL/6 mice and not Cav-1 -/- mice (Fig. 
2.5).  We attribute this protection in Cav-1 -/- mice to the considerably higher protein 
levels of antioxidant enzymes such as NQO1 and GST.  Cells isolated from Cav-1 -/- 
mice displayed approximately 10 fold and 3 fold increases in NQO1 and GST, 
respectively, in vehicle treated groups when compared to cells isolated from C57Bl/6 
control mice (Fig. 2.5).  Treating mouse endothelial cells with PCB resulted in the same 
trends observed in the previous porcine siRNA experiments (e.g. decreased levels of 
GST and higher levels of NQO1 compared to DMSO vehicle).  Importantly, although an 
overall interactive effect was not seen, we did see a trend toward significance (P=0.072) 
for increased Nrf2 protein levels in cells isolated from Cav-1 -/- mice when comparing 
baseline DMSO groups between mouse genotypes (Fig. 2.5).  Combining this finding 
with the EMSA results displayed in Fig. 2.2B, together, help to show that a decrease in 
cellular Cav-1 protein promotes upregulated Nrf2 activity that is evident in multiple 
species.  
2.5. Discussion        
There is a growing body of evidence that implicates human exposure to 
persistent organic pollutants (POPs) such as polychlorinated biphenyls with increased 
risk of inflammatory related diseases such as atherosclerosis.  The endothelium is a 
major target of PCB toxicity due to, e.g., constant low dose release from adipose fat 
stores caused by dynamic equilibrium and/or weight loss.  Understanding the multiple 
signaling pathways involved and their cross-talk is a critical step in designing 
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preventative and therapeutic methods to counteract pollutant-induced endothelial cell 
dysfunction and inflammation.   
 The importance of caveolae, lipid rafts, and Cav-1 in inflammation and heart 
disease has become a source of much research, but until recently, cross-talk between 
caveolae-related proteins and other factors has not been elucidated.  Now, evidence 
points to interactions between Cav-1, AhR, and Nrf2, all proteins involved in 
inflammation and toxicant-induced disease12b, 140, 160.  This work shows that a low dose of 
coplanar PCB 126 is sufficient to induce a pro-inflammatory endothelial cell environment 
and that loss of Cav-1 is protective and results in increased Nrf2 activity via multiple 
novel cross-talk mechanisms.   
 Coplanar PCBs have been shown to induce early stages of atherosclerosis via 
altering the cellular redox balance.  Treatment with coplanar PCBs such as PCB 77 or 
PCB 126 has been shown in endothelial cells to increase oxidative stress, and 
inflammatory markers such as MCP-1 expression, and monocyte adhesion, but 
protection is seen in cells and mice deficient for the Cav-1 gene12a, 12b, 23b.  The pro-
inflammatory effects of PCBs may be linked to their uptake via caveolae, and the work 
described here suggests that Cav-1 deficiency protects against PCB-induced cellular 
dysfunction by allowing for a more effective Nrf2-controlled antioxidant response.  
Previously it was believed that lack of Cav-1 protected these cells and animals from PCB 
toxicity through an impaired PCB uptake mechanism.  Previous work in our laboratory 
further has shown that PCBs preferentially sequester in the caveolae fraction of 
endothelial cells and PCB treatment increases the formation of functional caveolae at 
the lipid membrane12b.  Disruption of functional caveolae and/or downregulation of Cav-1 
may protect against toxicant-induced cytotoxicity via multiple mechanisms including 
altering the uptake of contaminants, altering toxicity kinetics and, as described in this 
work, inducing an upregulated Nrf2 antioxidant response.   However, specific uptake 
mechanisms of PCBs may vary in different cell types and among congener of PCBs 
which may implicate the importance of the upregulated Nrf2 response over other 
mechanisms of protection in certain cell types and cellular conditions161.  Loss of Cav-1 
has been shown by our laboratory and others to cause an upregulated Nrf2 antioxidant 
response159b, but until recently, mechanisms of this cross-talk had not been elucidated.  
Two groups have now shown that Nrf2 can be added to a growing list of proteins that 
can be inhibited by Cav-1 via direct binding within the cell140, 160.  These studies, 
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however, did not highlight other possible mechanisms of cross-talk such as decreased 
Keap1 or Fyn kinase levels in Cav-1 diminished cells.  Here, we show that protein levels 
of Keap1 and Fyn are diminished in cells silenced for Cav-1, which may help to 
mechanistically explain the observed upregulated Nrf2 response.  Keap1 has been 
indicated as the major inhibitor of Nrf2 by promoting ubiquitination and subsequent 
proteosomal degradation.  Very little is known however about cellular regulation of 
Keap1 expression levels, especially during transcription.  Studies have shown that 
Keap1 levels can be decreased by epigenetic mechanisms as well as endogenous 
microRNAs, but future work is required to clarify the mechanism connecting diminished 
Cav-1 levels with decreased Keap1 expression162.  It is important to mention that some 
groups have shown that loss of Cav-1 in certain cell types, especially in a cancer 
environment, promotes oxidative stress and can drastically alter tumor recurrence163.  In 
our endothelial cell models, though, we have not observed an increase in ROS levels 
with Cav-1 siRNA treatment and have only observed PCB-induced cellular dysfunction in 
mice and endothelial cells that have wildtype levels of Cav-112b.  It will be important to 
create endothelial specific Cav-1 -/- mice in the future to better understand important 
connections between endothelial Cav-1, oxidative stress levels, Nrf2, and protection 
from xenobiotic-induced toxicity. 
 Recently, alternative mechanisms of Nrf2 activation have been described 
including direct phosphorylation by PKC delta and Akt.  Articles have implicated Cav-1 
as a direct inhibitor of multiple PKCs, and loss of Cav-1 has resulted in increased PKC 
auto-phosphorylation and activation164.  Interestingly, we did not observe this trend with 
the PKC isotype that has been shown to directly activate Nrf2 (Fig. 2.4).  Some groups 
have shown, however, that activation of PKC isoform delta can be detrimental to the 
vasculature and can play an important role in the promotion of cardiovascular diseases, 
indicating that an increase in activated PKC delta may not be all positive165.  Activated 
Akt, however, was significantly increased in cells treated with Cav-1 siRNA.  An 
interaction between Cav-1 and Akt has been implicated previously, but more work is 
necessary to determine if this observed increase in Akt can be correlated with Nrf2 
activation166.  Future experiments should also investigate Cav-1’s role in other cellular 
Nrf2-related kinases such as phosphatidylinositol 3-kinase (PI3K), mitogen-activated 
protein kinase (MAPK), ER-localized pancreatic endoplasmic reticulum kinase (PERK), 
and protein kinase CK2167.  Here, we add to a growing body of evidence that cross-talk 
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between Cav-1 and Nrf2 exists and that multiple mechanisms of cross-talk may be 
evident (Fig. 2.6).              
 Downregulation of endothelial Cav-1 may prove to be an effective modulator of 
toxicant-induced disease as well as other pathologies hallmarked by chronic 
inflammation.  We have shown previously that healthful nutrition, which is high in 
bioactive food components such as polyphenols and omega-3 polyunsaturated fatty 
acids, can protect against PCB-induced cellular dysfunction73b, 116a, 155a.  Laboratories 
have shown that these nutrients may protect through multiple mechanisms including 
disruption of functional caveolae, increased Nrf2 activity, and decreased NFκB 
activation73b, 115b, 116b, 126, 158.  It is plausible to hypothesize that the cross-talk between 
Cav-1 and Nrf2 pathways is critical for nutritional and/or pharmacological modulation of 
toxicant-induced disease.  For example, statin treatment (simvastatin) can downregulate 
Cav-1 protein levels and activate endothelial nitric oxide synthase (eNOS)168.  Also, 
eNOS upregulation via statins was not as profound in Cav-1 deficient human endothelial 
cells169. To create more targeted and effective nutritional and pharmacological 
therapeutics, more work is needed to better elucidate the impact on the increasingly 
complex cross-talk between caveolae and Nrf2 (Fig. 2.6). 
 Our data suggest that cross-talk between Cav-1 and Nrf2 exists and may be 
more complex than described previously.  Cav-1 inhibits Nrf2 activation, and decreasing 
Cav-1 levels increases the expression of Nrf2 target genes.  This increased induction of 
protective genes may help to explain why cells and mice lacking Cav-1 are protected 
against pro-inflammatory polychlorinated biphenyl exposure.  Our studies provide 
concordant findings from experiments using cellular models from three different 
mammalian species, i.e., pig, mouse, and human, suggesting some relevance of our 
findings to human health and risk assessments.  Caveolae and Nrf2-related proteins 
may prove to be important targets for effective nutritional and/or pharmacological 
protection against the toxicity of pro-inflammatory xenobiotics.   
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Fig. 2.1. Expression of VCAM-1 mRNA in porcine vascular endothelial cells exposed to 
coplanar PCB 126.  Cells were transfected with either scrambled control or Cav-1 
targeted siRNA for 48 h and subsequently exposed to PCB 126 at a concentration of 
0.25 µM for 16 h. mRNA levels were measured using real-time PCR. Results were 
normalized to β-actin and are depicted as fold change compared to control siRNA 
DMSO treatments. Results represent the mean± SEM (n=2 for each treatment group).  
PCB 126 increases VCAM-1 mRNA levels only in endothelial cells with Cav-1 (*p<0.05).  
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Fig. 2.2.  Expression of antioxidant enzymes and Nrf2 transcriptional binding in cells 
silenced for Cav-1.  Porcine endothelial cells were transfected with either scrambled 
control or Cav-1 targeted siRNA for 48 h and subsequently exposed to PCB 126 at a 
concentration of 0.25 µM for 16 h. mRNA levels of GST and NQO1 were measured 
using real-time PCR. Results were normalized to β-actin and graphed as fold change 
compared to control siRNA DMSO treatments. Results represent the mean± SEM (n=2 
for each treatment group). (A)  Cells silenced for Cav-1 display increased mRNA levels 
of GST in both vehicle and PCB treated groups compared to control siRNA transfected 
cells (*p<0.05).  GST levels were diminished in Cav-1 siRNA transfected cells when 
exposed to PCB, but these levels were still statistically significantly higher than control 
siRNA transfected cells exposed to PCB (*p<0.05).  Also, PCB treatment increased the 
expression of NQO1 in both Cav-1 siRNA and control siRNA groups (*p<0.05), and there 
was a significant trend of increased expression in cells silenced for Cav-1 (p=0.063).  (B)  
Cells silenced for Cav-1 display increased levels of Nrf2 – ARE binding as determined 
by EMSA compared with control siRNA transfected cells.   
 
  
 
 
 
Fig. 2.3. Expression of Nrf2 inhibitory proteins is decreased in cells silenced for Cav-1.  
Human endothelial cells were transfected with either scrambled control or Cav-1 
targeted siRNA for 48 h and subsequently exposed to PCB 126 at a concentration of 
0.25 µM for 4 h. Protein levels of Keap1 and Fyn kinase were measured via western 
blot. Results were normalized to β-actin and graphed as fold change compared to 
control siRNA DMSO treatments. Results represent the mean±SEM (Fyn: n=2, Keap1: 
n=3 for each treatment group). Cells silenced for Cav-1 display decreased protein levels 
of Keap1 and Fyn in both vehicle and PCB treated groups compared to control siRNA 
transfected cells (*p<0.05).  PCB treatment also significantly decreased Fyn and Keap1 
levels within transfection groups (*p<0.05).   Western blot above shows representative 
sample of visual results. 
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Fig. 2.4. Expression of phosphorylated Akt and PKC delta proteins in human endothelial 
cells exposed to coplanar PCB 126.  Cells were transfected with either scrambled 
control or Cav-1 targeted siRNA for 48 h and subsequently exposed to PCB 126 at a 
concentration of 0.25 µM for 4 h. Protein levels of P-Akt and P-PKC delta were 
measured via Western blot. Results were normalized to β-actin and depicted as fold 
change compared to control siRNA DMSO treatments. Results represent the 
mean±SEM (n=3 for each treatment group). Cells silenced for Cav-1 display decreased 
protein levels of P-PKC delta in both vehicle and PCB treated groups.  Cells targeted 
with Cav-1 siRNA and treated with DMSO vehicle had significantly increased levels of P-
Akt compared to control transfected cells also treated with DMSO (*p<0.05).   Western 
blot above shows representative sample of visual results. 
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Fig. 2.5.  Confirmation of Cav-1 Nrf2 cross-talk in cells isolated from Cav-1 -/- mice.  
Endothelial cells from Cav-1 -/- and age matched wildtype control mice were isolated 
and subsequently exposed to PCB 126 at a concentration of 2.5 µM for 24 h. Protein 
levels of NQO1, VCAM-1, GST and Nrf2 were measured via Western blot. Results were 
normalized to β-actin and depicted as fold change compared to control siRNA DMSO 
treatments. Results represent the mean±SEM (NQO1, GST, Nrf2: n=3, VCAM-1: n=2 for 
each treatment group). Cells isolated from Cav-1 -/- mice did not display PCB-induced 
VCAM-1 upregulation and showed significantly increased levels of NQO1 (*p<0.05).  
Cells isolated from Cav-1 -/- mice displayed significantly higher levels of GST under 
DMSO vehicle conditions compared to wildtype cells treated with DMSO (*p<0.05).  
Also, cells isolated from Cav-1 -/- mice displayed a trend toward being significantly 
increased compared to vehicle treated control cells.  Western blots above show 
representative samples of visual results. 
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Fig. 2. 6.  The induction of Nrf2 is controlled by multiple inhibitory proteins and a 
complex regulatory mechanism.  A) Keap1 is the major inhibitory protein of Nrf2 and 
facilitates Nrf2’s ubiquitination and destruction.  B) Caveolin-1, the major structural 
protein of lipid raft caveolae, binds and inhibits Nrf2.  Also, caveolae concentrate other 
proteins involved in Nrf2 activation such as Akt which is known to phosphorylate and 
activate Nrf2.  Cav-1 is also a binding partner of the Aryl hydrocarbon receptor which is 
known to bind cis-acting sequences in the Nrf2 promotor.  C) Upon Nrf2 activation and 
subsequent translocation to the nucleus, additional regulatory mechanisms exist to 
remove Nrf2.  Direct phosphorylation from Fyn kinase or Bach1 decreases the Nrf2 
nuclear pool.  Cav-1 may also regulate Fyn and/or Bach1 levels via an unknown 
mechanism.  If Nrf2 evades cellular destruction and remains in the nucleus, the 
transcription factor can bind co-activators, bind cis-acting antioxidant response elements 
on DNA, and upregulate a battery of antioxidant related proteins such as GST and 
NQO1.     
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Fig. 2.7.  Expression of antioxidant enzymes in cells silenced for Cav-1.  Porcine 
endothelial cells were transfected with either scrambled control or Cav-1 targeted 
siRNA for (A) 48 h or (B) 24 h.  (A) NQO1 protein levels were measured via Western 
blot. Results were normalized to β-actin and depicted as fold change compared to 
control siRNA groups. Results represent the mean±SEM (n=5-6 for each group).  
Silencing of Cav-1 for 48 h increases basal levels of NQO1 protein (*p<0.05).  Western 
blots above show representative samples of visual results. (B)  mRNA levels of the Nrf2 
targets Glutathione Peroxidase-1 (GPx1)and Multi-drug resistance protein 1 (MRP1) 
were measured using real-time PCR.  Results were normalized to β-actin and graphed 
as fold change compared to control siRNA groups.  Results represent the mean± SEM 
(n=7-8 for each group).  Cells silenced for Cav-1 display increased mRNA levels of 
GPx1 and MRP1(*p<0.05).   
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Fig. 2.8. Expression of Keap1 mRNA in porcine endothelial cells exposed to vehicle and 
coplanar PCB 126.  Cells were transfected with either scrambled control or Cav-1 
targeted siRNA for 48 h and subsequently exposed to PCB 126 at a concentration of 
0.25 µM for 16 h. mRNA levels of Keap1 were measured via RT-PCR. Results were 
normalized to β-actin and depicted as fold change compared to control siRNA DMSO 
treatments. Results represent the mean±SEM (n=3 for each treatment group).  Silencing 
Cav-1 resulted in decreased Keap1 mRNA expression levels in both vehicle and PCB 
treated cells (*p<0.05).  
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Fig. 2.9. Expression of Keap1 mRNA in livers from age matched wild-type C57BL6 
mice and Cav-1 -/- mice.  mRNA levels of Keap1 were measured via RT-PCR. Results 
were normalized to 18S and depicted as fold change compared to control mice. 
Results represent the mean±SEM (n=4 for each treatment group).  Loss of Cav-1 
resulted in decreased Keap1 mRNA expression levels (p=0.049 for one tailed t-test and 
p=0.098 for two tailed t-test).  
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Chapter 3.  Green tea diet decreases PCB 126-induced oxidative stress in mice by 
upregulating antioxidant enzymes129b 
 
3.1 Synopsis 
Superfund chemicals such as polychlorinated biphenyls pose a serious human 
health risk due to their environmental persistence and link to multiple diseases such as 
atherosclerosis, diabetes, and cancer. Selective bioactive food components such as 
flavonoids/polyphenols have been shown to ameliorate PCB toxicity, but primarily in an 
in vitro setting. Here, we show that mice fed a green tea-enriched diet and subsequently 
exposed to multiple doses of coplanar PCB exhibit decreased overall oxidative stress 
levels primarily due to the upregulation of a battery of antioxidant enzymes. C57BL/6 
mice were fed a low fat diet supplemented with green tea extract for 12 weeks and 
exposed to 5 µmol PCB 126/kg mouse weight (1.63 mg/kg-day) on weeks 10, 11 and 12. 
HPLC-MS/MS plasma analysis showed that mice supplemented with green tea extract 
and subsequently exposed to PCB displayed a decrease in overall F2-Isoprostane levels 
compared to animals on a control diet exposed to PCB. Livers were collected and 
harvested for both mRNA and protein analyses, and it was determined that many genes 
transcriptionally controlled by the aryl hydrocarbon receptor (AhR) and nuclear factor 
(erythroid-derived 2)-like 2 (Nrf2) proteins were upregulated in PCB-exposed mice fed 
the green tea supplemented diet. An increased induction of genes such as SOD1, GSR, 
NQO1 and GST in these mice (green tea plus PCB) may explain the observed decrease 
in overall oxidative stress. A diet supplemented with green tea allows for an efficient 
antioxidant response in the presence of PCB 126 which supports the emerging paradigm 
that healthful nutrition may be able to bolster and buffer a physiological system against 
the toxicities of environmental pollutants.       
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3.2 Introduction 
The contamination of soil and groundwater aquifers by toxic chlorinated organic 
compounds at Superfund sites, e.g., polychlorinated biphenyls (PCBs) and 
trichloroethylene (TCE), is a pervasive environmental problem with serious public health 
consequences170. PCBs are persistent organic pollutants found in soil, air, and water, 
and a major source of human exposure to PCBs is from dietary intake of contaminated 
foods. Because PCBs are lipid soluble, they readily accumulate in human tissues, thus 
increasing human health concerns27. For example, results from the recent Aniston 
Community Health Survey observed a significant correlation between PCB levels and 
diabetes36f, and circulating levels of PCBs were associated with atherosclerotic 
plaques171. Prenatal exposure to PCBs also may be associated with increased weight in 
children172. The liver is one tissue particularly vulnerable to PCB-induced toxicity 
because it is the primary organ associated with detoxification, and there is strong 
evidence from NHANES data that PCBs are associated with liver disease in humans173.   
There is evidence that nutrition can modulate the toxicity of environmental 
pollutants174 and thus affect the vulnerability to environmental insults and compromised 
health. For example, PCBs can act as diet-dependent obesogens when administered 
with a high-fat diet, and thus worsen nonalcoholic fatty liver disease175. We have 
previously shown that PCB insult can modify lipid metabolism while dietary fat 
supplementation can ameliorate these negative effects112. For example, we have shown 
that PCB exposure increases neutral lipid staining in LDL-R−/− mice fed a corn oil-
enriched diet (i.e., a diet rich in omega-6 fatty acids), indicating increased inflammation, 
while inflammation was decreased in mice fed an olive oil-enriched diet. Additionally, 
omega-3 fatty acids derived from fish oil are protective and reduce PCB-induced toxicity 
in endothelial cells126;116a. Similarly, antioxidant nutrients such as dietary flavonoids can 
protect against endothelial cell damage mediated by these persistent organic 
pollutants128a;73b. This is important since coplanar PCBs (e.g., PCB 126) exert their 
toxicity primarily through activation of the aryl hydrocarbon receptor (AhR) and 
subsequent uncoupling of cytochrome P450 1A1 (CYP1A1), which can be a source of 
oxidative stress176;177.  
Mammalian cells are constantly bombarded with endogenous and exogenous 
sources of free radicals which tip the cellular balance towards an overall oxidative stress 
condition.  To counteract the ubiquitous nature of reactive oxygen species (ROS), such 
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as superoxide (O.- ), and reactive intermediates, such as hydrogen peroxide (H2O2), 
mammalian cells have evolved intricate and interrelated protein defenses that can work 
efficiently to limit the detrimental effects of these toxic molecules.  PCBs have been 
shown to cause oxidative stress primarily through a CYP1A1 uncoupling mediated 
mechanism178.  Production of O.- and related ROS triggers an upregulation of a battery of 
antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione 
reductase (GSR), glutathione transferases (GST), thioredoxins (Trx) and thioredoxin 
reductases (TrxR)179.  These proteins work in concert to either catalyze the 
transformation of ROS to benign molecules such as water and molecular oxygen or to 
reactivate enzymes, usually by catalytic reductions (e.g. TrxR reduces oxidized Trx to its 
active form180).  Such an interconnected system requires the crosstalk of multiple 
regulatory pathways including AhR and Nrf2 to function as intended (see Fig. 3.1). 
The aryl hydrocarbon receptor (AhR) and nuclear factor (erythroid-derived 2)-like 2 
(Nrf2) transcription factors work together to detoxify xenobiotics and to upregulate the 
antioxidant response.  Upon activation via endogenous ligands, such as arachidonic acid 
metabolites, or xenobiotics, such as dioxin (TCDD) or coplanar PCB 126, the AhR 
translocates to the nucleus, binds consensus cis-acting sequences known as dioxin or 
xenobiotic response elements (DRE or XRE) and facilitates the upregulation of multiple 
genes, especially those related to phase II detoxification (e.g. CYP1A1 and UDP-
glucuronosyl S-transferases)181.  Certain environmental toxicants with relatively long 
half-lives, such as TCDD and PCB 126, can promote sustained AhR activation resulting 
in chronic low levels of oxidative stress and inflammation182.  The Nrf2 pathway shares 
many target genes with AhR, but is generally regarded as more of a redox sensor, as its 
dissociation with inhibitory proteins (e.g. Keap1) and subsequent transactivation is 
promoted by ROS and electrophiles82a.  Binding of Nrf2 to consensus antioxidant 
response elements (ARE) upregulates a battery of protective genes including 
cytochrome P450s, GSTs and NAD(P)H dehydrogenase [quinone] 1 (NQO1)136a.  Nrf2 is 
a critical mediator of oxidative stress and xenobiotic toxicity as evidenced by multiple 
studies involving Nrf2 KO mice183,184.  It appears that the interrelatedness of Nrf2 and 
AhR pathways is not a coincidental occurrence as recently intimate cross-talk between 
the two xenobiotic related proteins has been illustrated138.  In fact, AhR and Nrf2 
promoter gene sequences contain binding sites for one another and in instances where 
either is absent (e.g., KO) a non-optimal protective response occurs139.   Importantly, 
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bioactive nutrients such as tea catechins may work through both Nrf2- and AhR-
mediated mechanisms to prevent toxicant-induced global inflammation73b.   
We have demonstrated previously that the tea catechin epigallocatechin-3-gallate 
(EGCG) can protect against vascular endothelial cell activation by coplanar PCBs73b, 158, 
and that EGCG can inhibit AhR-regulated genes and induce Nrf2-regulated antioxidant 
enzymes, thus providing protection against PCB-induced inflammatory responses in 
cultured endothelial cells73b.  EGCG also can inhibit oxidative damage and attenuate 
carbon tetrachloride-induced hepatic fibrosis185.  Mechanisms responsible for EGCG-
induced protection against environmental pollutants are not fully understood.  In the 
current study we provide evidence that green tea extract, composed primarily of EGCG 
(see Table 3.3), can decrease oxidative stress in livers of mice exposed to PCB 126 
and that part of the protection is due to induction of antioxidant genes.  Thus, diet 
supplementation with green tea may allow for an efficient antioxidant response to buffer 
against toxicities of environmental pollutants in humans129a.    
3.3. Materials and Methods 
3.3.1 Animals, diets, and dosing treatments 
Forty C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, ME) at 2 
months of age and evenly assigned to the following experimental groups: control diet 
(10% kcal as fat) + vehicle, control+1% green tea extract (GTE) + vehicle, control + PCB 
126, control+1% GTE + PCB 126. The control diet was purchased from Research Diets, 
Inc. (New Brunswick, NJ, catalog number D12450B). Sunphenon 30S-O organic green 
tea extract (lot number: 105131, containing 37.4% total polyphenols, 32.0% total 
catechins, and 5.3% caffeine) was obtained from Taiyo International Inc. (Minneapolis, 
MN) and incorporated into the control diet formulation, as described in Table 3.3. Green 
tea extract treatment amounts per body weight coincide with approximately 4 cups of tea 
(~200 ml/cup) per day in humans186. Mice were fed the control and GTE-supplemented 
diets for 12 weeks and were gavaged with PCB 126 (5 μmol/kg mouse) or vehicle 
(stripped safflower oil; Acros Chemical Company, Pittsburgh, PA) in weeks 10, 11, and 
12. The PCB 126 gavage concentration was chosen based on observations in 
preliminary studies where gavage of 5 μmol/kg PCB 126 showed pro-inflammatory 
responses in C57/BL6 mice but not wasting syndrome.  
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3.3.2 Blood and tissue harvesting 
 In this study, we examined the role that green tea extract catechins play in altering 
oxidative stress and inflammation following insult with environmental pollutants (i.e., 
PCB 126). 24 h after week 12 treatment, mice were euthanized with CO2 and quickly 
exsanguinated. 10X ethylenediaminetetraacetic acid (EDTA) was added to collected 
blood samples, briefly mixed, and centrifuged at 5000 g for 5 min at 4 °C to separate 
blood plasma. Plasma samples were frozen in liquid nitrogen and stored at -80 °C until 
processing. Livers were harvested, weighed, divided in half, and frozen in liquid nitrogen 
for protein studies or stored in RNAlater solution (Life Technologies, Grand Island, NY) 
at 4 °C for 24 h then -80 °C prior to mRNA analysis.  
  
3.3.3 Plasma PCB and isoprostane analysis 
PCB 126 and one of its metabolites were extracted from plasma samples to 
determine systemic PCB and metabolite concentrations and correlate these findings to 
potential PCB-induced oxidative stress as well as the role of green tea extract in 
mitigating these effects. PCB 126 and its hydroxy metabolites were isolated from plasma 
samples (plus 10 μM 13C12-labeled PCB 126 internal standard (IS), Cambridge Isotope 
Laboratories, Tewksbury, MA) through extraction with acetonitrile and subsequent 
sonication and centrifugation at 15,000 rpm for 5 min to pellet plasma debris. 
Supernatants were dried under N2 and reconstituted in 99:1 methanol:dI H2O solvent 
mixture with 0.5% formic acid and 0.1% 5 M ammonium formate. 
Measurement of F2-Isoprostanes (F2-IsoPs) provides one of the most reliable 
assessment methods for oxidative stress in vivo187. For F2-IsoP analysis, plasma 
samples were added to 5:1 ethyl acetate: methanol + 0.5% acetic acid (v/v) + 10 μM 8-
iso-PGF2α-D4 (internal standard, Cayman Chemical, Ann Arbor, MI), vortexed briefly, 
and centrifuged to pellet plasma debris. Supernatants were transferred and dried under 
N2 prior to reconstitution in methanol and addition of acetic acid for subsequent solid 
phase extraction (SPE).  
Reconstituted F2-IsoP samples were loaded onto pre-conditioned Supel-Select HLB 
SPE columns (Sigma-Aldrich, St. Louis, MO) and washed with 0.5% acetic acid followed 
by washing with 0.5% acetic acid containing 20% methanol. Columns were eluted with 
methanol, eluent was evaporated to dryness with N2, and samples were reconstituted 
with 50:50 methanol:dI H2O.  
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Plasma PCB 126 and a hydroxy metabolite as well as extracted plasma F2-IsoPs 
were analyzed using a Shimadzu ultra fast liquid chromatography (UFLC) system 
coupled with an AB Sciex 4000-Qtrap hybrid linear ion trap quadrupole mass 
spectrometer in multiple reaction monitoring (MRM) mode. MRM transitions monitored: 
325.9/256.1, 325.9/254.1, and 325.9/184 for PCB 126; 338/268.1, 338/196.1, and 
338/265.7 for 13C12 PCB126. In the MRM ion transition, the precursor ion represents 
the M+∙ and the product ion represents either [M-Cl]+ or [M-2Cl]+. MRM transitions 
monitored with regard to hydroxy PCB metabolites: 340.8/340.9 for hydroxy PCB126 
and 386.8/340.9 for dihydroxy PCB126. The precursor ion of the ion transition is a formic 
acid adduct: [M+FA-H]- and product ion is [M-H]-. All values were subsequently 
normalized for volume added and for IS recovery. 
 
3.3.4 RNA isolation and polymerase chain reaction (PCR) amplification 
Liver samples used to analyze oxidative stress and inflammatory mRNA markers 
were homogenized and mRNA was isolated with TRIzol reagent (Invitrogen, Carlsbad, 
CA) according to the manufacturer’s protocol. mRNA concentrations were then 
determined using a NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, 
MA). Reverse transcription was performed using the AMV reverse transcription system 
(Promega, Madison, MI). The levels of mRNA expression were assessed by quantitative 
real-time PCR using a 7300 Real-Time PCR system (Applied Biosystems, Foster City, 
CA) and SYBR Green master mix (Applied Biosystems) as compared to constitutively 
expressed β-actin (forward primer: 5’-TGTCCACCTTCCAGCAGATGT-3’; reverse 
primer: 5’-GCTCAGTAACAGTCCGCCTAGAA-3’) using the relative quantification 
method (ΔΔCt). Primer sequences (see Table 1) for SYBR Green reactions were 
designed using the Primer Express Software 3.0 for real-time PCR (Applied Biosystems) 
and synthesized by Integrated DNA Technologies, Inc. (Coralville, IA). 
 
3.3.5. Immunoblotting assays 
Liver samples used for protein analysis were homogenized in extraction RIPA buffer 
containing protease inhibitors (Pierce, Rockford, IL). Lysed tissue was centrifuged at 
10,000 g for 30 min at 4 ºC followed by Bradford protein assay (Pierce). Protein samples 
were separated using 10% SDS-PAGE and subsequently were transferred onto 
nitrocellulose membranes. Membranes were blocked with 5% non-fat milk buffer and 
incubated overnight at 4 ºC with the following primary antibodies: β-actin (product 
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#A2066, ~42 kD, Sigma, St. Louis, MO), GAPDH (product #sc-20357, ~37 kD, Santa 
Cruz Biotechnology, Dallas, TX), GSR (product #ab16801, ~58 kD, Abcam, Cambridge, 
MA), and NQO1 (product #ab34173, ~31 kD, Abcam). After washing, membranes were 
incubated with secondary antibodies conjugated with horseradish peroxidase and 
visualized using ECL detection reagents (Thermo, Waltham, MA). 
Liver samples used for nuclear translocation assays were prepared and cytoplasmic 
and nuclear protein was extracted according to manufacturer protocol (NE-PER® 
Nuclear and Cytoplasmic Extraction Method, Thermo). Translocation samples 
subsequently were processed as seen above, and probed with the following primary 
antibodies:  lamin (product #sc-7292, ~69 kD, Santa Cruz Biotechnology) and Nrf2 
(product #sc-722, ~59 kD, Santa Cruz Biotechnology).   
 
3.3.6. Data analyses 
Statistical analysis was performed using Student’s t-test for comparison of treatment 
groups.  Overall, no statistical differences were exhibited between vehicle control 
groups, thus Student’s t-test was used to analyze differences between PCB treatment 
groups. qRT-PCR mRNA analysis (n=8-10), Western blot protein analysis (n=8), and 
nuclear translocation analysis (n=4) represent three experimental replicates. A 
probability value of p ≤ 0.05 was considered statistically significant. All statistical 
analyses were overseen by staff of the University of Kentucky Department of Statistics. 
 
3.4. Results 
3.4.1 Systemic toxicity associated with PCBs 
PCB 126 levels in mouse plasma were examined as a measure of systemic PCB 
body burden and to determine green tea extract (GTE) diet supplementation’s role in 
increasing PCB metabolism/excretion. Ion transitions of PCB 126 and OH-PCB 126 
were measured by UFLC-MS/MS, normalized for sample volume, and compared to ion 
transitions of internal standard (13C12 PCB 126) with known concentration to determine 
PCB parent and metabolite concentrations (pmol/μL plasma). As seen in Fig. 3.2, 
plasma PCB 126 was found almost completely as its hydroxylated metabolite, OH-PCB 
126, with concentrations of approx. 0.04 pmol PCB 126/μL plasma versus approx. 30 
pmol OH-PCB 126/μL, respectively. GTE diet supplementation did not modulate PCB 
metabolism or plasma concentrations 24 h following PCB exposure, indicating that it 
plays a minimal role in pollutant clearance from the body. It is hypothesized, though, that 
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while GTE supplementation does not increase 24 h pollutant metabolism and clearance, 
it prepares the body’s defense mechanisms to more effectively modulate oxidative stress 
present during toxicant acute insult.  
 
3.4.2 F2-isoprostane levels are significantly reduced in green tea extract-supplemented, 
PCB-exposed mice 
Analysis of F2-isoprostanes (F2-IsoPs), prostaglandin-like eicosanoids formed during 
fatty acid peroxidation, has emerged as the most reliable method for assessing in vivo 
oxidative stress187. Plasma samples from mice fed control and GTE-supplemented diets 
and subsequently treated with vehicle or PCB 126 (n=8-10) were analyzed to determine 
GTE’s role in modulating environmental toxicant-induced oxidative stress. Plasma F2-
IsoP (including PGF2α, 8-iso-PGF2α, iPF2α-III, 8-epiPGF2α, 8-isoprostane, and 15-F2t 
isoprostanes) and F2-IsoP metabolite (13,14-dihydro-15-ketoPGF2α) concentrations 
were determined using UFLC-MS/MS and integrating peak area (area under the curve, 
AUC) with regard to known internal standard concentrations (AUC/IS). As seen in Fig. 
3.3, GTE diet supplementation led to drastically decreased F2-IsoP levels (p<0.05) in 
mice treated with PCB 126, indicating that GTE acts as a strong antioxidant to modulate 
against environmental toxicant insult. Additionally, GTE drastically decreased PCB-
induced F2-IsoP metabolite production (p<0.05); F2-IsoP metabolite analysis is 
developing as an even more sensitive measure of in vivo oxidative stress because the 
metabolites do not undergo autoxidation and artificial production as has been seen with 
parent F2-IsoP188. Interestingly, GTE supplementation led to no significant modulation of 
F2-IsoP parent or metabolite levels under control situations, indicating that antioxidant 
modulation occurs primarily when a system is under stress. 
 
3.4.3. Green tea extract increases mRNA antioxidant response  
Antioxidant enzyme levels were measured in mouse liver to further develop the role 
of GTE diet supplementation in modulating environmental insults in vivo. Table 3.2 
highlights antioxidant mRNA markers tested and overall results. qRT-PCR analysis (n=8-
10) shows a significant upregulation in catalase, glutathione peroxidase (Gpx3), 
glutaredoxin (Grx2), glutathione reductase (GSR), glutathione S-transferases (GSTa1, 
GSTa4, GSTm1, GSTm2, and GSTm3), NAD(P)H dehydrogenase [quinone] 1 (NQO1), 
superoxide dismutase 1 (SOD1), thioredoxin 2 (Trx2), and thioredoxin reductase 1 
(TrxR1) during the concomitant treatment of PCB 126 and GTE diet supplementation.  
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As before, in most cases GTE supplementation did not significantly modulate antioxidant 
response without the presence of secondary external insult. Analysis of NQO1 and 
GSTm3, enzymes associated with detoxification, exhibited significantly increased mRNA 
levels above vehicle control diet levels in the presence of PCB 126, while GTE diet 
supplementation drastically induced antioxidant mRNA expression following PCB insult. 
mRNA levels of SOD1, critical for modulating harmful superoxide radicals produced 
during toxicant insult, were significantly decreased following PCB gavage, while GTE 
supplementation returned mRNA expression to vehicle control diet levels. While PCB 
insult did not modulate GSR (an important cellular antioxidant) mRNA levels in mice fed 
vehicle control diets, GTE diet supplementation led to a significantly increased 
antioxidant response (see Fig. 3.4, p<0.01). Additionally, data shown in Fig. 3.9 further 
expounds upon these trends in response to GTE supplementation. For example, 
thioredoxin 2 (Trx2, an important redox protein) mRNA levels are significantly 
upregulated in the concomitant presence of GTE and PCB 126 although GTE does not 
induce increased antioxidant activity without the addition of secondary external insult.  
3.4.4 Green tea extract increases NQO1 and GSR antioxidant protein response against 
PCB 126 
Antioxidant marker protein analysis was performed in order to better understand the 
role that GTE diet supplementation plays in increasing the body’s defensive mechanisms 
against toxicant insult. Proteins of interest were compared to multiple housekeeping 
genes, β-actin and GAPDH, to further substantiate findings. In PCB 126-treated mouse 
liver samples, NQO1 protein was significantly upregulated when fed a GTE 
supplemented diet, as shown in Fig. 3.5 when quantified against GAPDH (p<0.01). The 
associated representative blot continues trends seen in mRNA with a large increase in 
antioxidant protein activity in GTE supplemented mice exposed to PCB insult. GSR 
protein activity was also statistically increased in response to diet supplementation and 
continues the trend seen in mRNA analysis in which neither GTE supplementation nor 
PCB treatment led to modulation of antioxidant response while their concomitant 
treatment led to significant upregulation (p≤0.05). 
3.4.5. Green tea extract drives Nrf2 nuclear translocation in the presence of PCB 126 
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Nuclear translocation assays are commonly used techniques that serve as a 
representation of cellular transcriptional activation. Nuclear factor (erythroid-derived 2)-
like 2 (Nrf2) nuclear translocation was analyzed in comparison to lamin, a nuclear 
fraction housekeeping gene; liver samples from GTE-supplemented mice exposed to 
PCB 126 showed a trend toward increased nuclear abundance of Nrf2 (p=0.1, n=4). As 
in antioxidant mRNA and protein studies, GTE without a concomitant insult from PCB did 
not modulate Nrf2 activity and translocation. The Nrf2 antioxidant pathway plays a 
pivotal role in modulating oxidative stress, and therefore its upregulation by GTE diet 
supplementation, as seen in Fig. 3.6, is an important indicator of GTE’s ability to 
increase the body’s responsiveness toward environmental stressors. 
 
3.4.6 Green tea extract modulates inflammatory and xenobiotic-related markers in the 
presence of PCB 126  
Cytochrome P450 (e.g., CYP1A1 and CYP1B1), a family of enzymes controlled by 
the aryl hydrocarbon receptor (AhR) and Nrf2 proteins that are vital for the metabolism of 
xenobiotic substances, including toxicants, was analyzed from liver samples to 
determine potential modulation of its activity in response to GTE diet supplementation. 
Substantial CYP upregulation was seen in the presence of PCB insult, as has been 
shown in past literature, while concurrent GTE supplementation causes a significant 
upregulation in CYP1B1 mRNA analysis (as seen in Fig. 3.7), indicating potential for 
higher toxicant degradation and clearance. In mice fed GTE-supplemented diets and 
exposed to PCB, major indicators of inflammation including monocyte chemoattractant 
protein-1 (MCP-1, also referred to as chemokine (C-C motif) ligand 2, CCL2) and CCL3 
(also referred to as macrophage inflammatory protein-1α, MIP-1α) were significantly 
decreased back to vehicle control levels. Interestingly, GTE supplementation alone led 
to significant increases in inflammatory marker mRNA levels, although these levels 
returned to vehicle control levels with concomitant treatment (p<0.05).    
 
3.4.7. The AhR is implicated as a control mechanism both in PCB 126 toxicity and 
antioxidant response   
As seen in Fig. 3.8, GTE diet supplementation led to significant upregulation of AhR 
mRNA levels in liver in the presence of PCB 126, a dioxin-like AhR ligand. PCB 126 
insult did not induce AhR mRNA in vehicle control, vehicle + GTE control, and PCB 
control settings, but, interestingly, concomitant treatment led to a two-fold upregulation, 
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similarly to that seen in mRNA and protein antioxidant and inflammatory markers, thus 
allowing for increased in vivo toxicant clearance (p<0.01). Nrf2 mRNA levels were also 
significantly increased during PCB 126 insult, although GTE supplementation did not 
cause significant modulation of PCB toxicity. AhR and Nrf2 signaling pathways control 
both xenobiotic responses and inflammatory cascades, therefore their modulation by 
GTE diet supplementation implicates further GTE’s role in strengthening antioxidant 
response toward insult by environmental pollutants.  
 
3.5. Discussion 
Healthy nutrition can positively influence, or lessen, the human health risks 
associated with exposure to mixtures of environmental chemicals189.  The liver is one 
tissue particularly vulnerable to environmental pollutants, and especially PCB-induced 
toxicity 173.  One type of liver disease that affects more than 20% of Americans is 
nonalcoholic fatty liver disease, which can lead to nonalcoholic steatohepatitis190.  
Industrial toxicants also have been linked to secondary insults that can lead to 
steatohepatitis190.  Mechanisms defining the involvement of environmental pollutants in 
the pathology of liver diseases may include a compromised redox status or toxicant-
induced increase in oxidative stress.   
Lifestyle modifications that include healthful nutrition have been suggested as a 
powerful means of reducing the vulnerability to environmental insults189 and in reducing 
the risk to environmental toxicant-induced liver disease190. For example, green tea 
extract has been shown to protect against hepatic steatosis in obese mice by reducing 
oxidative stress and enhancing hepatic antioxidant defenses191. In the present study we 
observed significant protection against PCB 126-induced oxidative stress by dietary 
supplementation with green tea extract. In fact, mice supplemented with green tea 
extract and subsequently exposed to PCB displayed a decrease in overall F2-
isoprostane and metabolite levels compared to animals on a control diet exposed to 
PCB. We did not see a large increase in oxidative stress as evidenced by an increase in 
F2-isoprostane levels in mice fed a control diet and subsequently gavaged with PCB.  
This may have been due to the fact that the amount of administered PCB 126 reflects 
more physiologically relevant PCB concentrations in humans than previous studies using 
high concentrations of PCB congeners (e.g., 150 μmol/kg versus 5 μmol/kg used 
herein)192. We hypothesize that levels of PCBs encountered by humans today initiate low 
levels of chronic oxidative stress and inflammation that, together with multiple other 
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factors including poor diet and exposures to other environmental stressors, leads to 
augmented or exacerbated human disease. The protective properties of green tea have 
been studied extensively, and recent human studies suggest that consumption of green 
tea may protect against cardiovascular disease and some forms of cancer, have anti-
hypertensive and anti-obesity effects, and contribute to antibacterial and antiviral 
activity193. 
Certain environmental pollutants, and in particular ligands for the AhR, induce 
oxidative stress, in part via induction and uncoupling of cytochrome P450 enzymes20a. 
Hepatic changes in lipid composition, altered membrane structure and membrane 
functions are well-described phenomena of PCB-induced liver damage194. The protective 
properties of green tea extracts against PCB-induced pathologies, and in particular liver 
damage, may be numerous. For example, green tea may normalize the formation of lipid 
peroxide products induced by exposure to toxicants to prevent hepatic fibrosis185, or 
green tea may favorably regulate intestinal tight junction proteins or overall intestinal 
barrier function195. It has been proposed that green tea can inhibit the intestinal 
absorption of lipids and highly lipophilic organic compounds130. Induction of antioxidant 
enzymes by green tea also may contribute to its tissue protective properties196. Our 
current study support this concept, and we observed an increased induction of 
antioxidant genes such as SOD1, GSR, NQO1 and GST in mice that were fed a green 
tea-supplemented diet and subsequently challenged with PCB, compared to animals 
exposed to the control diet plus PCB. This may explain in part the observed decrease in 
overall oxidative stress due to green tea supplementation. Of particular interest is our 
observed induction of NQO1, a Nrf2 target gene, which suggests that green tea protects 
in part by modulation of the Nrf2/ARE pathway. In fact, it has been shown that food 
polyphenols, including the green tea polyphenol EGCG, the primary component of GTE 
tested herein, can modulate Nrf2-mediated antioxidant and detoxifying enzyme 
induction197. Our own work with vascular endothelial cells further suggests that multiple 
pathways including lipid raft caveolae and the antioxidant defense controller Nrf2 play a 
role in nutritional modulation of PCB-induced vascular toxicity13b and that cross-talk 
between caveolae-related proteins and cellular Nrf2 may be required for optimal 
cytoprotection by green tea catechins and other diet-derived polyphenols. 
Many groups, including ours, have shown that green tea catechins such as EGCG 
can upregulate basal levels of antioxidant enzymes in vitro116b, 193, 198. Interestingly, our 
overall results show that green tea extract supplemented in the diet acts as an 
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antioxidant only in the presence of a secondary stressor, in this case, the pro-
inflammatory coplanar PCB 126. The inconsistencies between in vitro and in vivo studies 
may be explained by the relatively high doses of tea catechins usually employed in cell 
culture or the fact that most tea catechins are quickly biotransformed in vivo to 
metabolites that exhibit differential physiological effects196.  There are many other 
examples of instances where supplementation with GTE or specific catechins is 
protective in in vivo models of inflammation and oxidative stress. For many of our 
investigated antioxidant enzymes we saw decreased expression in the presence of PCB 
when fed a control diet, but levels were upregulated, many returning to control vehicle 
levels in PCB groups fed a GTE-rich diet (e.g., SOD1 in Fig. 3.4). These observations 
are in line with other groups who investigated GTE effects on other stressors including 
ethanol toxicity and bacterial infection199. 
Our past work in cell culture points to the antioxidant controller Nrf2 as a major 
player in nutritional modulation of PCB toxicity. Many nutrients other than green tea 
catechins, including resveratrol, found in the skins of grapes, and sulforaphane, which is 
found in broccoli, have been shown to activate Nrf2123c, 137. Nrf2 can become 
transcriptionally active through multiple mechanisms including direct phosphorylation by 
PKC delta and loss of contact between Nrf2 and inhibitory kelch-like ECH-associated 
protein 1 (Keap1)99b. Upon activation, Nrf2 is able to evade ubiquitination, enter the 
nucleus, and bind cis-acting antioxidant response elements in target genes such as 
NQO182a. Nrf2 activation leads to decreased overall oxidative stress and inflammation, 
which is a hallmark of PCB toxicity100. In this work we observed a relatively significant 
trend toward increased NRF2 translocation to the nucleus in animals supplemented with 
GTE and subsequently exposed to PCB (Fig. 3.6). More interestingly and novel, we also 
saw a drastic increase in AhR mRNA expression in this same treatment group (Fig. 3.8). 
This upregulation was mirrored in increases in both CYP1A1 and CYP1B1 mRNA levels 
in mice fed a GTE rich diet and subsequently exposed to PCB. An increase in AhR may 
help to detoxify the acute exposure to PCB by increasing metabolism-assisted excretion. 
Although a consistent, steady upregulation of AhR may create a negatively imbalanced 
redox situation, the GTE’s ability to upregulate AhR only in the presence of a toxicant 
may in some cases be a protective and positive mechanism. Other groups have shown 
that different catechins within GTE display either antagonistic or agonist activities 
against CYP1A1200, but to our knowledge no group has reported the mRNA upregulation 
as seen in Fig. 3.7. In our analysis of PCB concentrations in plasma we observed a very 
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slight trend towards decreased levels of parent PCB 126 in the plasma of mice 
supplemented with GTE (Fig. 3.2). Although plasma levels may be a good overall picture 
of body-burden of PCBs, in the future, collecting urine and feces may paint a clearer 
picture of GTE’s involvement with detoxification and excretion. Also, we may have been 
able to see a more significant decrease in PCB levels and or a modulation of PCB 
hydroxy metabolite in mice supplemented with GTE if we sacrificed the mice more than 
24 hours after the final PCB dose130a.       
PCBs can induce vascular inflammation by upregulating pro-inflammatory mediators 
such as MCP-1 and CCL3. We hypothesized that GTE would downregulate basal levels 
of these inflammatory markers in vehicle treated mice as well as decrease PCB-
mediated upregulation in PCB 126 treated mice. Interestingly however, for both of our 
inflammatory markers we saw a significant increase in mRNA levels in vehicle treated 
mice supplemented with GTE (Fig. 3.7).  This observation would suggest that the dose 
of GTE used in this study may not be optimal, and perhaps toxic to some degree, in 
basal levels of oxidative stress and inflammation. Other groups have shown GTE 
toxicities at certain doses in vivo201, and interestingly, data illustrating protection seems 
to be more conclusive in animal models of oxidative stress and inflammation.  
Importantly, for our study, both MCP-1 and CCL3 mRNA levels return to vehicle treated 
control diet levels in mice fed GTE and subsequently exposed to PCB. This may point to 
GTE as exhibiting possible hormetic activity by inducing a slight response by the 
organism that ultimately primes the protective antioxidant system for a future stressor, 
i.e., Superfund pollutant exposure. Understanding hormesis and the role that nutrients 
can play is an extremely interesting scientific discipline and demands much more future 
investigation202.            
In summary, our current study supports our in vitro data that green tea catechins can 
protect against PCB 126-induced cytotoxicity by reducing oxidative stress73b. Our current 
in vivo data contributes to the overall hypothesis that nutrition can modulate 
environmental insults. More studies are needed to further understand detailed 
mechanisms of protective benefits to consume diets high in protective and healthful 
nutrients such as plant-derived polyphenols and other bioactive compounds. 
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Table 3.1. Primers used for qRT-PCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
q
Gene name Forward primer 5'-3' Reverse primer 5'-3' Fragment size
Inflammatory and xenobiotic-related markers
CCL3 CACCCTCTGTCACCTGCTCAA TGGCGCTGAGAAGACTTGGT 100 bp
CYP1A1 TGGAGCTTCCCCGATCCT CATACATGGAAGGCATGATCTAGGT 100 bp
CYP1B1 TGCATCGGTGAGGAACTGTCT CTCATGTTTGAGGACTCATTTTGG 104 bp
MCP-1 GCAGTTAACGCCCCACTCA CCTACTCATTGGGATCATCTTGCT 63 bp
Antioxidant markers
AhR GACCAAACACAAGCTAGACTTCACACC CAAGAAGCCGGAAAACTGTCATGC 200 bp
Catalase CAGAGAGCGGATTCCTGAGAGA CTTTGCCTTGGAGTATCTGGTGAT 100 bp
Gpx2 GTGGCGTCACTCTGAGGAACA CAGTTCTCCTGATGTCCGAACTG 125 bp
Gpx3 CATACCGGTTATGCGCTGGTA CCTGCCGCCTCATGTAAGAC 80 bp
Grx2 CATCCTGCTCTTACTGTTCCATGGCCAA TCATCTTGTGAAGCGCATCTTGAAACTGG 123 bp
GSR TCGGAATTCATGCACGATCA GGCTCACATAGGCATCCCTTT 100 bp
GSTa1 AAGCCCGTGCTTCACTACTTC GGGCACTTGGTCAAACATCAAA 159 bp
GSTa4 TACCTCGCTGCCAAGTACAAC GAGCCACGGCAATCATCATCA 109 bp
GSTm1 ATACTGGGATACTGGAACGTCC AGTCAGGGTTGTAACAGAGCAT 349 bp
GSTm2 ACACCCGCATACAGTTGGC TGCTTGCCCAGAAACTCAGAG 118 bp
GSTm3 CCCCAACTTTGACCGAAGC GGTGTCCATAACTTGGTTCTCCA 208 bp
NQO1 GGCATCCAGTCCTCCATCAA GTTAGTCCCTCGGCCATTGTT 100 bp
Nrf2 GAGTCGCTTGCCCTGGATATC TCATGGCTGCCTCCAGAGAA 100 bp
SOD1 GAAACAAGATGACTTGGGCAAAG TTACTGCGCAATCCCAATCA 100 bp
Trx2 GCTAGAGAAGATGGTCGCCAAGCAGCA TCCTCGTCCTTGATCCCCACAAACTTG 168 bp
TrxR1 GGCCAAAATCGGTGAACACATGGAAG CGCCAGCAACACTGTGTTAAATTCGCCCT 175 bp
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Table 3.2. The effect of green tea extract (GTE) diet supplementation on PCB 126-
induced mRNA inflammatory, xenobiotic-related, and antioxidant markers. 
 
 
 
 
 
 
 
 
 
  
5 µmol PCB 126/kg mouse (fold change)
Control diet Control + 1% GTE p-value
Inflammatory and xenobiotic-related markers
CCL3 2.051±0.224 0.945±0.116 <0.001
CYP1A1 915.208±136.510 1169.338±78.900 N.S.
CYP1B1 87.504±7.694 146.998±12.329 <0.001
MCP-1 1.909±0.478 0.745±0.235 0.012
Antioxidant markers
AhR 0.771±0.096 1.506±0.131 <0.001
Catalase 0.495±0.057 0.817±0.071 0.003
Gpx2 0.339±0.161 0.682±0.098 0.08
Gpx3 0.925±0.167 1.411±0.159 0.004
Grx2 0.213±0.015 0.486±0.078 0.003
GSR 0.702±0.074 1.245±0.097 0.001
GSTa1 14.771±2.911 22.955±3.975 0.034
GSTa4 0.896±0.117 2.222±0.245 <0.001
GSTm1 2.306±0.450 4.024±0.301 0.006
GSTm2 0.868±0.097 1.366±0.114 0.004
GSTm3 4.469±0.664 18.596±1.819 <0.001
NQO1 1.980±0.051 6.138±0.031 0.006
Nrf2 3.088±0.307 3.212±0.234 N.S.
SOD1 0.311±0.041 0.684±0.063 <0.001
Trx2 0.731±0.050 1.556±0.152 <0.001
TrxR1 1.522±0.143 2.673±0.276 0.002
Gene name
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Fig. 3.1. Proposed signaling pathway for PCB detoxification in vivo. PCB 126, an AHR 
ligand and activator of NRF2, causes CYP1A1 upregulation, which leads to superoxide 
production. Green tea extract (GTE) diet supplementation effectively upregulates redox-
related enzymes in the presence of PCB 126 which allows for a more efficient 
antioxidant response to environmental insult. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2. The effect of green tea extract (GTE) diet supplementation on systemic PCB 
126 concentration and metabolism. PCB 126 and its hydroxy metabolites were 
measured in mouse plasma by UFLC/MS MS and normalized to sample volume and 
internal standard recovery. PCB 126 is heavily metabolized in vivo, as seen by very low 
levels of parent PCB 126 remaining in plasma samples while its hydroxylated 
metabolites predominate. GTE supplementation did not significantly modulate systemic 
PCB or metabolite concentrations. Data are presented as mean±S.E.M (n=5). 
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Fig.3.3. PCB 126-induced oxidative stress is modulated by green tea extract (GTE) diet 
supplementation. Plasma F2-isoprostane and metabolite levels were measured by 
HPLC/MS MS to assess in vivo oxidative stress induced by PCB 126 that is potentially 
mitigated by GTE supplementation. Relative levels of combined F-2 IsoPs, including 
PGF2α, 8-iso-PGF2α, iPF2α-III, 8-epiPGF2α, 8-isoprostane, and 15-F2t isoprostanes, 
were determined by averaging the AUC integration values from retention times of 8 and 
11.3 minutes (Q1 = 353.144, Q2 =193.1). Additionally, the level of 13,14-dihydro-15-
ketoPGF2α, an F-2 IsoP metabolite, was determined by integrating its peak at 11.3 
minutes (Q1 = 355.2, Q2 = 311.4). Data are presented as mean±S.E.M. (n=8-10). GTE 
supplementation significantly decreased oxidative stress induced by PCB 126 treatment 
(*p<0.01).  
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Fig. 3.4 Relative mRNA levels of representative antioxidant enzyme markers. Overall 
GTE supplementation did not significantly increase antioxidant mRNA levels in control 
diets, but, in the presence of environmental perturbation (i.e. PCB 126 gavage), 
significantly higher antioxidant levels were seen in mouse liver above non-supplemented 
diet. All values were determined using the relative quantification method (ΔΔCt) as a fold 
change from control. Data are presented as mean±S.E.M (*p<0.01, n=8-10). See Table 
3.2 and Fig. 3.9. for more information concerning all antioxidant markers tested. 
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Fig. 3.5. GTE supplementation leads to increased antioxidant protein expression in the 
presence of PCB 126. Protein samples were separated through gel electrophoresis and 
probed with NQO1 and GSR primary antioxidant-related antibodies. Statistically 
significant increases in antioxidant protein activity were seen in PCB 126-treated mice 
that were fed a GTE-supplemented diet. In addition to visualized Western blot 
comparison to β-actin, samples were compared to GAPDH for densitometry 
quantification to further substantiate findings. GTE supplemented mice exposed to PCB 
showed a significant increase in protein expression, indicating a strengthened 
antioxidant response due to GTE supplementation (*p<0.01,**p≤0.05, N=8).  
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Fig. 3.6. Mice fed a 1% GTE-supplemented diet and subsequently exposed to PCB 126 
displayed increased Nrf2 activation, as evidenced by increased Nrf2 translocation to the 
nucleus, compared to mice fed 10% fat control diet and exposed to PCB. Lamin was 
used as a nuclear fraction housekeeping gene for densitometry quantifications. GTE 
supplemented mice exposed to PCB showed a trend toward increased nuclear 
abundance of Nrf2 (*p=0.1, n=4).    
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Fig. 3.7. Relative mRNA levels of inflammatory and xenobiotic-related markers. GTE 
supplementation led to increased cytochrome P450 (CYP1A1 and CYP1B1) mRNA 
expression in the presence of both GTE and environmental toxicant (i.e., PCB 126), 
indicating increased activity for toxicant degradation and/or excretion. MCP-1 and CCL3 
inflammatory markers were statistically increased in GTE-supplemented mice liver 
samples but toxicant-induced inflammatory markers returned to control levels due to 
GTE supplementation. All values were determined using the relative quantification 
method (ΔΔCt) as a fold change from control. Data are presented as mean±S.E.M. 
(*p<0.01, **p<0.05, n=8-10).  
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Fig. 3.8. GTE diet supplementation leads to significant upregulation of AhR mRNA levels 
in the presence of PCB 126, thus increasing in vivo toxicant clearance. Nrf2 mRNA 
levels are significantly increased during PCB 126 insult, although GTE supplementation 
does not cause statistically significant modulation of PCB toxicity. All values were 
determined using the relative quantification method (ΔΔCt) as a fold change from 
control. Data are presented as mean±S.E.M (n=8-10). GTE supplementation significantly 
increased AhR in the presence of PCB 126 treatment (*p<0.01).  
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Fig. 3.9. Relative mRNA levels of antioxidant enzyme markers. Overall, GTE 
supplementation did not significantly increase antioxidant mRNA levels in control diets, 
but, in the presence of environmental perturbation (i.e., PCB 126 gavage), significantly 
higher antioxidant levels were seen in mouse liver above non-supplemented diet. All 
values were determined using the relative quantification method (ΔΔCt) as a fold change 
from control. Vehicle and PCB 126-treated mice with 10% fat control and GTE-
supplemented diets: n=8-10. Data are presented as mean±S.E.M (*p<0.01, **p<0.05). 
See Table 3.2 and Fig. 3.4. for more information concerning antioxidant markers tested. 
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Fig. 3.10. PCB 126 exposure leads to a significant increase in liver/body weight ratio 
(hepatosomatic index, HSI) in both control and GTE-supplemented diets, although GTE 
supplementation did not significantly mitigate this PCB-induced increase. Statistical 
analysis was performed using two-way ANOVA followed by Tukey test with *p<0.001. A 
trend toward a statistically significant interaction between diet and PCB 126 treatment 
(p=0.06) was also seen. 
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Table 3.3.  A:  Dietary make up of low fat control and low fat 1% green tea extract 
mouse diets.  B:  Polyphenol formulation of Taiyo 1% GTE. 
A: 
B: 
Manufacturer's Description: Certified organic, excellent tea taste, stable in 
beverages. 
Catechins>15%(ECG average 11.75%), caffeine<10% (average 6.6%) 
% Total %Catechins 
Caffeine 7.5  
EGC 9.3  35.1  
EC 2.8  10.6  
EGCG 11.7  44.1  
ECG 2.7  10.2  
Total Catechins 26.6  100.0  
pp p
g/kg kcal g/kg kcal
Protein 19 (20%) 19 (20%)
Carbohydrate 67 (70%) 67 (70%)
Fat 4 (10%) 4 (10%)
Casein 190 800 190 800
L-Cystine 3 12 3 12
Corn Starch 299 1260 299 1260
Maltodextrin 10 33 140 33 140
Sucrose 332 1400 332 1400
Cellulose, BW200 47 0 47 0
Soybean Oil 24 225 24 225
Lard 19 180 19 180
Mineral Mix 
S10026
9 0 9 0
Vitamin Mix 
V10001
9 40 9 40
Green Tea Extract 10 ‐‐ 0 ‐‐
Total 1065 4057 1055 4057
1% GTE-supplemented diet Control diet
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Chapter 4. Nitration of linoleic acid modulates polychlorinated biphenyl-induced 
endothelial cell dysfunction 
4.1 Synposis 
Data now implicate correlations between persistent organic pollutants, such as 
polychlorinated biphenyls, and cardiovascular diseases. We have shown that coplanar 
PCBs can initiate endothelial cell dysfunction, oxidative stress, and inflammation. Recent 
evidence shows that toxicant-nutrient interactions exist, and a diet high in pro-
inflammatory omega-6 lipids such as linoleic acid, may exacerbate PCB-induced 
cardiovascular disease. However, recently discovered anti-inflammatory lipid 
metabolites, such as nitro-fatty acids, may limit this exacerbated effect. The aim of our 
research was to determine if pro-inflammatory lipids could increase the toxicity of the 
coplanar PCB 126, and if nitration of these pro-inflammatory lipids could ameliorate this 
exacerbated effect.  First, vascular endothelial cells were treated with linoleic acid or 
nitrolinoleic acid and harvested for mRNA.  Linoleic acid treatment alone increased AhR, 
CYP1A1, MCP-1, and VCAM-1 message in a dose dependent manner, but the 
upregulation of these pro-inflammatory mediators was not observed in nitrolinoleic 
treated cells.  Also, nitrolinoleic acid upregulated heme-oxygenase 1, a protective 
antioxidant enzyme, which may help to explain the anti-inflammatory role of nitro-fatty 
acids.  Next, vascular endothelial cells were pretreated with linoleic acid or nitrolinoleic 
acid and subsequently exposed to physiologically relevant concentrations of PCB 126. 
Treatment with linoleic acid was pro-inflammatory as evidenced by increased mRNA 
levels (RT-PCR) of vascular cellular adhesion molecular-1 (VCAM-1), monocyte 
chemoattractant protein-1 (MCP-1) and caveolin-1 (Cav-1). Levels of MCP-1 and VCAM-
1 were most exacerbated in linoleic acid/PCB treated cells. Interestingly, the addition of 
a nitro group to linoleic acid prevented this exacerbated PCB effect.  More research is 
necessary to determine if the protective effects observed herein are due to an 
upregulated antioxidant defense or rather the nitro group protecting against oxidation 
and subsequent formation of toxic pro-inflammatory metabolites.  Understanding diet 
toxicant interactions is a critical step towards more effective risk assessment and public 
health outcomes for at-risk populations who reside near hazardous and Superfund sites   
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4.2 Introduction 
 Cardiovascular disease is the leading cause of death in the developed world and 
can be modified depending on nutritional habits of the individual.  Certain dietary choices 
have been shown to be pro-atherosclerotic and proinflammatory whereas other, more 
healthful choices, have been shown to decrease oxidative stress, inflammation, and 
vascular diseases.  An increasing body of scientific research now implicates dietary fats 
as important mediators of cardiovascular disease.  Certain fatty acids such as linoleic 
acid (parent omega-6 polyunsaturated fatty acid) have been shown to promote 
endothelial cell inflammation primarily by an increase in toxic linoleic acid metabolites.   
 Many inexpensive plant derived oils are rich in linoleic acid, which makes this 
fatty acid a predominate component in Western diets.  Reducing the intake of this 
nutrient has been shown to be protective against multiple proinflammatory diseases203.   
Linoleic acid can be metabolitzed by multiple cell types, including endothelial cells, into 
bioactive mediators such as cis-epoxyoctadecenoic acids (9, 10- and 12, 13-EOA), 9- 
and 13- hydroxy-octadecadienoic acid (9- and 13-HODE), and 9- and 13-oxo-
octadecadienoic acid (9- and 13-oxoODE)8, 204.  The formation of these toxic metabolites 
can be due to random radical-mediated oxidation, or enzymatically controlled by 12/15-
lipoxygenases, cyclooxygenases, or even cytochrome P450s8.  The monoepoxides of 
linoleic acid are commonly referred to as leukotoxins (LTX) and their abundance is 
related to cytochrome P450 activation205.  There is evidence that links these toxic 
metabolites to organ failure, pulmonary edema, and endothelial cell damage205.  LTX 
have been shown to increase endothelial cell permeability and activation of 
proinflammatory NFκB205.  There are however, metabolites of linoleic acid that appear to 
be anti-inflammatory and may be effective protective mediators of endothelial cell 
dysfunction. 
 Recently identified endogenous fatty acid metabolites known as nitro-fatty acids 
have been implicated as possible protective mediators of inflammation and 
cardiovascular disease.  Unsubstituted fatty acids such as oleic acid (18:1), arachidonic 
acid (20:4), and linoleic acid (18:2) can be nitrated endogenously by multiple enzymatic 
and non-enzymatic reactions, resulting in the inhibition of pro-inflammatory mediators, 
induction of protective heme oxygenase-1, and blood vessel relaxation146.  Nitro-fatty 
acids can protect via multiple mechanisms including upregulation of PPARγ and Nrf2 as 
well as downregulation of pro-inflammatory NFκB147.  ApoE-/- animals administered a 
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nitro-fatty acid displayed reduced foam cell formation, decreased lesion formation, and 
inhibited pro-inflammatory adhesion molecule expression compared to vehicle treated 
control mice144d.  Recently, Shin et al., reported that nitro-fatty acids may directly 
modulate endothelial cell signaling, specifically by altering caveolin-1 and eNOS 
signaling206.  Vascular endothelial cells are dynamic modulators of CVD and come in 
contact with heterogenous blood components and stimuli such as a wide assortment of 
dietary nutrients, lipid soluble toxic pollutants, and endogenous pro-inflammatory signals 
and compounds.  Once believed to be a relatively unimportant regulatory cell type, 
endothelial cells are now known to be critical mediators of platelet adherence, 
modulators of vascular tone, regulators of thrombosis, and controllers of immune and 
inflammatory responses 5.  Since endothelial cells are constantly exposed to blood and 
associated proteins, it is not surprising that nutrient and chemical compounds from the 
diet may play a critical role in the regulation of endothelial cell dysfunction and 
subsequent cardiovascular disease.  Due to commonalities between certain dietary 
nutrients and toxicants in regards to activation of endothelial cells, more research 
describing the interplay between nutrition and toxicology is critical to better understand 
the risks of environmental pollutants in a world of multiple concomitant stressors.    
    Accompanying nutrients from the diet, many lipophilic persistent organic 
pollutants (POPs) are also distributed throughout the body via blood flow and plasma 
proteins.  Developing a body burden of POPs is not rare; for example, in studies 
attempting to identify the concentrations of multiple pollutant compounds in human 
plasma, it is not uncommon for the researchers to find known toxicants in 99-100% of 
their test subjects in the parts per billion range (ppb)10.  Not surprisingly, many of these 
manmade compounds have been shown to interact and activate endothelial cells; some 
causing toxicity via many of the same mechanisms as detrimental nutrient components.  
For example, certain toxicants such as PCBs have been shown to increase oxidative 
stress, upregulate NFκB, and lead to endothelial cell dysfunction and inflammation12.  
Interestingly, it appears that certain nutritional choices, such as diets high in linoleic acid,   
may actually exacerbate the toxicity of persistent organic pollutants13.   
 
Previous work has shown that linoleic acid can amplify the endothelial cell toxicity 
of polychlorinated biphenyls109.  Linoleic acid pretreatment exacerbated PCB-induced 
oxidative stress, NFκB DNA binding, and albumin transfer in primary vascular 
endothelial cells, which mechanistically may be explained by an observed exacerbated 
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cytochrome P450 1A1 (Cyp1A1) upregulation109.  Other groups have also documented 
detrimental nutrient/toxicant interactions; elevated levels of linoleic acid may enhance 
the cellular bioavailability of PCBs, PCBs can downregulate delta 5 and delta 6 
desaturases which are critical for the breakdown of linoleic acid, and PCBs can promote 
the transport of linoleic acid from circulating plasma into vascular tissues112, 126.  Finally, it 
was shown that the exacerbated effects observed may be due to the creation of 
metabolites such as LTX and LTXD205.  Although it has been shown that detrimental 
metabolites of linoleic acid may exacerbate toxicant-induced endothelial cell dysfunction, 
it is not known if other endogenously formed metabolites such as nitro-linoleic acid may 
be protective.     
 Thus, the current study has been designed to investigate mechanistically if pro-
inflammatory lipids could increase the toxicity of the coplanar PCB 126, and if nitration of 
these pro-inflammatory lipids could ameliorate this exacerbated effect.  Our data provide 
evidence that free linoleic fatty acid is pro-inflammatory to vascular endothelial cells, and 
this toxicity can be exacerbated in the presence of PCBs.  On the contrary, our data also 
provide evidence that nitration of linoleic acid blunts these exacerbated effects.  Since 
linoleic acid makes up a large portion of Western diets, it may be beneficial for future 
research to investigate mechanisms of endogenously increasing the formation of nitro-
fatty acids in humans.   
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4.3 Materials and methods 
4.3.1 Materials and Chemicals 
3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) was obtained from AccuStandard Inc. (New 
Haven, CT).  Linoleic and nitro-linoleic acids were purchased from Cayman Chemical 
(Ann Arbor, MI).   
4.3.2 Cell culture and experimental media 
Primary vascular endothelial cells were isolated from porcine pulmonary arteries (Han et 
al., 2010). Cells were cultured in M199 (Gibco, Grand Island, NY), supplemented with 
fetal bovine serum (FBS; Gibco).  Endothelial cells were grown to confluence, followed 
by incubation overnight in medium containing 1% FBS prior to cell treatment. Stock 
solutions of linoleic acid or nitro-linoleic acid were purchased or diluted to 1 mg/mL 
(EtOH) and subsequently diluted to working stocks.  Cells were pretreated with fatty acid 
or vehicle control with total volume being 0.1%.  Stock solutions of PCB 126 were 
prepared in DMSO at 4 mM and subsequently diluted to working stocks in DMSO; 
control cultures were treated with DMSO vehicle. The levels of DMSO in experimental 
media were 0.05%. Porcine vascular endothelial cells were treated with PCB 126 at 0.03 
nM for 6 h.   
4.3.3 Real-time PCR  
The levels of mRNA expression were assessed by real-time PCR using a CFX96 Touch 
Real-Time PCR detection system (BioRad, Hercules, CA) and SYBR Green master mix 
(Applied Biosystems) as described earlier (Han et al., 2010). Sequences were designed 
using the Primer Express Software 3.0 for real-time PCR (Applied Biosystems) and 
synthesized by Integrated DNA Technologies, Inc. (Coralville, IA). Sequences for 
porcine VCAM-1 and β-actin were described in earlier articles published from our 
laboratory (Ramadass et al., 2003; Majkova et al., 2009). Porcine NQO1 sequences 
were: sense, 5′-CCCGGGAACTTTCAGTATCCT-3′; and antisense, 5′-
CTGCGGCTTCCACCTTCTT-3′; porcine HO-1 sequences were: sense, 5’-
GCCATGTGAATGCAACCCTGTGAA-3’; and antisense, 5’-
TTGGGAAAGATGCCACAGACTCCT-3’.  Porcine AhR sequences were: sense, 5’-
AGCTGCACTGGGCGTTAAA-3’; and antisense, 5’-GCCACTCGCTTCATCAATTCT-3’.  
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Porcine Cyp1A1 sequences were: sense, 5’-CATCCGGGACATCACAGACA-3’; and 
antisense, 5’-GCATTCTCGTCCATCCTCTTG-3’.  Porcine MCP-1 sequences were: 
sense, 5’-CGGCTGATGAGCTACAGAAGAGT-3’; and antisense, 5’-
GCTTGGGTTCTGCACAGATCT-3’.             
   
4.3.4 Statistical analysis  
Data were analyzed using SigmaStat software (Systat Software, Point Richmond, CA). 
Comparisons between treatments were made by one-way ANOVA or two-way ANOVA 
as appropriate with post-hoc comparisons of the means (Tukey).  To elucidate trends 
within groups, multiple comparison procedures were completed for tests that displayed 
overall significance (p≤0.05-0.1).  Interactions between fatty acid treatment and toxicant 
exposure were denoted.  Groups were considered significantly different with a 
determined p value of p≤0.05.     
 
4.4 Results 
 
4.4.1 Parent linoleic acid is pro-inflammatory whereas nitro-linoleic acid is anti-
inflammatory 
  Previously, we have shown that linoleic acid can promote endothelial cell 
dysfunction, as evidenced by a decrease in endothelial barrier function and an increase 
in LDL transcytosis109, 207.  These studies used fatty acid concentrations up to 90 µM 
bound to 30 µM albumen109.  Here, we treated primary porcine vascular endothelial cells 
with a low concentration (1-3 µM) of free linoleic fatty acid dissolved in EtOH for 6 h and 
saw a statistically significant upregulation of VCAM-1 and MCP-1 mRNA expression in a 
concentration dependent manner (Fig. 4.1, Fig. 4.2).  However, this upregulation was not 
observed in cells treated with nitro-linoleic acid.  Interestingly, treatment with nitro-
linoleic acid decreased levels of VCAM-1 mRNA approximately 50% compared with 
ethanol control (Fig. 4.2).   
4.4.2 Parent linoleic acid increases AhR and Cyp1A1 expression, but nitro-linoleic acid 
has no effect 
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 Since it is known that coplanar PCBs exert their toxicity primarily through the 
AhR, we were interested in determining if linoleic or nitro-linoleic acid would modulate 
this pathway.  Therefore, we treated primary porcine vascular endothelial cells with 1 or 
3 µM parent or nitro-metabolite of linoleic acid for 6 hours and harvested for mRNA.  
Nitro-linoleic acid had no effect on AhR or Cyp1A1 mRNA expression, however, parent 
linoleic acid significantly increased AhR and Cyp1A1 mRNA expression in a dose 
dependent manner (Fig. 4.3 and Fig. 4.4).   
 
4.4.3 Nitro-linoleic acid upregulates the antioxidant defense greater than parent linoleic 
acid 
 Recently, it has been shown that certain PUFA metabolites may be protective by 
upregulating the endogenous antioxidant defense.  Therefore we treated our endothelial 
cell model with parent or nitro-linoleic acid for 6 hours and determined mRNA expression 
levels of the antioxidant enzymes NQO1 and heme oxygenase-1 (HO-1) via real-time 
PCR.  Treatment with parent and nitro-linoleic acid both caused an upregulation of 
NQO1 at approximately a 4 and 8 fold increased level respectively (Fig. 4.5).  
Interestingly, HO-1 was only induced in nitro-fatty acid treated cells and this upregulation 
was considerably higher than observed with NQO1 (Fig. 4.5).      
 
4.4.4 PCBs exacerbate linoleic acid-induced increases in Cyp1A1, but pretreatment with 
nitro-linoleic acid prevents this exacerbated effect. 
 In an attempt to determine interactions between diet and toxicant exposure, 
primary vascular endothelial cells were pretreated with a low level of linoleic or nitro-
linoleic acid (0.1 μM) for 6 h and then exposed to physiological relevant levels of PCB 
126 (0.03 nM) for another 6 h. Since AhR activation has been shown to be necessary for 
coplanar PCB toxicity, mRNA levels of the downstream AhR target, Cyp1A1, were 
investigated via real time-PCR.  Cyp1A1 induction has long been used as a surrogate 
marker for coplanar PCB exposure, and in this study, Cyp1A1 was significantly 
upregulated in all PCB treatment groups (Fig. 4.6).  As was also seen in the experiments 
described within section 4.4.2 which utilized 1-3 µM of fatty acid, parent linoleic acid 
significantly increased Cyp1A1 mRNA levels in vehicle control (DMSO) treated cells.  
Interestingly, in cells that were pretreated with linoleic acid and subsequently exposed to 
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low concentrations of PCB 126, this increase in Cyp1A1 was significantly exacerbated.  
However, pretreatment with nitro-linoleic acid returned PCB-induced Cyp1A1 levels back 
to vehicle control levels and the observed exacerbated effect was lost.    
 
4.4.5 PCBs exacerbate linoleic acid-induced increases in pro-inflammatory mediators, 
but pretreatment with nitro-linoleic acid prevents this exacerbated effect. 
Levels of pro-inflammatory mediators such as MCP-1, VCAM-1, and caveolin-1 were 
also examined in cells pretreated with fatty acids and subsequently exposed to PCBs.   
In ethanol control cells, treatment with low dose of PCB for 6 h did not significantly 
upregulate the pro-inflammatory mediators (Fig. 4.7).  Parent linoleic acid significantly 
increased MCP-1 and VCAM-1 mRNA levels in DMSO treated cells.  Interestingly, in 
cells that were pretreated with linoleic acid and subsequently exposed to low 
concentrations of PCB 126, this increase in MCP-1 and VCAM-1 was significantly 
exacerbated.  However, pretreatment with nitro-linoleic acid returned PCB-induced 
MCP-1 and VCAM-1 levels back to control vehicle levels and the observed exacerbated 
effect was lost.        
 
4.5 Discussion 
 Emerging data now implicate both positive and negative effects related to the 
interplay between nutrition and toxicology.  Originally, food from the diet were believed to 
be an exposure route of toxicants.  However, evidence suggests that a person’s diet, 
and perhaps more appropriately the specific nutrients found within one’s diet, may either 
exacerbate or prevent toxicant-induced diseases13.  The protective or detrimental 
interactive effects observed may be due to commonalities between toxicant and nutrient 
signaling pathways.  Nutrients and toxicants can both modulate transcription factors and 
signaling mediators related to redox balance, stress response, and inflammation.  
Endothelial cells are prime candidates to use as a tool to examine the interplay between 
toxicology and nutrition because this cell type normally comes into contact with an array 
of circulating nutrients and pollutants.  Dysfunction of endothelial cells can occur by 
toxicants and be exacerbated by certain pro-oxidative and/or pro-inflammatory diet 
derived lipids, which can lead to atherosclerosis and vascular related diseases.    
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 Atherosclerosis is a disease of lifelong progression and can be modulated by 
many controllable and non-controllable risk factors.  Dietary habits, sedentary lifestyle, 
and smoking may all be risk factors related to choice, but pollutant exposures leading to 
heart disease risk may occur invisibly.  Low level exposures occur daily to a wide variety 
of environmental stressors including chlorinated toxicants, endocrine disrupting 
chemicals, and heavy metals, which by themselves may not elicit life threatening 
reactions, but in combination as daily pollutant mixtures or in conjunction with other poor 
lifestyle choices (e.g., poor nutritional choices or sedentary lifestyle) may increase the 
risk for multiple pro-inflammatory chronic diseases.  The results described within this 
chapter provide evidence that certain dietary nutrients can exacerbate the toxicity of 
physiologically relevant low levels of persistent organic pollutants.  Also, it was 
determined that the addition of an NO2 moiety to form the nitro-fatty acid version of 
linoleic acid effectively eliminated this exacerbated toxicity.  This observation is of 
importance because linoleic acid can be endogenously nitrated within the body, but the 
control mechanisms regulating nitro-fatty acid formation are not well understood. 
 Nitro-fatty acids are a group of endogenously formed bioactive lipid metabolites 
that have been examined for protective roles in multiple chronic diseases.    Nitro-oleic 
and nitro-linoleic acid are two highly studied fatty acid derivatives due to their observable 
presence in human plasma and anti-inflammatory nature in cell and mouse models of 
disease.  Nitro-oleic acid has been shown to prevent against angiotensin II- induced 
hypertension, endotoxin-induced endotoxemia, and LPS-induced lung injury208.  
Researchers may be focused primarily on nitro-oleic acid in an attempt to identify novel 
mechanisms of protection from the consumption of oleic acid-rich extra virgin olive oil.  In 
this current study, treatment with nitro-linoleic acid increased the expression of 
protective HO-1 (a Nrf2 controllable antioxidant enzyme) and decreased pro-
inflammatory mediators, especially when compared to cells treated with pro-
inflammatory parent linoleic acid.  Interestingly, both nitro-linoleic and parent linoleic acid 
increased the expression of GST.  GST has binding sites for both Nrf2 and AhR, and in 
this current study it was observed that parent linoleic acid treatment upregulated AhR209.  
AhR and Nrf2 can work in concert to eliminate compounds from the body, but sometimes 
AhR activation can lead to the creation of even more toxic metabolites.  Identifying the 
causative bioactive nutrients within an overall healthful diet is an emerging but still 
difficult field of study.  Arguably, it may be even more helpful to identify detrimental 
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nutrients and nutrient metabolites that can detrimentally effect health outcomes or act as 
biomarkers. 
 The endogenous metabolism and breakdown of nutrients can lead to the 
formation of mediators linked to inflammation and chronic disease.  Specifically related 
to this chapter, the parent omega-6 fatty acid Linoleic acid can be oxidized enzymatically 
and non-enzymatically to produce possibly harmful byproducts.  Interestingly, 
cytochrome P450s have been shown to be critical mediators of both PCB toxicity and 
the formation of toxic linoleic acid metabolites called leukotoxins (LTX and LTXD).  In 
this current work, it was determined that treatment for 6 h with linoleic acid upregulated 
Cyp1A1 mRNA levels, which has routinely been utilized as a marker for AhR activation.  
The observed upregulation of Cyp1A1 may have been due to the observed AhR 
message increase, but others have shown that Cyp1A1 can be upregulated by fatty 
acids and fatty acid metabolites in a PPARα-mediated mechanism210.  In similar previous 
work, 6 h treatment with linoleic acid lead to an upregulation of another CYP family 
member Cyp2C9 and ultimately leading to superoxide formation and oxidative stress211.  
Our current work did not examine oxidative stress conditions in our porcine endothelial 
cell model, but did look at downstream markers of inflammation such as MCP-1 and 
VCAM-1.  In each of these cases linoleic acid was pro-inflammatory.  Certain omega-6 
fatty acids and their metabolites are known to be toxic to endothelial cells.  It is unknown 
what levels of toxic linoleic acid metabolites are formed within the cell after the exposure 
conditions in this current work, but others have reported toxicity of linoleic acid 
metabolites such as LTX and LTXD at concentrations of 40 µM205.  These low levels 
were shown to increase albumin transfer and cause endothelial cell dysfunction.  
Linoleic acid is found abundantly in Western diets and may reach 8-12 grams per day in 
adults210.  Lipid peroxidation products of linoleic acid also exist, and in fact, the pool of 
peroxidation productions is dominated by linoleic acid-based compounds212.  Cellular 
lipoxygenases generate lipid hydroperoxides and reactive oxygen species and the major 
metabolites formed from linoleic acid are 9-hydroperoxy-10,12-octadienoic acid (9-
HPODE) and 13-hydroperoxy-9,11-octadecadienoic acid (13-HPODE).  Lipid 
peroxidation can also lead to the formation of highly reactive and toxic metabolites such 
as 4-hydroxynonenal (4-HNE)212.  Levels of these toxic metabolites were not examined 
in this current work, but would be a beneficial mechanistic link between the observed 
toxicity of parent but not nitro-linoleic acid.  Perhaps the addition of the NO2 to the 
linoleic acid can prevent or slow the enzymatic and non-enzymatic production of toxic 
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metabolites.  Therefore, it may be critical to better understand the formation of toxic and 
protective linoleic metabolites to better identify and communicate risks with eating diets 
high in omega-6 fatty acids.   
 Understanding the interplay and interactions between toxicants and nutrients will 
allow for more effective exposure risk assessments.  The exacerbated effect of certain 
nutrients on toxicological outcomes has been proposed previously and has been seen 
with multiple toxicants and nutrient combinations13.  In this work, pretreatment with 
linoleic acid but not nitro-linoleic acid exacerbated PCB-induced Cyp1A1, VCAM-1, and 
MCP-1 upregulation.  This effect may be linked to PCB 126 and linoleic acid treatments 
both being able to activate the AhR and subsequently increase oxidative stress 
conditions.  It would be interesting to examine the interactive effects between a nutrient 
and toxicant that activate dissimilar pathways.  Pretreatment with nitro-linoleic acid may 
be protective by not sensitizing AhR prior to toxicant exposure and in addition may 
activate Nrf2 and the antioxidant response.  As seen in Chapter 3 of this dissertation, 
dietary interventions upregulated the antioxidant response which allowed for a more 
efficient and effective physiological response in the presence of PCB.      
 In summary, our current study supports our previous work illustrating that a major 
dietary nutrient found in Western diets, linoleic acid, is pro-inflammatory to endothelial 
cells and exerts exacerbated effects in the presence of PCBs. Interestingly, our current 
in vitro data contribute to the overall hypothesis that certain nutrients can decrease the 
toxicity of environmental insults.  Although the parent linoleic acid appeared to be pro-
inflammatory, pretreatment with the endogenously created metabolite, nitro linoleic acid, 
prevented this exacerbated effect.  More studies are needed to further understand 
detailed mechanisms of the creation of endogenously controlled nutrient metabolites and 
how to possibly shift the pool of bioactive lipids from detrimental to positive.   
 
  
 
  
  
 
 
 
 
 
  
 
 
 
 
Fig. 4.1 Relative mRNA levels of monocyte chemoattractant protein-1 in cells treated for 
6 h with parent or nitrated linoleic acid (1 or 3 μM). Parent linoleic acid was pro-
inflammatory and increased MCP-1 levels but this increase was not seen in nitro-fatty 
acid treated cells. All values were determined using the relative quantification method 
(ΔΔCt) as compared to EtOH control. Data are presented as mean±S.E.M (n=3).  
Different letters denote statistical significance between treatment groups. 
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Fig. 4.2 Relative mRNA levels of vascular cell adhesion molecule-1 in cells treated for 6 
h with parent or nitrated linoleic acid (1 or 3 μM). Parent linoleic acid was pro-
inflammatory and increased VCAM-1 levels but nitro-fatty acid treatment was anti-
inflammatory. All values were determined using the relative quantification method (ΔΔCt) 
as compared to EtOH control. Data are presented as mean±S.E.M (n=3).  Different 
letters denote statistical significance between treatment groups. 
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Fig. 4.3 Relative mRNA levels of Aryl hydrocarbon receptor and cytochrome P4501A1 in 
cells treated for 6 h with parent or nitrated linoleic acid (1 μM). Parent linoleic acid 
upregulated AhR as well as Cyp1A1, but this upregulation was not seen in nitro-fatty 
acid treated cells. All values were determined using the relative quantification method 
(ΔΔCt) as compared to EtOH control. Data are presented as mean±S.E.M (n=3).  
Different letters denote statistical significance between treatment groups. 
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Fig. 4.4 Relative mRNA levels of aryl hydrocarbon receptor and cytochrome P4501A1 in 
cells treated for 6 h with parent or nitrated linoleic acid (3 μM). Parent linoleic acid 
upregulated AhR as well as Cyp1A1, but this upregulation was not seen in nitro-fatty 
acid treated cells (ptrend=0.09). All values were determined using the relative 
quantification method (ΔΔCt) as compared to EtOH control. Data are presented as 
mean±S.E.M (n=3).  Different letters denote statistical significance between treatment 
groups. 
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Fig. 4.5 Relative mRNA levels of heme oxygenase-1 and NADPH quinone oxido-
reducatase-1 (antioxidant enzymes) in cells treated for 6 h with parent or nitrated linoleic 
acid (3 μM). Parent linoleic acid upregulated NQO1, but not HO-1 whereas nitro-fatty 
acid upregulated both protective enzymes. All values were determined using the relative 
quantification method (ΔΔCt) as compared to EtOH control. Data are presented as 
mean±S.E.M (n=3).  Different letters denote statistical significance between treatment 
groups. 
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Fig. 4.6 Relative mRNA levels of cytochrome p4501A1 in cells pretreated for 6 h with 
parent or nitrated linoleic acid (0.1 μM) and subsequently treated for 6 h with 0.03 nM 
PCB 126. Cells treated with PCB 126 exhibited an upregulated CYP1A1 response 
(*p<0.05).  This upregulation of Cyp1A1 was exacerbated in cells treated with parent 
linoleic acid, but not in cells pretreated with nitro-fatty acid.  All values were determined 
using the relative quantification method (ΔΔCt) as compared to EtOH control. Data are 
presented as mean±S.E.M (n=3).  * denotes p<0.05 compared to corresponding DMSO 
control. 
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Fig. 4.7 Relative mRNA levels of MCP1 or VCAM-1 in cells pretreated for 6 h with parent 
or nitrated linoleic acid (0.1 μM) and subsequently treated for 6h with 0.03 nM PCB 126. 
Control cells treated with PCB 126 exhibited low induction of the pro-inflammatory 
markers after an acute exposure to PCB (6 h).  Parent linoleic acid was pro-inflammatory 
and significantly exacerbated the PCB effect. Cells pretreated with nitro-fatty acid 
mirrored control cells’ responses.  All values were determined using the relative 
quantification method (ΔΔCt) as compared to EtOH control. Data are presented as 
mean±S.E.M (n=3). * denotes p<0.05 compared to corresponding DMSO control. 
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Chapter Five.  Overall discussion 
 
5.1. Discussion 
 
5.1.1 Summary 
 The research presented within this dissertation provides new mechanistic 
toxicological insights into polychlorinated biphenyl-induced endothelial cell dysfunction 
and inflammation.  Ultimately, we are interested in decreasing the negative health risks 
associated with pollutant exposures; thus this dissertation also provides novel evidence 
that diets high in healthful bioactive nutrients may be a sensible means of modulating 
associated disease risks.  Caveolae harbor numerous inflammatory proteins, and Nrf2 is 
considered the master antioxidant controller in most cell types including those that make 
up vascular tissues.  Caveolae and Nrf2 pathways are critical mediators of PCB-induced 
endothelial cell dysfunction as well as nutritional modulation of PCB vascular toxicity.  
Decreasing Cav-1 in endothelial cells prevents PCB-induced upregulation of pro-
inflammatory mediators, and this protection may be due to a direct upregulation of 
protective antioxidant enzymes under the control of the transcription factor Nrf2.  Dietary 
intervention strategies utilizing flavonoid or bioactive fatty acids can modulate the toxicity 
of coplanar PCB 126.  We demonstrated that a diet enriched in green tea polyphenols 
can decrease oxidative stress and inflammation in mice subsequently exposed to PCB.  
Finally, we also examined the role of bioactive nutrient metabolites, such as the 
endogenously formed nitro-fatty acids, as possible novel modulators of toxicant-induced 
endothelial cell dysfunction.       
5.1.2 Decreasing Cav-1 upregulates the Nrf2 antioxidant response 
 Endothelial cells come in to contact with an array of persistent organic pollutants 
daily and have evolved multiple means of protecting against associated cellular stresses.  
Coplanar PCBs, the most toxic to endothelial cells, have been shown to induce an 
increase in ROS and RNS primarily through an AhR and Cyp1A1 mediated 
mechanism12b, 12c.  AhR has been shown to locate and concentrate within caveolae lipid 
domains and specifically has been shown to co-immunoprecipitate with the major 
structural protein of caveolae, Cav-112b.  In fact, treatment of endothelial cells with 
coplanar PCBs induces Cav-1 expression and increases this partnership with AhR.  Our 
98 
 
  
laboratory determined that loss of Cav-1, either through siRNA knockdown in cells or the 
use of Cav-1 null mice, was protective and mitigated PCB-induced endothelial cell 
dysfunction and the earliest stages of PCB-induced atherosclerosis12a, 23b.  Multiple 
hypotheses were postulated to explain this protection including decreased uptake of 
PCBs into endothelial cells, modulation of AhR signaling due to the loss of Cav-1, and 
perhaps modulation of cross-talk with other signaling partners related to inflammation 
and PCB-induced endothelial cell toxicity.  This dissertation has investigated this final 
hypothesis and determined that Cav-1 signaling can modulate the antioxidant defense 
within a cell by altering the Nrf2 pathway. 
 Recently it has been shown that downregulation of Cav-1 leads to an increase in 
protective HO-1, an antioxidant controlled by Nrf2116b.  This observation led us to 
investigate mechanistically the link between Cav-1 and Nrf2.  We determined that 
decreasing the protein levels of Cav-1 upregulated Nrf2 activation leading to an increase 
in cellular levels of multiple antioxidant enzymes and ultimately prevented PCB-induced 
endothelial cell activation.  Interestingly, two other independent research groups also 
recently published similar results detailing Cav-1’s inhibitory role of Nrf298, 140, 160.  These 
highly mechanistic works focused on direct inhibition of Nrf2 through Cav-1’s binding 
domain.  Their work suggests that one of the interaction mechanisms linking Cav-1 and 
Nrf2 pathways is a direct binding and inhibition, much like in the case of eNOS/Cav-1 
interaction.  The work described within this dissertation details other possible 
mechanisms of Cav-1 Nrf2 cross-talk, including the modulation of Nrf2 inhibitor proteins 
such as Keap1 and Fyn kinase.  Mechanisms linking the downregulation of Cav-1 levels 
to also downregulation of Keap1 and Fyn are unknown and present the possibility for 
multiple future studies.  A better understanding of this “blackbox” could lead to new 
therapeutic targets that ultimately activate Nrf2 and prevent inflammation and oxidative 
stress.   
 The crosstalk between caveolae and Nrf2 signaling pathways appears to be 
evolutionarily conserved among mammalian species.  A strength of chapter two of this 
dissertation is that cross-talk between Cav-1 and Nrf2 was observed in three distinct 
species; human, pig, and mouse.  This may support the hypothesis that caveolae and 
specifically Cav-1 are critical mediators of inflammation and oxidative stress within 
endothelial cells, and targeted downregulation of endothelial cell Cav-1 may protect 
against atherosclerosis, inflammation, and toxicant-induced disease.  A goal of our 
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laboratory is to determine therapeutic bioactive nutrients that can modulate caveolae 
and/or Nrf2 signaling mechanisms and ultimately protect against environmentally-
induced stress and disease.    
 
5.1.3 A diet high in green tea polyphenols modulates the toxicity of PCB 126 
 Nutrients found within fruits and vegetables are gaining much attention for their 
possible anti-inflammatory and cardioprotective effects. Our laboratory has focused 
primarily on flavonoids and polyphenols and their protective effects related to PCB-
induced endothelial cell dysfunction.  Recently we determined, in our porcine endothelial 
cell model, that pretreatment with a flavonoid found within green tea, epigallocatechin 
gallate (EGCG), limited PCB-induced upregualtion of MCP-1 and VCAM-1.  This 
protection may have been due to an increase in Nrf2 controlled antioxidant genes in the 
cells pretreated with the bioactive nutrient73b.  In work described within chapter three of 
this dissertation we attempted to further substantiate this previous study by 
supplementing mice with a diet high in green tea catechins and subsequently treating 
with low level does of coplanar PCB.   
   Green tea supplementation in the diet had interesting effects on PCB toxicity 
and overall was anti-inflammatory when in the presence of PCB.  We originally 
hypothesized, based off of previous cell culture work, that supplementation with green 
tea catechins would increase Nrf2 activation, decrease AhR signaling, and ultimately act 
as an anti-inflammatory agent in both vehicle and PCB-treated groups.  Interestingly, we 
saw barely any green tea-induced upregulation of Nrf2-controlled genes in the 
associated DMSO group, but saw drastic and consistent responses in mice fed a green 
tea supplemented diet and subsequently exposed to PCBs.  Concerning AhR, green tea 
supplementation did not decrease basal levels of AhR or AhR targets such as Cyp1A1 
and Cyp1B1, but interestingly caused an increase in these three targets in mice 
supplemented with green tea and subsequently exposed to PCB.  Ultimately however, 
we determined that the unexpected upregulation of both AhR and Nrf2 in the 
concomitant group resulted in a significant decrease in in vivo oxidative stress markers 
and a downregulation of pro-inflammatory mediators.  Our current working hypothesis is 
that the green tea extract worked as a hormetic and ultimately primed the mouse’s 
antioxidant and xenobiotic defenses prior to the subsequent PCB exposure.  Thus, once 
a secondary stressor was encountered, a set of more efficient and effective anti-
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inflammatory events occurred.  AhR upregulation can lead to increased metabolism and 
excretion of xenobiotics and this was examined partially in this study.  Unfortunately, 
feces and urine were not collected and only plasma levels of PCB 126 and PCB126-OH 
metabolites were examined.  We believe that certain nutrients can increase the excretion 
of toxicants ultimately decreasing the body burden and decreasing the potential toxicity 
of lipid soluble pollutants.  Proof of principle studies have investigated this hypothesis 
and the exciting results garner further future investigation129a, 133a.  Although the mice 
were supplemented with an extract of green polyphenols, more than likely the individual 
catechins were quickly metabolized to multiple breakdown products.  An emerging field 
of nutrition now is interested in determining the kinetics of formation and 
pharmacological effects (either positive or negative) of nutrient metabolites.  It is 
unknown if the interaction between PCBs and green tea diet altered the cellular pool of 
catechins or catechin metabolites, but this would be an interesting future study that may 
help mechanistically explain protection observed only in the concomitant group.  In 
chapter four of this dissertation, this emerging area of nutrition research was examined 
by comparing the detrimental and protective effects of parent versus an endogenous 
metabolite using an omega-6 fatty acid as a model.    
 
5.1.4 Parent linoleic acid exacerbates PCB-induced endothelial cell dysfunction whereas 
treatment with the endogenously formed metabolite, nitro-linoleic acid, is anti-
inflammatory. 
 The endogenous metabolism of nutrients can lead to toxic and/or protective 
bioactive mediators.  Many inexpensive plant derived oils are rich in linoleic acid, which 
makes this fatty acid a predominate component in Western diets.  Reducing the intake of 
this nutrient has been shown to be protective against multiple proinflammatory 
diseases203.  Linoleic acid can be broken down by multiple metabolic enzymes including 
cytochrome P450s leading to toxic metabolites such as leukotoxin (LTX) 205.  However, 
emerging evidence now shows that linoleic acid can be metabolized into protective anti-
inflammatory mediators such as the recently identified nitro-linoleic acid.  Nitro-fatty 
acids can activate Nrf2 and inhibit pro-inflammatory NFκB, and in mouse models of 
disease, have been shown to prevent atherosclerosis, sepsis, and vascular injury144c, 144d, 
147a, 208a.  Understanding the cellular control mechanisms governing the formation of 
either protective or detrimental metabolites is important, but more work is needed so that 
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these pathways can be effectively manipulated.  Western diets are high in linoleic acid 
but can also include other pro-inflammatory compounds that result in exacerbated toxic 
effects. 
 Environmental pollutants such as lipophilic polychlorinated biphenyls enter the 
body primarily through ingestion and can be stored for long durations in adipose tissues.  
Endothelial cells are prime candidates to study the interactions between pollutants and 
nutrients because this cell type routinely comes in to contact with a myriad of 
compounds via the circulation.  Our laboratory previously reported that endothelial cells 
pretreated with an omega-6 fatty acid were at greater risk for PCB-induced 
complications including exacerbated oxidative stress and decreased endothelial cell 
barrier function109.  Also, it was determined in a more recent study that pretreatment with 
linoleic acid exacerbated tumor necrosis factor alpha (TNF-alpha) induced oxidative 
stress and endothelial cell dysfunction213.  Interestingly, caveolae and Cav-1 may be 
upregulated both by linoleic acid and coplanar PCBs, and silencing of Cav-1 has been 
shown in our laboratory to prevent linoleic acid as well as PCB-induced endothelial cell 
activation23b, 214.  A recent publication implicated nitro-fatty acids as possible 
downregulators of Cav-1, so we investigated the hypothesis that pretreatment with nitro-
linoleic acid could prevent PCB-induced endothelial cell toxicity.  In our current study we 
again determined that linoleic acid was pro-inflammatory, when treated alone, as 
evidenced by increases in expression levels of MCP-1 and VCAM-1.  The levels of these 
pro-inflammatory mediators were significantly exacerbated once PCB added.  On the 
contrary, treatment with nitro-linoleic acid was anti-inflammatory and did not result in an 
exacerbated PCB response.  Importantly, the low concentrations of PCB utilized within 
this study mirror blood levels found in humans, and since linoleic acid is found also at 
high levels in humans, interactive exacerbatory effects may be physiologically common.        
 
5.2 Future directions and conclusions 
 The interplay between nutrition and toxicology is a growing field of discovery 
worthy of intense investigation.  Data described within this dissertation and elsewhere 
now implicate either a protective or detrimental modulatory role of nutrients on the 
toxicity of environmentally relevant pollutants.  Numerous synthetic chemicals exist that 
may exert stress on physiological systems, and countless more emerging pollutants will 
be introduced into the environment as a growing number of countries become ever more 
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industrialized.  Toxicologists have long studied the detrimental effects of individual 
compounds, and their perseverance has helped to impact change at the highest levels of 
industry and government.  However, as body burdens of complex mixtures increase and 
the production of potential dangerous compounds overtakes the capacity for in-depth 
toxicity testing, it is important to identify sensible means of biomedically reducing the 
risks of environmental pollutant-induced diseases.     
 There is strong evidence that diets rich in bioactive lipids and plant-derived 
polyphenols protect against cardiovascular diseases generally215. This may be due in 
part to a significant improvement in endothelial function and a decrease in inflammatory 
cytokines216. Polyphenols (e.g., flavonoids and other bioactive compounds) are found in 
fruits and vegetables217 and share antioxidant and anti-inflammatory properties218. The 
health effects of polyphenols depend on the amount consumed and on their 
bioavailability217, 219. Little is known about the effects of bioactive lipids and other 
antioxidant and anti-inflammatory plant-derived nutrients (e.g., polyphenols) on 
environmental contaminant-induced cytotoxicity. Potential protective mechanisms of 
nutrients may involve modification of AhR and CYP1A1 expression and activation200, 220. 
Our own data suggest that protective effects of bioactive fatty acids and flavonoids are 
initiated upstream from Cyp1A1 and that these nutrients may be of value for inhibiting 
the toxic effects of PCBs on vascular endothelial cells 97, 221.  
We hypothesize that bioactive compounds common in fruits and vegetables protect 
the vascular endothelium against toxic insults by induction of Nrf2 signaling and 
subsequent upregulation of detoxifying or antioxidant enzymes.  We have generated 
evidence indicating that the complex interplay between toxicant exposure and nutritional 
profile is integral to the development of new multi-faceted, thus more precise, risk 
assessment models that accomplish a more comprehensive set of perspectives on true 
risk to an at-risk population. Traditional risk assessment is limited to studying the harmful 
effects to human health/ecological systems resulting solely from exposure to an 
environmental stressor. However, multiple stressors, chemical and non-chemical in 
origin, likely contribute to the overall disease risk that is related to exposure to a toxicant 
or mixture of pollutants. To better qualify cumulative risk in an individual or a population, 
non-chemical stressors, including psychosocial, physical, and/or dietary components 
need to be considered. We propose a paradigm shift whereby nutritional status or 
dietary health is a critical player in the overall vulnerability to environmental  
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stressors, and thus nutrition must be considered in overall risk assessment222. A body of 
evidence suggests that healthful nutrition offers a viable modulator that could markedly 
buffer the body against toxic chemical insult from persistent chlorinated organics.    
 Multiple future directions can be examined related to the work described within 
this dissertation.  First off, our laboratory has long investigated the role endothelial cell 
caveolae play in PCB-induced endothelial cell dysfunction.  Endothelial cell dysfunction 
is just one important component of the initiation of atherosclerosis, and impacts of 
immunological cells such as macrophages may also play a critical role.  Interestingly, 
Cav-1 appears to be critical for the differentiation of monocytes into macrophages and 
Cav-1 is increased once monocytes adhere to the endothelium223.  Therefore in the 
future we could examine the impact of downregulating Cav-1 in macrophages and the 
impact on PCB-induced vascular toxicity.  It would be interesting to observe similar Cav-
1 Nrf2 crosstalk in macrophages and other vascular related cell types.   
 Another future direction for the laboratory will be to continue to better identify and 
mirror true human exposures to environmental pollutants.  Throughout this dissertation 
we have utilized a single PCB congener, PCB 126, as a model toxicant.  Since human  
exposures to a single PCB congener rarely occur, we could study primarily PCB 126 and 
a simple mixture consiting of a coplanar (126), noncoplanar (153) and mixed congener 
(118) PCBs, all of which are detectable in human serum at significant levels224; 46. 
Concentrations of the individual congeners to be used in these studies would reflect 
levels found in human plasma225.  Our laboratory has long been priviledged to be part of 
the NIEHS-funded Superfund Research Program, and this funding has allowed for us to 
create strong collaborations with analytical instrumentation experts that can help identify 
concentrations of a wide variety of environmental pollutants within plasma and tissues of 
people.  Also, these collaborations have helped our nutritional modulation studies by 
identifying levels of bioactive mediators within our samples.  We plan to identify 
biomarkers which can predict successful nutritional interventions against environmental 
pollutants and associated diseases.  Personally, I have worked with the Superfund 
Research Support Core to identify levels of nitro-fatty acids in human and mouse 
plasma, and hopefully these preliminary studies can lead to future directions for our 
laboratory  (see Appendix A).  It would be extremely interesting to identfiy correlations 
between nutrition, toxicant body burden, and predisposition to cardiovascular disease in 
populations residing near hazardous waste sites.      
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In conclusion, we were able to demonstrate that PCB 126 induces endothelial 
cell dysfunction in a Cav-1 mediated mechanism.  Downregulating Cav-1 was shown to 
upregulate the protective Nrf2 pathway which helped to block PCB-induced endothelial 
cell toxicity.  We have shown that dietary nutrients can modulate the toxicity of PCBs 
through Cav-1 and/or Nrf2 pathways, and nutritional modulation may be an effective 
means of preventing toxicant-associated diseases.  Within this dissertation, we 
demonstrated that a flavonoid-rich diet could decrease oxidative stress and inflammation 
when in the presence of PCB.  Additionally, we also showed that certain pro-
inflammatory nutrients could exacerbate PCB-induced endothelial cell toxicity whereas a 
bioactive nutrient metabolite was anti-inflammatory.  Together, these data support the 
paradigm that nutritional modulation may be a sensible means of reducing disease risks 
associated with exposure to environmental pollutants.         
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Appendices 
Appendix A.   Novel analytical methodologies to study anti-inflammatory nitro-
fatty acids 
 
A.1 Synopsis 
It is widely hypothesized that the possible beneficial health effects of certain 
polyunsaturated fatty acids involves their enzymatic or non-enzymatic conversion to 
biologically active metabolites.  Accordingly, definitive identification and quantitation of 
bioactive fatty acid derivatives is essential for both evaluating the beneficial effects of 
these nutrients and identifying biological markers to monitor the therapeutic efficacy of 
fatty acid administration in clinical or preclinical settings. Nitro-fatty acids are a class of 
fatty acid metabolites that are formed by chemical nitration of the double bonds of 
unsaturated fatty acids, and in mouse models, nitro-fatty acids decrease systemic 
oxidative stress and inflammation suggesting that these could be biologically relevant 
mediators.  However, in large part due to inherent limitations of currently used analytical 
approaches for the detection and quantitation of free and esterified nitro-fatty acids, 
many questions remain to be elucidated regarding their abundance endogenous 
metabolism and biological actions.  In this study we developed a sensitive and specific 
method for detection and quantitation of nitro fatty acids by combining chemical 
derivatization with electrospray ionization high resolution tandem mass spectrometry. 
This method involves formation of methyl pyridinium derivatives of nitro-fatty acids which 
ionize very strongly in positive mode resulting in increased sensitivity of more than 500-
fold over underivatized fatty acids monitored in negative ionization mode. These 
derivatives were analyzed by HPLC electrospray ionization tandem mass spectrometry 
using an AB Sciex 5600 quadrupole TOF MS.  Together, these methods allow us to 
identify the ions of the parent nitro-fatty acid derivative at high resolution and confirm 
their identities by high resolution analysis of their product ion spectra.  To validate these 
methods, we demonstrate detection and quantitation of nitro oleate in plasma following 
intraperitoneal administration to mice.  In conclusion, we have developed and validated 
novel analytical methodologies to study anti-inflammatory nitro-fatty acids which may 
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aide in advancing research of nitro-fatty acids as a therapeutic agent against 
inflammation and atherosclerosis. 
 
A.2 Introduction 
Nitro-fatty acids are a relatively newly discovered class of modified lipids that exhibit 
anti-inflammatory properties via multiple mechanisms.  Unsubstituted fatty acids such as 
oleic acid (18:1) and arachidonic acid (20:4) can be nitrated endogenously by multiple 
enzymatic and non-enzymatic reactions such as peroxynitrite mediated events145.  The 
addition of NO2 moieties to unsaturated fatty acids has been shown to result in 
generation of strongly anti-inflammatory mediators as evidenced by their ability to inhibit 
production of pro-inflammatory mediators, to induce expression of protective heme 
oxygenase-1 and to promote relaxation of blood vessels146.  Most notably, 
atherosclerosis prone ApoE mice administered nitro-oleic acid were protected from 
tissue oxidation, foam cell formation, and overall inflammation144d.  Mechanistically, this 
class of bioactive lipid can protect via multiple mechanisms including upregulation of 
PPARγ and Nrf2 as well as downregulation of pro-inflammatory NFκB147.  Importantly, 
recent evidence suggests that activation of these pathways exhibits specificity for the 
chain length and positional substitution of the nitro group147a.  Although a large body of 
evidence supports the paradigm that nitro-fatty acids are anti-inflammatory and 
protective, many unresolved and controversial issues remain.  
 Integrally important to the progress and advancement of nitro-fatty acid research 
is the ability to sensitively and accurately measure these species in plasma and tissues.  
Even though nitro-fatty acids have been studied for over a decade, there still is no 
universally agreed upon method to extract, identify, and quantitate these species.  Due 
to technological limitations explained in more detail below, relatively basic problems, 
such as the identification and quantification of free nitro-fatty acid levels in plasma, 
remain unresolved.  For example, depending on what extraction and analysis techniques 
were utilized, published baseline levels of nitro-oleic acid have ranged from pM to nM 
concentrations, and no true consensus exists if the observed levels are skewed by 
artifacts created during sample preparation226.   
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Current analytical limitations concerning nitro-fatty acid detection 
To date, published measurements of nitro-fatty acids have used electrospray 
ionization tandem mass spectrometry using triple quadrupole instruments operated in 
selected ion monitoring mode.  A common problem with this approach for free fatty acids 
is that these species only ionize in negative mode which can result in skewed data due 
to the acidic conditions necessary for reverse phase chromatography.  Nitro-fatty acids 
do ionize in negative mode but the diagnostic nitrite product ion formed is not truly 
conclusive of the parent nitro-fatty acid species.  An additional issue is that because of 
the chemical diversity of fatty acids in biological samples, theoretically, these could 
contain multiple nitro-fatty acid species (or their isotopomers) at every mass unit which 
traditional quadrupole instruments could misconstrue.  Although some of the published 
work in this field likely provides convincing evidence for the presence of particular nitro-
fatty acids in biological samples, these described concerns probably account for much of 
the uncertainty and confusion in the field regarding the spectrum and absolute levels of 
nitro-fatty acids present in biological samples.  To address these issues we adapted a 
chemical derivatization approach used in conjunction with high resolution tandem mass 
spectrometry using a quadrupole time of flight (TOF) instrument to provide a sensitive 
and specific way to profile and quantitate nitro-fatty acids.   
As explained above, a second concern is that nitro-fatty acid parent ions may not 
be selected specifically at the resolution of quadrupole mass analyzers.  To circumvent 
this problem we next developed methods for analysis of methyl pyridinium derivatives of 
nitro-fatty acids using our AB Sciex 5600 quadrupole TOF mass spectrometer.  In brief, 
these methods allow us to identify the ions of the parent nitro-fatty acid derivative at high 
resolution and confirm their identities by other state of the art LC/MS/MS techniques 
such as mass defect and isotopomer ratio pattern analyses.  Further identification of 
these species is then accomplished by generating high resolution product ion spectra 
which can help to confirm the presence of the nitronium ion that is diagnostic of nitro-
fatty acids. 
Nitro-fatty acids are anti-inflammatory and anti-atherosclerotic lipid species that 
hold much clinical promise, however, due to technological limitations, multiple 
controversial issues remain unsolved.  This proposed study will (1) validate an effective, 
specific and sensitive nitro-fatty acid extraction procedure; (2) use chemical 
derivatization HR electrospray ionization tandem mass spectrometry and stable isotope 
dilution to profile and quantitate nitro-fatty acids in biological samples.  
   
109 
 
 
 
 
A.3 Materials and methods: 
 
A.3.1 Animal handling and use 
Animal procedures were conducted under the approval of the University Committee on 
Use and Care of Animals at the University of Kentucky and conform to the Guide for the 
Care and Use of Laboratory Animals, US National Institutes of Health.  The animals 
used in this study, C57BL/6J mice, were obtained from the Jackson Laboratory.  Mice 
were injected with 2 nanomoles/gram mouse of 10-nitro-oleate for 10 minutes or vehicle 
and plasma was collected via cardiac puncture. 
 
A.3.2 Mass spectrometric analysis of nitro-oleate 
Quantification of Nitro-oleate in plasma was conducted by high-performance liquid 
chromatography electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) 
using an ABSciex 5600 “Triple TOF” hybrid quadrupole time of flight mass spectrometer. 
9 and 10-nitro-octadecenoic acid was purchased from Cayman Chemical.  Quantification 
of nitro-oleate in plasma was determined by calibration curve of infused nitro-oleate 
standard and extraction recovery was normalized to C17 fatty acid internal standard.    
Plasma (20 μl) were extracted with 80 μl of cold acetonitrile in the presence of C17 fatty 
acid internal standard (1µM). Samples were vortexed, centrifuged at 14000g 4ºC, for 10 
min and supernatant transferred directly into vials to be analyzed by HPLC-MSMS. Nitro 
FA were measured either in the negative mode or as methyl pyridinium derivatives in 
positive mode.  Samples were derivatized with 2-bromo-1-methylpyridinium iodide 
(BMP) and 3-carbinol-1-methylpyridinium iodide (CMP), forming 3-acyloxymethyl-1-
methylpyridinium iodide (AMMP).  Samples were dried, reconstituted in 99/1 
methanol/water containing 0.1% ammonium formate and 0.5% formic acid, and analyzed 
using the ABSciex 5600 instrument.  Underivatized Nitro-fatty acids in negative mode 
were resolved using a Agilent Eclipse XDB C8 column, 5 µM, 4.6 X 150 mm with  water 
+ 0.05% formic acid as solvent A and / 95/5- acetonitrile/ water+ 0.05% formic as solvent 
B.   AMMP derivatized nitro-FAs were resolved using a 75/25 of methanol/ water with 
formic acid (0.5%) and 5 mM ammonium formate (0.1%) (A) & 99/1of methanol/ water 
with formic acid (0.5%) and 5 mM ammonium formate (0.1%) (B) solvent system.   
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HR product ion spectrum of (Nitrooleate, m/z 326.233 M-H-) in the negative mode 
resulted in product ions of 45.998 and 170.155, which are representative of nitro-oleate.  
HR MRM scans of 433.2 (AMMP-Nitrooleate) in the positive mode resulted in product 
ions of m/z 107.07, 122.06, and 386.31 which are derived from AMMP-nitro-oleate. 
 
A.3.3 Acidic chloroform lipid extraction 
Ice cold MeOH was added to chloroform and 0.1M HCl.  50 µL of plasma was added 
to each sample vial along with 50 µL of 1 µM internal standard.  Too separate phases, 
CHCl3 and 1.3 ml 0.1M HCl were added.  The lower phase was transferred to 4ml screw 
cap vial using a pasteur pipette.  This was volume was evaporate to dryness under N2 
using N-evap in fume hood and subsequently suspended in 100 µL methanol or 
derivatized as described above. 
 
 
A.4 Results 
A.4.1 Nitro-oleic acid identification in positive mode is more efficient due to chemical 
derivatization. 
 We developed methods for detection and quantitation of nitro-oleic and other 
nitro-fatty acids using both negative and positive analysis modes using HPLC 
electrospray ionization tandem high resolution mass spectroscopy.  Fragmentation of 
nitro-oleic acid resulted in ions representing loss of NO2 (45.99), parent nitro-oleic acid 
(326.23), and others (Fig. A.1). For positive mode analysis, fatty acids were extracted 
from plasma and subsequently chemically derivatized to methylpyridinium derivatives.  
Fragmentation of AMMP-nitro-oleic acid resulted in a TOF product ion scan illustrating 
ions representing AMMP-nitro-oleic minus loss of NO2 (386.31), parent AMMP-nitro-oleic 
acid (433.31), and others (Fig. A.2). The use of derivatization and positive ion mode 
resulted in approximately a 500 fold enhancement of sensitivity compared to negative 
mode analysis. 
A.4.2 Confirmation of analytical methods using mice exogenously administered nitro-
oleic acid. 
To test our analytical methodologies in an in vivo system, mice were injected with 
2 nanomoles/gram mouse nitro-oleic acid and were sacrificed 10 minutes after injection.  
Blood plasma was collected at this early time point due to nitro-fatty acids’ propensity to 
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adduct to nucleophilic proteins and endogenous glutathione.  Nitro-oleic acid was 
identified both in negative and positive mode (A.4, 5).  We were able to detect increases 
in nitro-oleic acid in mouse plasma following intra peritoneal administration of a single 
dose (Fig. A.6). 
A.4.3 Comparison of two fatty acid extraction procedures 
 To identify possible alternative extraction procedures that may be more efficient 
than the acetonitrile extraction commonly used, a secondary extraction procedure was 
attempted.  Use of the acidified chloroform extraction resulted in approximately a 4 fold 
increase in observable nitro-oleic acid from mouse plasma (Fig. A.7).  It is unknown 
however if the chloroform extraction is more efficient, or produces additional artifact 
nitro-oleic acid due to the acidified nature of the procedure.  
A.5 Discussion    
Unsaturated fatty acids and notably certain polyunsaturated fatty acids exhibit 
beneficial effects in clinical settings and experimental models of cardiovascular and 
metabolic disease, in part through mechanisms that involve attenuation of oxidative 
stress and inflammation.  It is widely hypothesized that these effects involve enzymatic 
or non-enzymatic conversion of unsaturated fatty acids to biologically active metabolites.  
Inconsistencies and/or inter individual variation in formation of these active metabolites 
may account for variable observations that have plagued this field.  Accordingly, 
definitive identification and quantitation of bioactive fatty acid derivatives is essential for 
both evaluating the beneficial effects of these nutrients and identifying biological markers 
to monitor the therapeutic efficacy of fatty acid administration.  Nitro-fatty acids are a 
class of fatty acid metabolites that are formed by chemical nitration of the double bonds 
of unsaturated fatty acids.  Several laboratories have shown that nitro-derivatives of 
some unsaturated fatty acids can decrease inflammation by down regulation of pro-
inflammatory mediators such as NFκB and by activating the antioxidant master controller 
Nrf2.  In mouse models, exogenously supplied nitro-fatty acids decrease systemic 
oxidative stress and inflammation suggesting that these could be biologically relevant 
mediators.   However, the role of endogenously generated nitro-fatty acids as protective 
mediators of the actions of dietary unsaturated fatty acids is less clear, in large part due 
to inherent limitations of currently used analytical approaches for the detection and 
quantitation of free and esterified nitro-fatty acids.  To address these issues we have 
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developed sensitive, quantitative, and specific methods for analysis of nitro-fatty acids 
using chemical derivatization and high resolution (HR) tandem mass spectrometry.  With 
these methods in hand we are now in a position to investigate nitro-fatty acid metabolism 
in vivo and evaluate the relationship of nitro-fatty acid formation, vascular inflammation, 
and toxicant modulation.   
 The capability to identify and quantitate these and other bioactive lipid species 
opens up many possible future directions.  We have begun to profile levels of nitro-fatty 
acids in humans and hope to identify previously un-discovered metabolites including 
nitro-DHA and nitro-EPA fatty acids.  PUFAs are known to form multiple anti-
inflammatroy bioactive metabolites such as E and D-series resolvins, and the formation 
of nitro-EPA or nitro-DHA may also be beneficial127.  It will also be interesting to gain a 
better understanding of the endogenous control mechanisms of nitro-fatty acid 
formation.  One possible mechanism could be the upregulation eNOS or related NOS 
enzymes.   
 Endothelial NOS activation is known to increase cellular nitric oxide levels and is 
integral to proper cardiovascular function.  Normally inhibited by the caveolae associated 
protein Caveolin-1 (Cav-1), eNOS activation can lead to improved blood pressure and 
decreased atherosclerotic risk.  Endothelial nitric oxide synthase generates nitric oxide 
which is a key player in vasodilation, thrombosis and cell growth, and decreased 
activation of eNOS can contribute to hypertension and atherosclerosis 227.  Normally 
inhibited within caveolae by Cav-1, eNOS can be activated by multiple signaling 
cascades and molecules such as PI3 kinase, calcium, HDL and estrogen227.  Activation 
of eNOS leads to a conversion of L-arginine to L-citrulline which results in the formation 
of diffusible nitric oxide.  If nitric oxide interacts with cellular reactive oxygen species, 
then nitro-fatty acids are likely to be formed144b.  Activation of eNOS leads to a greater 
abundance of nitric oxide and may increase the probability that unsaturated fatty acids 
become nitrated.  Not surprisingly, mice lacking inhibitory Cav-1 exhibit increased eNOS 
activation, higher levels of nitric oxide, and protection from inflammation and 
atherosclerosis. Endothelial nitric oxide synthase can be activated during inflammatory 
responses which may lead to higher levels of anti-inflammatory nitro-fatty acids.  A 
biological system may utilize nitro-fatty acid formation as a mechanism to keep harmful 
inflammation in-check.  It would be interesting to examine the levels of nitro-fatty 
acids before and after exposure to environmental pollutants or other stressors, 
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and also determine if upregulation of eNOS or related enzymes prior to the 
exposure would be protective.  Interestingly, multiple lifestyle modifications such 
as exercise228 or nutritional modulation have been shown to alter eNOS signaling 
which may be prime candidates to increase the levels of nitrated fatty acid 
species.     
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Figure A.1. HR-LC/MS/MS analysis of nitro-oleic acid. A. Extracted ion chromatogram 
showing the ability to detect nitro-oleic acid by infusing standards. B. Fragmentation 
pattern of 9 nitro-oleic acid. C. TOF Product ion spectra of nitro-oleic acid. Stars 
delineate observed ions corresponding to identified fragment ions.  
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Figure A.2. HR-LC/MS/MS analysis of AMMP-derivatized- 9 nitro-oleic acid. A. 
Extracted ion chromatogram showing the ability to quantitate AMMP-nitro-oleic acid. B. 
Fragmentation pattern of AMMP-9 nitro-oleic acid. C. TOF Product ion spectra of 
AMMP-nitro-oleic acid. Stars delineate observed ions corresponding to identified 
fragment ions.  
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Figure A.3.  Quantitation of nitro-oleate using high resolution methodologies.  A.  
Concentration curve for nitro-oleate standard. B.  Concentration curve for AMMP-
nitro-oleate.  C.  Concentration curve for AMMP-C17 fatty acid internal standard. 
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Figure A.4:.Methodologies confirmed using mice exogenously injected with nitro-
oleate (negative mode) A: HR-LC/MS/MS analysis of nitro-oleic acid in negative 
ionization mode from plasma obtained from mice injected for 10 minutes post 
administration of 10-Nitro-oleate.  No nitro-oleate was observed in vehicle treated 
mice.    
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Figure A.5. Methodologies confirmed using mice exogenously injected with nitro-
oleate (positive mode)   HR-LC/MS/MS analysis of AMMP-10-nitro-oleic acid in 
positive ionization mode from plasma from mice injected for 10 minutes with 10-Nitro-
Oleate.  AMMP-10-nitro-oleic acid was observed in both control and exogenously 
administered mice, but to a higher degree in mice injected for 10 minutes with nitro-
oleate.  
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Figure A.6. Concentration of nitro-oleate in mice exogenously administered nitro-oleate.  
Mice were I.P. injected with 2 nano mole per gram of mouse and sacrificed 10 minutes 
post injection.  Plasma concentrations were determined using AMMP-derivatization 
technique and positive mode high resolution analysis.    
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Figure A.7. Comparison of nitro-fatty acid extraction procedures.  A. Standard curve of 
AMMP-nitro oleic acid used for quantitation.  B. Two extraction procedures were 
compared (see materials and methods) and the acidic chloroform extraction resulted in 
~4 fold increase in observable nitro oleic acid in plasma.  
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Appendix B. Lab protocols 
 
1. mRNA related protocols: 
 
 Trizol Harvest 
 
 Warm up Trizol reagent in water bath for about 20-30 minutes prior to harvest 
 For 6 well plates (in vitro experiments) 
o Wash each well once with 1 mL cold PBS and aspirate 
o Add 600 µL Trizol to each well and scrape with reusable cell scraper 
o For each well, pipet up and down 7 times to homogenize liquid and 
transfer to new autoclaved 1.7 mL Eppendorf tube.    
o Place in -80 freezer overnight. 
 For mouse tissues (e.g., liver and hearts) 
o Harvest tissues and place in RNA Later solution (enough solution to cover 
tissue) 
o Place in 4 degree fridge for short term (few days) or -20 freezer for longer 
o In 2 mL colored tubes (round bottomed) add 1 mL Trizol reagent, 50-100  
mg tissue of interest, and 2 autoclaved homogenizer balls (ball bearings). 
o Use the Cassis lab’s homogenizer per their instructions for your tissue of 
interest. 
o Remove ball bearings with “super magnet” and freeze tubes at -80 
overnight. 
mRNA isolation: 
 For 6 well plates (in vitro experiments) 
o Let tubes thaw at room temperature in hood. 
o Add 120 µL Chloroform to each tube and calmly shake for 15 seconds.  
Incubate at room temperature for 5 minutes 
o Centrifuge tubes at 12,000 X g for 15 minutes at 4 degrees.  Upon 
completion you should see distinct phase separation. 
o Using a p200 pipet, carefully collect the clear phase without disrupting 
the cloudy or red phases (I pipet 150 µL twice in to a new tube). 
o Add 300 µL of isopropyl alcohol to each tube and invert each tube just 
twice to mix. 
o Centrifuge at 12,000 x g for 10 minutes at 4 degrees.  Hopefully you can 
see a pellet. 
o Remove the supernatant by decanting and then place each tube inverted 
on kim wipe to remove excess isopropyl alcohol 
o Wash the pellet with 600 µL of 75% ethanol solution (made up with 
rnase/dnase free water).  Vortex briefly. 
o Centrifuge at 7,500 x g at 4 degrees for only 5 minutes.  
o Decant the ethanol and then place each tube inverted on Kim wipe to 
remove excess.  Cap tubes and do a quick spin to collect all remaining 
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liquid.  Using small pipet, carefully remove all remaining liquid without 
sucking up pellet.  Dry pellet for 5 minutes. 
o Add 12 µL of dnase/rnase free water and pipet up and down 3 times to 
dissolve pellet.   
o Quantify RNA concentration using the nanodrop down the hall. 
 For mouse tissues 
o Let tubes thaw at room temperature in hood. 
o To remove tissues, centrifuge at 12,000 x g for 10 minutes at 4 degrees.  
Pipet supernatant to new tube. 
o Add 200 µL Chloroform to each tube and calmly shake for 15 seconds.  
Incubate at room temperature for 5 minutes 
o Centrifuge tubes at 12,000 X g for 15 minutes at 4 degrees.  Upon 
completion you should see distinct phase separation. 
o Using a p200 pipet, carefully collect the clear phase without disrupting 
the cloudy or red phases (I pipet 210 µL multiple times in to a new tube). 
o Add 500 µL of isopropyl alcohol to each tube and invert each tube just 
twice to mix. 
o Centrifuge at 12,000 x g for 10 minutes at 4 degrees.  Hopefully you can 
see a pellet. 
o Remove the supernatant by decanting and then place each tube inverted 
on kim wipe to remove excess isopropyl alcohol 
o Wash the pellet with 1 mL of 75% ethanol solution (made up with 
rnase/dnase free water).  Vortex briefly. 
o Centrifuge at 7,500 x g at 4 degrees for only 5 minutes.  
o Decant the ethanol and then place each tube inverted on Kim wipe to 
remove excess.  Cap tubes and do a quick spin to collect all remaining 
liquid.  Using small pipet, carefully remove all remaining liquid without 
sucking up pellet.  Dry pellet for 5 minutes. 
o Add 50-250 µL of dnase/rnase free water depending on the size of pellet 
and pipet up and down 3 times to dissolve pellet.  If not sure always be 
conservative and then check via Spec.  Can always dilute more in front of 
the nanodrop.   
o Quantify RNA concentration using the nanodrop down the hall. 
 
Reverse Transcription protocol: AMV reverse transcription system (Promega) 
 Make 1-2 µg cDNA per sample depending on your spec values. 
o Use “Spec spreadsheet” to determine how much mRNA and water is 
needed to have 2 ug in 9.9 µL total volume.  Spin down using small 
table top centrifuge. 
o Place PCR tubes in thermo cycler and run “LEI/HEAT” program (~10 
minutes). 
o Make Master Mix for all samples in 1.7 mL Eppendorf.  If you have 20 
samples, make the mix for 22 or 23 samples.  See below.  All values 
are micro liters 
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   x40 
MgCl2  4 160
RT 10x buffer 2 80
dNTP  2 80
RNAsin  0.5 20
Random Primers 1 40
AMV 
RT  0.6 24
Total  10.1 404
  
o Add 10.1 µL of Master Mix to each tube containing mRNA and spin 
with small centrifuge.   
o Place tubes in thermo cycler and run “LEI/RT” (~90 minutes). 
o When finished, dilute 1:10 with dnase/rnase water. 
 
Real Time PCR 
 
*Every plate contains 96 wells.  You must always run a control such as Actin or GAPDH 
on EVERY plate.  Run every sample with duplicates or triplicates.   
Set up plate as shown in template. 
 Add 2 µl of cDNA per well.   
 Make a master mix for each gene of interest (e.g., actin gets one tube and 
AhR gets a second Eppendorf). 
o If you have 48 rxns.  Make master mix for 51 or 52: 
 10 µl of Cyber Green reagent 
 5.6 µl of dnase/rnase free water 
 1.2 µl Forward primer of interest 
 1.2 µl Reverse primer of interest 
o Seal tightly with plastic plate sealer and centrifuge for 5 minutes (800 
rpm). 
 
2. Isolation of mouse lung endothelial cells 
 DAY 1: 
Lung tissue isolation: 
 Use lung tissue from 2-3 mice per isolation 
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 Record the weight, #, genotype, and punch of each mouse 
 Anaesthetize mice using Isoflurane and euthanize by cervical dislocation 
 Sterilize skin with 70% ethanol and remove underlying tissues (the heart should be 
beating) 
 Locate and cut the right atrium flap at the base of the heart 
 Insert an 18 gauge needle (connected to a 50ml syringe filled with PBS) into the left 
ventricle and perfuse SLOWLY with (5ml of pre-warmed heparinized PBS with 
heparin to prevent clotting (3ml heparin/500ml PBS; prepared on same day) 
 If perfusion is done properly: 
o Perfused fluid should flow out of the right atrium 
o Liver color will change from dark red to light brown 
o Fast perfusion may cause damage to blood vessels and endothelial cells 
 Isolate lungs using forceps and immerse into pre-chilled 0.1% BSA/DMEM (High 
glucose) solution until ready for the next step (up to 6 hrs) 
 
Homogenization: 
 Mince tissue (using a blade) into 1.1-2mm pieces and place in a 50ml conical tube 
filled with pre-warmed culture media (prepared on the same day) containing 
o DMEM (45ml) 
o 1% fatty acid free BSA (5ml of 10% stock solution) 
o Type II Collagenase- 2.0mg/ml (100mg) 
o Dispase II- 4mg/ml (200mg) 
 Cap tubes tightly and wrap with parafilm; shake horizontally at 37°C for exactly 1hr 
at 225rpm 
 Filter the homogenized tissue through a stainless mesh into a pre-labeled 50ml 
conical tube  
 Centrifuge the filtered tissue at 37°C for 8min at 1000rpm 
  Discard the supernatant using suction and resuspend the pellet in 1ml of lung 
endothelial cell growth media (LECM) containing the following: 
o DMEM (387ml) 
o 20% FBS (100ml) 
o 100ug/ml heparin (3ml) 
o P/S antibiotics (10ml) 
 Aliquot LECM into pre-labeled 50ml conical tubes and store in the 4°C refrigerator 
 Thaw and add 1ml of Endothelial Cell Growth Supplement (ECGS stored in -80 
freezer) to each 50ml aliquot to prepare complete LECM prior to use (on the same 
day and up to 1wk)  
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Plating cells (P0): 
 Coat 35mm plates (preferably in 6 well plates) with 0.5% gelatin (prepared fresh and 
stored in 15ml aliquots in the 4°C refrigerator) and incubate under UV light for 1hr 
(on the same day) 
 Label the plate clearly with the date, generation (P0) and genotype for each well 
 Add 1ml of complete LECM to each well and pre-warm in the 37°C incubator  
 Resuspend each pellet in 1ml of complete LECM and transfer to the corresponding 
well in the 6-well plate (final volume of 2ml LECM/well) 
 Swirl gently to spread cells homogenously and incubate at 37°C, 5% CO2 overnight 
 
DAY 2: 
 
Washing cells: 
 Wash P0 plates 5 times with pre-warmed PBS to eliminate cellular debris 
 
DAY 3: 
 
Preparing antibody coated bead mix for bead selection:  
 Amounts of beads and antibody are scaled to one 35mm plate 
 Add 25ul of M450 sheep anti-rat IgG beads in a 1.5ml eppendorf tube 
 Wash the beads: 
o Add 1ml of PBS to the tube, and gently invert the tube 3 times to suspend the 
beads 
o Place the tube in the Dynacare magnet, gently invert the tube 3 times  
o After beads adhere to the wall of the tube, aspirate PBS using suction 
o Repeat the steps described above 3 times 
 Resuspend the beads with 1ml PBS, add 2.5ul of rat anti-mouse ICAM-2 or CD31 
PECAM antibody 
 Cap the tube tightly and incubate for 1hr/overnight on the nutator under UV light 
 Pull the ICAM-2 antibody bound beads using the magnet and wash 3 times with 1ml 
LECM 
 Resuspend the ICAM-2 antibody bound beads in 1ml of LECM and incubate at 37° 
until P0 plates are ready for bead selection 
 
First bead purification of endothelial cells (P1): 
 Wash P0 endothelial cells (in 35mm plates/wells) 3 times with pre-warmed PBS 
 Aspirate PBS and add 1ml of LECM 
 Add 1 ml of the antibody-bound beads suspended in LECM 
 Incubate the  plates at 37°C, 5% CO2 for 1hr, and gently shake every 15min 
 Wash plates with 2-3 times with PBS, add 1ml trypsin/35mm plate, and incubate at 
37°C, 5% CO2 for 5min or until cells are afloat 
 When cells are dissociated, add 0.5ml of LECM to stop trypsin reaction 
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 Transfer the contents of each 35mm plate to a pre-labeled 1.5ml eppendorf tubes 
and apply to the Dynal magnetic separator 
 Wash bead-bound endothelial cells 4-5 times with DMEM/0.1% FBS 
 Resuspend cells in ECGM and count the cells using the hemacytometer (described 
below) 
 Seed 2.0-4.0x105 cells in a final volume of 1ml ECGM/35mm plate 
 Shake gently to mix and incubate at 37°C, 5% CO2 overnight 
 Label plates with date, phenotype, Passage number (P1) 
 Change LECM every 2-3 days 
 
3.  Silencing protocol 
 
 Label 3, 15mL Falcon tubes  
o Cav-1, Ctl, Gene Silencer 
 
Tube X10
siRNA diluent 24 240
1 optimem 15 150
ctl siRNA 1 10
2 cav‐1 (2) 0.5 5
cav‐1 (5) 0.5 5
X20
3 Gene Silencer 5 100
Optimem 25 500  
 Add dilluent, Optimem, and appropriate siRNA to tubes 1 & 2 
o Mix by flicking tube ~15 times 
 Add Gene silencer and Optimem to tube 3 
o Mix by hand gently by slightly inverting tube. 
 INCUBATE ALL 3 TUBES FOR 5 MINUTES 
 Take half of volume in Gene Silencer tube (tube 3) and pipet directly into tube 1.  
Other half to tube 2. 
o Mix tube 1 & 2 gently by hand by slightly inverting tube 
 INCUBATE FOR 20 MINUTES 
o After 10 minutes prepare cells for transfection by washing twice with 
Optimem. 
 1 mL for 6 well plate & 0.5 mL for 12 well plate 
 After 15 minutes, dilute tubes 1 & 2 with Optimem up to total volume necessary 
for amount of wells (Use graduations on Falcon Tube). 
o For Example : 10mls total in each tube for 1, 6 well plate and 8 wells of a 
single 12 well plate 
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 Add 1 mL per well in 6 well plate, and 0.5 mL per well in 12 well. 
o DROP BY DROP using large serological pipet 
 After 4 hours add 20% FBS M199 without antibiotics 
 Incubate for 48 hours before continuing with experiments. 
 
 4. Acidic chloroform lipid extraction 
 Need 8 ml borosilicate glass tubes with Teflon cap 
 Add 2ml ice cold MeOH and add 1ml CHCl3  
 Add 450 µL 0.1M HCl to tube 
 Add 50 µL of plasma to each sample 
 Add 50 µL of 1 µM internal standard to each tube 
 Vortex for 5 minutes (works best if you have a multi tube vortexer) 
 Place on ice or at 4 degrees for at least 1 hour 
 Add 1 ml CHCl3 and 1.3 ml 0.1M HCl to separate phases 
 Vortex for 5 minutes 
 Centrifuge at >3,000 x g for 10 minutes 
 Transfer lower phase to 4ml screw cap vial using a pasteur pipette.  Take care to 
avoid the protein interface and upper phase.  Leave behind ~50 microliters if 
needed  (don’t worry about being more accurate than this- we have an internal 
standard to correct for recovery) 
 Evaporate to dryness under N2 using N-evap in fume hood 
 Resuspend in 100 µL methanol 
 Transfer to autosampler vial with glass or polypropylene insert for LC MS 
analysis 
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